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Abstract 
 
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder 
affecting almost 2% of people over 65 years of age. The primary neuropathological 
hallmark of PD is the degeneration of the nigrostriatal dopaminergic pathway which, by 
depleting dopamine in the brain, initiates abnormal motor symptoms including resting 
tremor, bradykinesia, postural instability, gait difficulty and rigidity. A second relevant 
hallmark is the presence of intracellular inclusion bodies, known as Lewy bodies that 
mainly contain aggregated α-synuclein.  
 While the etiology involved in the development of PD is unknown, 90-95% of PD 
cases occurs sporadically and correlates, in part, with mitochondrial dysfunction and 
oxidative stress. Furthermore, the identification of single genes associated to the familial 
forms of PD has revolutionized this field of research, providing unique opportunities to 
pursue novel mechanisms and clues to the pathogenesis of PD. The sustained study of 
the cellular functions of each PD-related gene indicates that protein misfolding and 
aggregation, as well as, dysfunction of their quality control systems may play a crucial 
role in the cascade of deleterious events implicated in the neurodegenerative process of 
PD. Thus, clear insights into how mitochondrial dysfunction, oxidative stress and protein 
homeostasis systems interconnect, overlap or converge to produce nigral neuronal 
degeneration is essential to understand the pathogenesis of sporadic PD (sPD). 
 In this thesis, we initially addressed the potential implications of an altered 
structural and functional crosstalk between mitochondria and the endoplasmic reticulum 
(ER), two important metabolic organelles for the maintenance of cellular protein 
homeostasis. We reported that mitochondrial dysfunction induced by an acute stimulus 
of the neurotoxin MPP+ renders cells more susceptible to develop an ER stress 
response. We found that MPP+ was able to evoke a sustained flux of Ca2+ from the ER to 
mitochondria which subsequently triggered ER- and mitochondria-dependent apoptotic 
pathways. Our findings highlight the inevitable role of ER to mitochondria Ca2+ fluxes and 
their requirement for a mitochondria-dependent cell death induction, enclosing a 
feedback loop whereas mitochondria signals ER and ER induces further mitochondrial 
alterations, leading to the activation of cascade of signals that culminates in apoptotic 
cell death. 
 Furthermore, we also found that ER stress response strengthens mitochondrial 
stress-induced abnormalities. We demonstrated that sustained ER stress caused by 
accumulation of unfolded or misfolded proteins potentiated Ca2+ overload and impairment 
 
xiv 
of mitochondrial function mainly characterized by dissipation of mitochondrial membrane 
potential and substantial decline in the mitochondrial respiratory chain complex I activity. 
These cumulative events led to induction of apoptotic cell death.  
 In addition, we assessed the role of mitochondrial metabolism in the regulation of 
the autophagy-lysosomal pathway, a major cellular homeostatic process that mediates 
the degradation of long-lived proteins and dysfunctional or superfluous organelles in 
eukaryotic cells. We demonstrated that prolonged metabolic failure due to mitochondrial 
dysfunction, either in cellular models harboring sPD subjects mtDNA (sPD cybrids), cells 
depleted of all mtDNA (Rho0 cells), or in MPP+-treated rat cortical neurons causes a 
functional decline in the activity of the autophagic system. This defect is a consequence 
of alterations in microtubules (MT) assembly that hamper mitochondria and 
autophagosome transport along the MT network toward the lysosomal compartment. 
Consequently, deficient autophagic turnover potentiates the accumulation of α-synuclein 
oligomers and, ultimately, prompts apoptosis. Our data identify for the first time the PD-
associated defects in mitochondrial dysfunction as the basis for the selective transport 
abnormalities and highly characteristic pattern of neuritic dystrophy associated to the 
autophagic pathology in PD. 
 Finally, we dissected the molecular mechanisms by which mitochondrial 
metabolism in sPD can affect MT-directed autophagic turnover that, in turn, regulates 
intracellular protein homeostasis. We demonstrated that sirtuin 2 (SIRT2), a NAD+ 
dependent protein deacetylase, controls the functional ability of the autophagic system 
by modulating the acetylation status of the MT cytoskeleton. 
 The studies presented here provide novel insights into the multiple mechanisms 
that dictate the association between mitochondria, intracellular metabolism and 
proteotoxicity in sPD, and contribute with new findings that could have important 
therapeutic implications to halt or retard the progression of sPD pathology. 
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Resumo 
 
A doença de Parkinson (DP) é a segunda doença neurodegenerativa mais comum, 
afectando cerca de 2% dos indivíduos com idade superior a 65 anos. A marca 
neuropatológica primária desta doença é a disfunção da via dopaminérgica 
nigroestriatal, da qual resulta a depleção de dopamina no cérebro, conduzindo aos 
principais sintomas motores que caracterizam a clínica da doença e que incluem tremor 
de repouso, bradicinesia, instabilidade postural e rigidez muscular. Outra característica 
neuropatológica da DP é a presença de corpos de inclusão intracelulares, designados 
de Corpos de Lewy, que são maioritariamente constituídos por α-synucleína na forma 
agregada.  
 Embora a etiologia da doença permaneça por esclarecer, sabe-se que 90-95% 
dos casos de DP ocorrem de uma forma esporádica e pensa-se que, em parte, se 
correlacionam com a disfunção da mitocôndria e com o stresse oxidativo. A identificação 
de genes associados às formas familiares da DP revolucionou a forma de pensar dos 
investigadores da área, proporcionando oportunidades únicas para estudar novos 
mecanismos envolvidos na etiopatogenia da DP. O estudo continuado das funções 
celulares de cada um dos genes relacionados com a DP indica que o misfolding e a 
agregação proteica, bem como a disfunção dos sistemas de controlo de qualidade 
proteica, desempenham um papel crucial na cascata de eventos implicada no processo 
de neurodegeneração da DP. Assim, uma visão clara de como e quando a disfunção 
mitocondrial, o stresse oxidativo e os mecanismos de homeostase proteica se 
entrecruzam, sobrepõem ou convergem para produzir degeneração nigorestriatal é 
essencial para a compreensão da fisiopatologia da DP do tipo esporádico (sDP). 
 Nesta tese, abordámos, inicialmente, as potenciais implicações das alterações na 
interação estrutural e funcional entre a mitocôndria e o retículo endoplasmático (RE), 
dois organelos importantes envolvidos na manutenção da homeostase proteica celular. 
Reportamos que a disfunção mitocondrial induzida por um estímulo agudo da 
neurotoxina MPP+ aumenta a susceptibilidade das células para o desenvolvimento de 
uma resposta ao stresse do RE. Verificámos que o MPP+ foi capaz de evocar um fluxo 
contínuo de Ca2+ entre o RE e a mitocôndria, desencadeando, subsequentemente, a 
activação de vias apoptóticas dependentes do RE e da mitocôndria. Os resultados 
obtidos destacam o papel inevitável dos fluxos de Ca2+ entre o RE e a mitocôndria, e a 
sua relevância para a indução de morte celular dependente da mitocôndria, 
estabelecendo-se um ciclo de retrocontrolo em que a mitocôndria sinaliza o RE e o RE 
 
xvi 
induz alterações posteriores na mitocôndria, conduzindo à activação de uma cascata de 
sinalização que culmina na morte celular por apoptose. 
 Do mesmo modo, observámos que o stresse do RE potencia alterações ao nível 
da função mitocôndrial. Demonstramos que stresse do RE prolongado devido à 
acumulação de proteínas mal processadas no seu interior conduz a um fluxo excessivo 
de Ca2+ para o interior mitocôndria e a um comprometimento da função mitocondrial, 
caracterizada principalmente pela dissipação do potencial de membrana e por um 
decréscimo substancial da actividade da cadeia respiratória mitocondrial. 
Cumulativamente, estes eventos desencadeam a indução de morte celular por 
apoptose. 
 Por outro lado, avaliámos o papel do metabolismo mitocondrial na regulação da 
via autofágica-lisossomal, um processo homeostático celular que medeia a degradação 
de proteínas de longa duração e organelos disfuncionais em células eucarióticas. 
Demonstramos que uma falência metabólica prolongada devido a disfunção mitocondrial 
quer em células híbridas portadoras de ADN mitocondrial de doentes de sDP (cíbridos 
sDP), em células depletadas do seu ADN mitocondrial (células Rho0) ou em culturas 
primárias de neurónios corticais de rato tratados com MPP+, provoca um declínio 
funcional na actividade do sistema autofágico. Este defeito é uma consequência de 
alterações estruturais na rede microtubular (MT), comprometendo o transporte de 
mitocôndrias e autofagossomas para o compartimento lisossomal, onde ocorre 
degradação. Consequentemente, um ineficaz turnover autofágico potencia a 
acumulação de oligómeros de α-sinucleína e, em última análise, desencadeia apoptose. 
Assim, os dados obtidos identificam pela primeira vez os defeitos na função mitocondrial 
associados à DP como a base para alterações específicas no transporte intracelular e 
no padrão característico da distrofia neurítica associado à patologia autofágica na DP. 
 Por fim, analisámos os mecanismos moleculares através dos quais o metabolismo 
mitocondrial em sDP pode afectar o turnover autofágico dependente da rede MT, o qual, 
por sua vez, regula a homeostase proteica intracelular. Demonstramos que a sirtuina 2 
(SIRT2), uma desacetilase citoplasmática dependente do NAD+, controla a capacidade 
funcional do sistema autofágico, modulando o estado de acetilação do MTs. 
 Os estudos apresentados fornecem novas pistas relativamente aos múltiplos 
mecanismos que determinam a associação entre mitocôndria, metabolismo intracelular 
e proteotoxicidade e contribuem com novas perspectivas que poderão ter importantes 
implicações terapêuticas no sentido impedir ou retardar a progressão da sPD. 
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1.1 Parkinson’s disease: a single disorder? 
Parkinson disease (PD) is a chronically progressive, age-related neurodegenerative 
disease considered the most common movement disorder that is estimated to affect 
1.5% to 2% of the population older than 60 years of age (Lang and Lozano, 1998b, a). 
This disorder was first described in 1817 by James Parkinson in his seminal monograph 
“An Essay on the Shaking Palsy” where the core clinical features were presented 
(Parkinson, 2002). However, after almost two centuries since its description, PD remains 
an idiopathic disorder without cure and with limited symptomatic treatment. While the 
etiology of PD is still unknown, remarkable research advances have shed light on what 
fails in this disorder, and how those failures might be overcome. In addition to the motor 
symptoms primarily described by Parkinson, one has come to realize that this disorder is 
much more complex and includes panoply of convergent factors that may concur to the 
pathophysiology and pathologic biochemistry of PD. 
 Clinically, PD presents with four cardinal motor manifestations: tremor at rest, 
rigidity, bradykinesia (or slowing of movement), and postural instability. Many patients 
also suffer from non-motor symptoms, including disturbances of autonomic functions and 
deterioration of cognition (Poewe, 2008). These symptoms result from the progressive 
and selective degeneration of dopaminergic neurons in the substantia nigra pars 
compacta (SNpc), visible in brain sections as depigmentation of the SNpc in the 
midbrain, which constitutes a major signature of PD (Figure I.1). The loss of inhibitory 
dopaminergic innervation causes overactivity of the subthalamic nucleus and globus 
pallidus, which causes the movement symptoms (Hirsch et al., 2000; Obeso et al., 
2000). Neuroimageing reveals a typically asymmetric loss of dopamine terminals in the 
striatum. However, it is now clear that other neurons are also affected, and there are 
even suggestions that PD may initiate in other brainstem, subcortical and cortical 
structures or elsewhere in the central nervous system (CNS) and spread to the nigral 
neurons by, perhaps, noncell autonomous processes (Braak et al., 2003; Ilieva et al., 
2009; Bosco et al., 2011). PD surviving neurons exhibit the formation of round 
eosinophilic intracytoplasmic protein inclusions termed Lewy bodies (LBs), when they 
are present in cell bodies, and dystrophic neurites (Lewy neurites), when they are 
present in neuronal processes (Forno, 1996). These LBs comprise a dense core of 
different proteins, such as α-synuclein, parkin, synphilin-1, tubulin and other cytoskeletal 
proteins, components of the ubiquitin-proteasome system (UPS) and molecular 
chaperones, and lipids (Halliday et al., 2005; Uryu et al., 2006; Uversky, 2007) (Figure 
I.1).  
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Figure I.1. Neuropathology of Parkinson's disease. 
A. Schematic representation of the normal nigrostriatal pathway (in red). It is composed of 
dopaminergic neurons whose cell bodies are located in the substantia nigra pars compacta 
(SNpc; see arrows). These neurons project (thick solid red lines) to other basal ganglia and 
synapse in the striatum (i.e., putamen and caudate nucleus). The photograph demonstrates the 
normal pigmentation of the SNpc, produced by neuromelanin within the dopaminergic neurons. B. 
Schematic representation of the PD nigrostriatal pathway (in red). In PD, the nigrostriatal pathway 
degenerates. There is a marked loss of dopaminergic neurons that project to the putamen 
(dashed line) and a modest loss of those that project to the caudate (thin red solid line). The 
photograph demonstrates depigmentation (i.e., loss of dark-brown pigment neuromelanin; arrows) 
of the SNpc due to the marked loss of dopaminergic neurons. C. Photographic images of Lewy 
bodies stained with antibodies against α-synuclein and ubiquitin [Adapted from (Dauer and 
Przedborski, 2003)].  
 
 
Although the constituents of LBs have been characterized, few insights into the formation 
and function of LBs within cells have been achieved. The localization of LBs to regions of 
the CNS undergoing neuronal cell death further suggests a key role for protein 
misfolding and aggregation in the PD pathogenesis. For example, the number of LBs-
containing neurons was positively correlated with the expression of clinical symptoms 
(Kovari et al., 2003). 
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 In the outline of the protein misfolding and aggregation hypothesis for midbrain 
degeneration in PD, a crucial question is: why those proteins are prone to misfold, 
aggregate and accumulate in these selective brain regions, thereby leading to such 
specific patterns of neurodegeneration?  
 Actually, we can speculate about the answer. Local changes in expression or in 
post-translational modifications of the proteins that are misfolded might explain the 
selectivity of protein aggregation. Also, local alterations in the concentration or activity of 
chaperone proteins, or organelles that specifically control the folding of certain proteins, 
such as the endoplasmic reticulum (ER), might also be involved. Another potential 
mechanism involves selective alterations in clearance pathways that will remove different 
misfolded and aggregated proteins, such as the autophagy-lysosomal system. Finally, 
SNpc dopaminergic neurons might be more vulnerable to toxic stimuli, which in turn 
contribute to an accumulation of protein aggregates in these cells. But, a basic question 
arises: Does a unifying event trigger and account for all of these potential alterations?  
 An emerging concept is that SNpc homeostasis is vulnerable to different genetic, 
cellular and environmental factors that independently or concomitantly promote neuronal 
cell death over time (Perier et al., 2007; Sulzer, 2007). However, one factor that most 
strongly relates to the onset of PD is age or the ageing process. Indeed, epidemiological 
studies have identified age as the greatest risk factor for PD, and mitochondria through 
accumulation of mitochondrial DNA (mtDNA) mutations and production of reactive 
oxygen species (ROS) as the driving force of that process (Thomas, 2009). Accordingly, 
experimental data indicate that dopaminergic neurons are particularly sensitive to 
mitochondrial impairment and oxidative damage (Jenner, 2003). This can be due to their 
reliance on a high metabolic demand and should mean that they age more rapidly than 
other types of neurons. Consistent with this hypothesis studies on normal ageing-related 
cell death have suggested that SNpc dopaminergic neurons are lost at a considerably 
higher rate (5–10% per decade) than many other types of neurons (Stark and 
Pakkenberg, 2004). Functional measurements have shown that the nigrostriatal system 
activity is reduced with normal ageing (Backman et al., 2000), although not as rapidly as 
neuron loss, presumably because of the capacity of the remaining neurons to 
compensate (Zigmond et al., 1990). 
 Over the course of a lifetime, the rate of cellular ageing might have a significant 
effect on the time at which cell loss reaches the threshold necessary for the appearance 
of the first PD symptoms. Obviously, causative factors may differ among individuals 
determining different clinical subtypes of the disease or no disease at all. These 
differences might arise from diverse genetic backgrounds (genetic mutations or 
polymorphisms) that discreetly change the efficiency of the mitochondrial oxidative 
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phosphorylation system and the rate of generation of ROS. Indeed, some mutations or 
polymorphisms in mtDNA have been associated with different incidence of PD (Ghezzi et 
al., 2005; Huerta et al., 2005; Pyle et al., 2005; Larsson, 2010) and at least nine nuclear 
genes have been identified as causing or affecting the risk of PD. These include α-
synuclein, parkin, ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), DJ-1, phosphatase 
and tensin homologue (PTEN)-induced kinase 1 (PINK1), leucine-rich-repeat kinase 2 
(LRRK2), the nuclear receptor related-1 (NURR1), heat transfer requirement 2 
(OMI/HTRA2), and tau. Among the nuclear genes, mutations in α-synuclein, parkin, DJ-
1, PINK1, LRRK2, and HTRA2 are either directly or indirectly associated with 
mitochondrial dysfunction (Thomas and Beal, 2007). However, the genetic burden of 
actual mutations in PD is small, accounting for only 5–10% of the overall PD population.  
 The rate of ageing and neuronal cell loss could also be accelerated by secondary 
factors arising from exposure to environmental toxins that compromise mitochondrial 
function or that of cellular systems dealing with the consequences of oxidative stress. 
These factors might per se be fairly inoffensive but, due to their potential to synergise 
with the intrinsic vulnerabilities of SNpc dopaminergic neurons, might become relevant.  
 Thus, cumulative “normal” stress over a long period of time, such as the ageing 
process, or exposure to toxins could further tip the balance from a genetically determined 
cellular state to programmed cell death culminating in neuronal cell loss. This explains 
why several distinct molecular mechanisms may converge to a final common 
pathological and clinical phenotype in different individuals, unifying the molecular 
pathways implicated in the familial forms of PD into a “puzzling” multifactorial profile for 
sporadic PD (sPD), making it a “single disorder”. 
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1.2 Mitochondria: the trigger of Parkinson’s disease?  
Mitochondria are intracellular membrane enclosed organelles exceptionally primed to 
play a key role in cell biology. The intrinsic properties of mitochondria make them 
essential integrators of cellular functions, such as pyruvate oxidation, the citric acid or 
tricarboxylic acid (TCA) cycle, the metabolism of amino acids, fatty acids, steroids, and 
most importantly, the generation of energy as adenosine triphosphate (ATP).  
 Structurally, each mitochondrion comprises a matrix delimited by two membranes, 
the mitochondrial inner membrane (MIM) and the mitochondrial outer membrane (MOM), 
which occasionally came together to form junctional complexes or contact sites. The 
space between the two membranes is referred to as the intermembrane space (IMS), 
housing some proteins which play major roles in cell physiology, in mitochondrial 
energetics and in cell death, particularly cytochrome c. The convoluted and invaginated 
MIM includes multiple enzymes of oxidative phosphorylation system, the cofactor 
coenzyme Q1 or ubiquinone, the F0-F1-ATP synthase and some ion channels and carrier 
proteins [e.g., the voltage-dependent anion channel (VDAC-1) and the translocase of 
outer mitochondrial membrane (TOM20)]. In the matrix, surrounded by the MIM, there 
are many enzymes for different metabolic pathways, including the TCA cycle, fatty acid 
oxidation and the urea cycle, peptidases and chaperones (e.g., heat shock protein 60, 
Hsp60).  
 Mitochondria are the only organelles of the cell besides the nucleus that contain 
their own DNA (i.e., mtDNA), and their own machinery for synthesizing RNA and 
proteins. A given mitochondrion contains several copies of its genome (2–15 copies, 
termed “polyplasmia”), within its matrix, which codes for a small (12S) and large (16S) 
ribosomal RNA (rRNA), 22 transfer RNAs (tRNA) and 13 polypeptides that are all 
components of the oxidative phosphorylation system. The majority of proteins required to 
assemble and regulate mitochondrial function are therefore encoded by nuclear DNA, 
synthesized in the cytosol, and imported into mitochondria, where they are targeted to 
one of the four mitochondrial compartments. An example is NDUFA2, a subunit of the 
hydrophobic protein fraction of the NADH:ubiquinone oxidoreductase (complex I), which 
is thought to be involved in regulating complex I activity or its assembly via assistance in 
redox processes. 
 In addition to their role as ATP suppliers, mitochondria are critical as calcium 
buffers and as transducers of intracellular signaling pathways which integrate 
programmed cell death, marking the point of no return in apoptosis. Furthermore, 
mitochondria are highly dynamic organelles and are actively transported throughout 
axons and dendrites in neurons to facilitate their recruitment to critical subcellular 
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compartments distant from the cell body. Therefore, mitochondrial function has a critical 
role in the brain physiology and, alterations in any of these mitochondrial features can 
potentially be associated to the pathogenesis of PD. 
 
1.2.1 Mitochondrial metabolism and the oxidative phosphorylation system 
Mitochondria are usually considered to be “the powerhouses of the cell” and to be 
responsible for the aerobic production of ATP, via the combined efforts of the TCA and 
the respiratory chain/oxidative phosphorylation system. 
 The mitochondrial respiratory chain is implanted in the MIM and consists of five 
enzyme complexes and cofactors, arranged functionally according to the electrochemical 
hierarchy based on their redox potentials: reduced nicotinamide adenine dinucleotide 
(NADH) dehydrogenase-ubiquinone oxidoreductase (complex I, approximately 46 
subunits), succinate dehydrogenase- ubiquinone oxidoreductase (complex II, four 
subunits), ubiquinone-cytochrome c oxidoreductase (complex III, 11 subunits), 
cytochrome c oxidase (complex IV, 13 subunits), and ATP synthase (complex V, 
approximately 16 subunits). 
 The TCA cycle maintains the coenzymes NADH and flavoproteins in a reduced 
state to supply reducing equivalents for the electron transport chain (ETC). The transfer 
of electrons occurs due to the oxidation of NADH (at complex I) or FADH2 (at complex III) 
by ubiquinone to complex IV where they react with molecular oxygen (O2) to reduce it to 
H2O. The transport of electrons down the ETC releases favorable energy that is used by 
Complex I, III, and IV to pump protons from the matrix to the mitochondrial IMS, thus 
creating a proton gradient (basic inside) and an electrochemical gradient (negative 
inside) across the MIM. The electrochemical gradient (known as mitochondrial 
membrane potential, m) is used by the F1F0-ATP synthase for running the endoergonic 
reaction of adenosine diphosphate (ADP) phosphorylation (Figure I.2). 
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Figure I.2. Mitochondrial compartimentalization and the oxidative phosphorylation system.  
The mammalian oxidative phosphorylation system consists of five enzyme complexes. 
Complexes I–IV constitute the respiratory chain, whereas complex V is the ATP synthase. 
Complex I (NADH dehydrogenase) and complex II (succinate dehydrogenase) receive electrons 
(e−) from intermediary metabolism and translocate them to coenzyme Q, which, in turn, delivers 
the electrons to complex III (cytochrome c reductase). The electron shuttling protein cytochrome c 
then transfers the electrons to complex IV (cytochrome c oxidase), which constitutes the final step 
in the electron transport chain that reduces molecular oxygen (O2) to water (H2O). The electron 
transport is coupled to proton (H
+
) pumping across the inner mitochondrial membrane by 
complexes I, III, and IV. The resulting proton gradient drives ATP synthesis, and there is thus a 
coupling between electron transport and ATP synthesis. Protons can be translocated from the 
intermembrane space to the mitochondrial matrix through the activated uncoupling protein or by 
other uncoupling mechanisms, which leads to a dissociation (uncoupling) of electron transport 
and ATP synthesis. The mtDNA encodes critical subunits of complexes I, III, IV, and V (orange 
dots). Electrons may also exit the respiratory chain at the level of complex I or III to form the 
reactive oxygen species superoxide (O2
·−
) as a result of the one-electron reduction of O2 [Adapted 
from (Larsson, 2010)]. 
 
 
 Defective mitochondrial function, in particular at the level of complex I, has long 
been associated with the pathogenesis of PD. Indeed, the first report comes in 1975, 
when Ahlqvist et al. showed ultrastructural abnormalities in mitochondria of muscle 
biopsies from PD patients (Ahlqvist et al., 1975). However, the most compelling evidence 
of mitochondrial complex I involvement PD emerged following the human accidental 
exposure to the synthetic meperidine analogue 1-methyl-4-phenyl-1,2,3,6-
tetrahydrodropyridine (MPTP) which induced a parkinsonian syndrome (Langston et al., 
1983; Burns et al., 1985). Mitochondrial association with idiopathic PD was first 
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established when a mitochondrial complex I activity deficit was identified in the SNpc of 
post mortem PD patients brains (Schapira et al., 1989) and in PD patient platelets 
(Parker et al., 1989). Further evidences suggested a similar complex I deficiency in PD 
patients lymphocytes (Yoshino et al., 1992; Barroso et al., 1993) and skeletal muscle 
(Penn et al., 1995), although some studies failed to demonstrate consistent changes 
between healthy individuals and idiopathic PD patients (Mann et al., 1992; Taylor et al., 
1994; Hanagasi et al., 2005). In addition, cell lines engineered to contain mitochondria 
derived from platelets of PD patients (cybrids) were also shown to exhibit a stable 
decrease in complex I activity, increased ROS production, proton leak and decreased 
maximum respiratory capacity (Swerdlow et al., 1996; Cassarino et al., 1997; Esteves et 
al., 2008; Esteves et al., 2010c).  
 Supporting a functional role of complex I dysfunction in PD-related 
neurodegeneration, the feeding of mitochondrial ETC directly at complex II by infusion of 
the ketone body D-b-hydroxybutyrate was shown to bypass complex I blockade, 
enhance oxidative phosphorylation, and confer protection against the structural and 
functional deleterious effects of MPTP in mice (Tieu et al., 2003). In addition, viral 
injection of the alternative single polypeptide NADH-quinone oxidoreductase of 
Saccharomyces cerevisiae mitochondria (Ndi1), which is insensitive to complex I 
inhibitors, has been shown to protect against neurodegeneration and behavioral deficits 
of acute MPTP and rotenone mouse models of PD (Seo et al., 2006a; Richardson et al., 
2007; Marella et al., 2008). Also, methylene blue, an alternative electron carrier which 
accepts electrons from NADH and transfers them to cytochrome c and bypasses 
complex I/III blockage, was shown to dramatically reduce behavioral, neurochemical, 
and neuropathological impairments induced by rotenone in a PD rat model (Wen et al., 
2011). Reinforcing the involvement of respiratory chain dysfunction in PD, most of the 
pesticides which have been epidemiologically associated to an increased risk of PD are 
able to induce complex I dysfunction (Sherer et al., 2002; Schuh et al., 2005; Richardson 
et al., 2009; Schuh et al., 2009). However, the finding that the knockout (KO) mice for the 
Ndufs4 gene, encoding a subunit required for the complex I assembly and activity, are 
not protected from MPTP, rotenone, and paraquat-induced dopaminergic neuron death 
(Choi et al., 2008) raised the possibility that they can cause parkinsonism by acting also 
on different targets or that other complex I subunits are involved in toxicity. In fact, 
Ndufs4-deficient dopaminergic neurons are even more sensitive to rotenone, and 
complex I-independent mechanisms have been reported to contribute to the toxicity of 
rotenone, such as microtubule depolymerization (Ren et al., 2005; Choi et al., 2011). 
However, it was recently shown that complex I activity is only partially decreased but not 
abolished in Ndufs4 KO mice due to the formation of respiratory supercomplexes with a 
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stabilizing effect of complex III (Calvaruso et al., 2012; Sterky et al., 2012). This finding 
can explain why Ndufs4-deficient neurons are still sensitive to MPTP and rotenone 
toxicity. Dopaminergic neuron-specific conditional Ndufs4 KO mice do not show overt 
nigrostriatal degeneration, only a mild decrease (7.5%) in tyrosine hydroxylase-positive 
neurons at 24 months of age (Sterky et al., 2012). Nevertheless, striatal dopamine 
turnover is increased and dopamine release is decreased in Ndufs4-deficient mice, 
which may reflect an early consequence of mitochondrial impairment. These findings 
support the notion that complex I deficiency can contribute to the pathogenesis of PD. 
 
1.2.2 Mitochondrial DNA (mtDNA) and the energetic threshold effect 
The human mitochondrial genome (mtDNA) is a circular double-stranded molecule 
containing 37 genes (16,569 base pairs), 13 of which encode protein subunits of the 
mitochondrial respiratory apparatus (seven subunits of NADH:ubiquinone 
oxidoreductase, one subunit of cytochrome c reductase, three subunits of cytochrome c 
oxidase, and two subunits of ATP synthase) (Figure I.3).  
 The rules of inheritance of mtDNA differ considerably from Mendelian inheritance. 
In fact, a peculiar characteristic of mtDNA is that it is inherited almost exclusively through 
the mother, and may exist in many different copies in the oocyte cytoplasm. This implies 
that no mtDNA recombination occurs at fertilization and only a sequential accumulation 
of mutations from the maternal lineage account for mtDNA variations. Moreover, mtDNA 
is particularly prone to mutations, being estimated as 10 times greater than nuclear DNA, 
due to the absence of protective proteins (such as histones) and of a high-efficiency 
repair system, although short and long-patch base excision repair systems are now well 
documented. Thus, mutant mtDNA can coexist with normal mtDNA, a condition referred 
to as heteroplasmy, and the levels of mutant mtDNA could vary dramatically during 
ageing. It was also discovered that pathogenic mtDNA mutations only cause 
mitochondrial respiratory chain dysfunction if they are present above a certain threshold 
level, which is >60% for single large mtDNA deletions and >90% for certain point 
mutations in tRNA genes (“threshold effect”). Single large mtDNA deletions, which 
always remove one or several tRNA genes, as well as point mutations of tRNA genes, 
lead to impaired mitochondrial translation and respiratory chain deficiency (Figure I.3).  
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Figure I.3. Mitochondrial DNA (mtDNA) and the energetic threshold effect. 
A. Mammalian mtDNA is a double-stranded circular molecule. The two strands are denoted the 
heavy (H) andlight (L) strand due to different buoyant densities. The only longer noncoding 
region, the displacement loop (D loop), contains a triplex structure with a nascent H strand. The D 
loop contains the promoters for transcription of the H and L strand (HSP and LSP) as well as the 
origin of replication of the leading strand of mtDNA (OH). The origin of replication of the lagging 
strand (OL) is located in a cluster of tRNA genes.Transcription from HSP produces 2 rRNAs (12S 
and 16S rRNA), 12 mRNAs (ND1–5, ND4L, Cyt b, COI–III, ATP6, and ATP8), and 14 tRNAs (F, 
V, L1, I, M, W, D, K, G, R, H, S1, L2, T). Transcription from LSP has a dual function. First, it 
produces RNA primers needed for initiation of replication at OH. Second, it is needed to produce 
one mRNA (ND6) and eight tRNAs (P, E, S2, Y, C, N, A, Q). B. Clonal expansion of mutated 
mtDNA molecules. In a normal situation, all mtDNAs within a cell are identical (homoplasmy). In a 
pathological situation linked to pathogenic mtDNA mutations, cells can harbor both normal and 
mutant mtDNA (heteroplasmy). Somatic mtDNA mutations tend to undergo clonal expansion and 
thereby cause focal respiratory chain deficiency and clinical signs (“threshold effect”) [Adapted 
from (Perier and Vila, 2012)]. 
 
 
The threshold for disease is lower in cells with high energy demands, such as neurons 
and muscle cells, rendering them particularly vulnerable to the effects of pathogenic 
mtDNA mutations (Perier and Vila, 2012). SNpc neurons seem to be especially 
vulnerable to mtDNA mutations, since hippocampal neurons or pyramidal cortical 
neurons of aged individuals did not contain high levels of mtDNA mutations. 
 Evidence regarding inherited “damaged” mtDNA that could explain mitochondrial 
dysfunction observed in PD patient brains and blood peripheral models is still 
inconsistent, but several studies have suggested an association between mtDNA 
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mutations and PD (Parker and Parks, 2005; Winkler-Stuck et al., 2005). As mentioned in 
the section 1.2.1, cybrids generated with mitochondria harvested from PD patient 
platelets exhibit complex I deficiency similar to patient cells, showing direct inheritance of 
the biochemical abnormality through mitochondria. Cybrids are produced by fusing cells 
previously deprived of their endogenous mtDNA (called Rho0
 
cells) with mitochondria 
from patient samples, resulting in a hybrid with a constant nuclear background and a 
transfered mitochondrial gene complement. In this way the influences of the 
mitochondrial genome on the physiology of a cell can be separated from nuclear factors, 
and direct comparisons can be made between the functional properties of mtDNA from 
various sources. Since this complex I deficiency is stable over tens of cell doublings, any 
protein or membrane components transferred with mtDNA become diluted and removed, 
leaving only mtDNA as the carrier of information causing complex I dysfunction. In 
addition to complex I deficiency, PD cybrids exhibit a number of other physiological 
alterations found in PD patient tissues, including abnormalities of calcium homeostasis 
(Sheehan et al., 1997; Esteves et al., 2010b), increased antioxidant enzymes, increased 
ROS production (Cassarino et al., 1997; Esteves et al., 2009), and protein aggregation in 
the form of LBs, the histopathological hallmarks of PD (Trimmer et al., 2004a; Esteves et 
al., 2009, 2010a). These observations suggest that PD-derived mtDNA encodes 
pathogenic information and highlight the possibility that mitochondrial abnormalities in 
PD may be inherited from mtDNA or related to somatic mtDNA alterations acquired 
during the ageing process. In fact, Swerdlow et al. found that cybrid cell lines prepared 
using platelet mitochondria from PD-affected kindred members and the young, 
asymptomatic descendents of PD mothers had lower complex I activity, increased ROS 
production and more abnormal mitochondrial morphologic features than cybrid cell lines 
containing mtDNA from paternal descendants (Swerdlow et al., 1998). These results 
support a precedent for inherited mtDNA as causative of mitochondrial dysfunction in PD 
sporadic cases. Accordingly, analysis of multiple PD subject databases found sex ratio 
differences between PD probands and the PD-affected parents of those probands 
(Swerdlow et al., 2001). While the proband sex ratio showed more men than women, the 
PD-affected parental generation showed more women than men. This finding is 
consistent with a maternal inheritance bias [reviewed in (Swerdlow, 2011)]. Also, the 
existing defect of complex I activity in PD patient platelets, a non-degenerating tissue, 
represents a systemic dysfunction, which is more compatible with inherited rather than 
somatic mtDNA alterations.  
 There is, however, considerable evidence showing that mtDNA acquires mutations 
during ageing, more prevalent in the brain, composed of long-lived postmitotic neurons, 
which have a great rate of oxidative metabolism, with increased ROS production 
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(Terman et al., 2010). Consistent with this observation, a new conditional KO mouse 
modeling PD was generated by disruption of the gene for mitochondrial transcription 
factor A (TFAM) in dopaminergic neurons, termed “MitoPark” mouse. This is the first 
animal model showing slow progressive degeneration of dopaminergic neurons similar to 
PD patient brains. This mouse show reduced mtDNA expression, reduced respiratory 
chain function in midbrain dopaminergic neurons which, in turn, lead to a parkinsonian 
phenotype, with adult onset of slowly progressive impairment of motor function 
associated to the formation of intraneuronal inclusions and dopamine nerve cell death, 
suggesting that impaired mtDNA expression may primarily contribute to the 
pathogenesis of PD (Ekstrand et al., 2007). Similarly, expression of mitochondrially 
targeted PstI endonuclease in dopaminergic neurons, which induces double-strand 
breaks in mtDNA, causes progressive neuronal degeneration and striatal dopamine 
depletion (Pickrell et al., 2011). Moreover, transgenic mice expressing a proofreading-
deficient version of the mtDNA polymerase γ (POLG) accumulate mtDNA mutations and 
display features of premature ageing (Trifunovic et al., 2004; Kujoth et al., 2005). 
Remarkably, cosegregation of parkinsonism with mutations in the human POLG1 gene 
has been reported in several families [reviewed in (Orsucci et al., 2011)]. 
 An age-dependent increase in mtDNA deletions have been observed in individual 
dopaminergic neurons dissected from the SNpc of post mortem human brains from 
normal individuals and idiopathic PD patients (Bender et al., 2006; Kraytsberg et al., 
2006). Different types of mtDNA deletions were found in the same individual, but each 
neuron contained only a single mtDNA mutation, indicating that the mutation was 
acquired and clonally expanded. In comparison with age-matched controls, the amount 
of mtDNA mutations was slightly higher in dopaminergic neurons from PD patients 
(Bender et al., 2006). 
 Therefore, either by inherited mtDNA mutations or by somatic mutations which 
initially occurs in a single DNA molecule but can clonally expand, mtDNA mutational 
burden ultimately might exceed the phenotypic threshold, resulting in focal ETC defects. 
 
1.2.3. Mitochondrial motility: an on track sliding-dependent cellular process 
Mitochondria are extremely dynamic organelles that undertake constant changes in 
shape and distribution into the cell in order to achieve their exact assignment at the 
suitable time and site. Therefore, mitochondria accumulate in subcellular regions with 
high metabolic energy demands and/or where calcium buffering is required (Morris and 
Hollenbeck, 1993) and reallocate in response to changes in the local energy state 
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(Hollenbeck, 1996). Proper functioning of mitochondria depends on their intracellular 
location which is decisively governed by aspects of mitochondrial spatial arrangement 
and motility beyond fusion and fission. Mitochondria apparently maintain their identity as 
discrete organelles through long travels that involve frequent stops and re-starts and 
some changes in direction (Fahim et al., 1985). Their movement is, to varying degrees, 
saltatory and bidirectional, and this sets them apart from small vesicles, endosomes and 
most other axonally transported organelles (Hollenbeck, 1996; Ligon and Steward, 
2000a). These aspects are critically important when we look to neurons (Hollenbeck and 
Saxton, 2005) which require mitochondria at sites distant from the cell body. Throughout 
their traffic in the axon, mitochondria can quickly switch between anterograde and 
retrograde movement, and their net direction has been shown in isolated neurons to 
result primarily from modulation of the fraction of time spent moving anterogradely 
(Morris and Hollenbeck, 1993). 
 Neuronal populations particularly vulnerable to PD, such as SNpc dopaminergic 
neurons, have common features as they have long and thin axons, which have little or 
no myelination (Braak et al., 2004). Neurons with these features are more vulnerable to 
degeneration and require high energy demands and so they are particularly dependent 
on suitable mitochondrial trafficking. Indeed, the evidence of reduced cytoplasmic 
mitochondrial mass and size (Liang et al., 2007; Kim-Han et al., 2011) and impaired 
axonal transport (Kim-Han et al., 2011) in mice SNpc dopaminergic neurons when 
compared with non-dopaminergic neurons suggests selective vulnerability of 
dopaminergic neurons as a result of a mitochondrial dysfunction. 
 The main mechanism to deliver cellular components to their action site is the long-
distance microtubule (MT)-based transport. In turn, fast, long distance, axonal transport 
of mitochondria is accomplished through the MT network. MTs are one of the main 
constituents of the cytoskeleton, constituting parallel polymers of α- and β-tubulin dimers 
which have nearly all of their plus ends directed towards the nerve terminal (Heidemann, 
1996; Baas, 2002). Essential to the function of MTs is their rapid and time-sensitive 
growth and shortening dynamics (dynamic instability) and this stochastic switch from 
growth to shrinking involves the binding and the hydrolysis of guanosine 5’- triphosphate 
(GTP) by tubulin. Also implicated in mitochondrial transport and distribution are the motor 
proteins of the kinesin superfamily in anterograde organelle transport and those of the 
dynein family in retrograde transport (Hollenbeck, 1996). For short range transport, 
mitochondria can also move along actin filaments which serve as tracks to areas where 
the MTs do not reach (Kuznetsov et al., 1992; Morris and Hollenbeck, 1995; Ligon and 
Steward, 2000b; Langford, 2002; Bridgman, 2004). Kinesins and dyneins are typical 
molecular motors as they convert the energy of ATP in their work. So, it seems that the 
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ATP/ADP and GTP/GDP recycling and bioavailability through functional active 
mitochondria control their proper motility and localization into the cell and that distribution 
is exquisitely regulated. In fact, it has been shown that mitochondrial movements depend 
on respiration (Katayama et al., 2006) and stop if respiration is inhibited or under 
extreme energetic conditions, i.e., in the presence of high ATP and high ADP 
concentrations in the cytoplasm. Inhibition of mitochondrial migration by ADP has been 
considered to be the mechanism by which mitochondria become trapped at sites with 
high energy demand (Katayama et al., 2006; Riva et al., 2006). Part of the mechanism 
underlying this trapping could be a lack of ATP for binding and activity of the motor 
molecules driving the organelles along cytoskeletal structures. Inhibition of motility by 
high cytoplasmic ATP is supposed to follow similar principles. Motor molecules lose their 
connection to the cytoskeletal fibrils at increased ATP concentrations, as shown for the 
dynein-microtubule interaction (Johnson, 1983).  
 Relevant to PD, MPP+ (1-methyl-4-phenylpyridinium) and rotenone were shown to 
affect MT dynamics (Cappelletti et al., 2005; Ren and Feng, 2007). Moreover, MPP+ was 
found to impair anterograde and increase retrograde transport of both mitochondria and 
other vesicles in isolated squid axoplasm (Morfini et al., 2007), and overall axonal motility 
of mitochondria but not of other moving particles in mouse dopaminergic neurons (Kim-
Han et al., 2011). Supporting the concept that mitochondria has a main role on the 
control of the microtubule dynamics and microtubule-dependent trafficking, cells 
harboring mitochondrial deficits (PD cybrids) were found to exhibit ATP-dependent 
cytoskeletal changes (Esteves et al., 2009, 2010a). Accumulation of functionally 
impaired mitochondria and MT network destabilization can be counteracted by the 
formation of new mitochondria, degradation of non-functional organelles and/or 
aggregated proteins within a cell, as will be further discussed in the sections 1.4.2 and 
1.4.3. 
 
1.2.4 Mitochondria and cellular signaling  
Mitochondria have long been considered as crucial organelles, primarily for their roles in 
biosynthetic reactions such as ATP synthesis. However, it is becoming increasingly 
apparent that mitochondria are intimately involved in cell signalling pathways. 
Mitochondria perform various signalling functions, serving as platforms to initiate cell 
signalling, as well as acting as transducers and effectors in multiple processes.  
 
 
Introduction  
 
17 
 
1.2.4.1 Mitochondria and calcium homeostasis 
The calcium ion (Ca2+) is one of the most important elements in cellular signaling 
because Ca2+ binding is involved in a great number of cellular processes ranging from 
the modulation of enzyme activity and gene expression to programmed cell death. 
Particularly in neurons, Ca2+ fluxes across the plasma membrane and between 
intracellular compartments play significant roles, including the regulation of neurite 
outgrowth and synaptogenesis, synaptic transmission and plasticity, and cell survival 
(Mattson, 2007). The concentration of cytosolic free Ca2+  in resting neurons (100 nM) is 
10,000-fold lower than the concentration of Ca2+  in the extracellular space (1.2 mM) 
(Berridge et al., 2000; Rizzuto, 2001). This steep Ca2+ concentration gradient creates a 
huge driving force allowing a rapid increase in intracellular Ca2+ when Ca2+ channels 
located in the plasma membrane open. Therefore, it is critical to regulate the 
mechanisms governing Ca2+ entering neurons, as Ca2+ can be either a physiological 
messenger or a very toxic element when its concentration dynamics is deregulated. Ca2+ 
entering neurons is rapidly sequestered in intracellular organelles such as mitochondria 
or ER, or pumped back out of the cell across plasma membrane after interaction with 
mobile buffering proteins within the cytosol. These processes require energy stored in 
ATP or ion gradients that are maintained through ATP-dependent pumps. The major 
intracellular storage site of Ca2+ is the ER, and there is a significant interplay between 
mitochondria and ER regarding Ca2+ homeostasis, which will be further discussed in the 
section 1.3.3.1. 
 Ca2+ sequestration by mitochondria is based on their ability to uptake Ca2+, through 
a uniporter located in the MIM, and to accumulate it in the matrix, a process driven by 
Δm. Ca
2+ accumulation in the mitochondrial matrix starts when extramitochondrial Ca2+ 
concentration exceeds 400 nM and results from the balance between the low-affinity 
Ca2+ uptake and the efficient Ca2+ extrusion from the mitochondrial matrix, occurring via 
Ca2+/Na+ or Ca2+/H+ antiporters. Intramitochondrial Ca2+ concentration within the 
physiological range leads to the activation of mitochondrial catabolic processes due to 
stimulation of three mitochondrial dehydrogenases: pyruvate-, NAD+-isocitrate- and 2-
oxoglutarate-dehydrogenase (Duszynski et al., 2006). Therefore, mitochondrial 
metabolism and Ca2+ homeostasis are mutually coupled, thus sustaining the energy 
requirements associated with neuronal activity. 
 During normal physiological activity, the intracellular Ca2+ concentration increases 
only transiently (seconds to a few minutes) and has no detrimental effects on the 
neurons. However, unlike most neurons in the brain, SNpc dopaminergic neurons are 
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autonomously active, generating action potentials at a clock-like 2–4 Hz in the absence 
of synaptic input (Grace and Bunney, 1983) (Figure I.4). 
 
 
Figure I.4. Mitochondria, ER and Ca
2+
 transport in SNpc dopaminergic neurons.  
The steep concentration gradient for Ca
2+
 enables it to cross the plasma membrane readily into 
cells through open pores such as L-type Ca
2+
 channels. Once inside neurons, it is either 
transported back across the plasma membrane or sequestered in intracellular organelles. Ca
2+
 is 
transported across the plasma membrane through either the Ca
2+
-ATPase or through a Na
+
/Ca
2+
 
exchanger that relies upon the Na
+
 gradient. Ca
2+
 is rapidly sequestered either by ionic 
interactions with buffering proteins or by transport into cytosolic organelles (i.e. the mitochondria 
and the ER). The ER uses high-affinity smooth ER Ca
2+
 (SERCA) pumps that depend upon ATP 
to take Ca
2+
 from the cytoplasm into the ER lumen. Ca
2+
 flows back into the cytoplasm after the 
opening of inositol trisphosphate receptors (IP3R) and ryanodine receptors (RyR) studding the ER 
membrane. Mitochondria are often found in close apposition to the ER and plasma membrane, 
creating a region of high (but localized) Ca
2+
 concentration that drives Ca
2+
 into the matrix of 
mitochondria through a Ca
2+
 uniporter [Adapted from (Chan et al., 2009a)].  
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In this regard, they are much like cardiac pacemakers, relying on a peculiar class of L-
type channels, characterized by the presence of Cav1.3 pore forming subunit that 
confers to this type of Ca2+ channels the property to be open at relatively hyperpolarized 
potentials and thus exposing SNpc dopaminergic neurons to larger Ca2+ influxes than 
other neurons (Wilson and Callaway, 2000). The high magnitude of Ca2+-influx through 
plasma membrane L-type channels in SNpc dopaminergic neurons ultimately 
compromises mitochondrial function, resulting in mitochondrial oxidative stress and 
oscillations in mitochondrial potential, the latter being associated with impaired ATP 
production (Guzman et al., 2010). Supporting the pathogenic role for Ca2+ overload 
associated to the pacemaking activity in SNpc dopaminergic neurons, the L-type Ca2+ 
channels antagonist iraspidine protects striatal dopaminergic terminals and parent SNpc 
cell bodies to both acute and chronic challenges with MPTP (Chan et al., 2007) or 6-
hydroxydopamine (6-OHDA) (Ilijic et al., 2011). These observations suggest that 
prolonged Ca2+ overload in SNpc dopaminergic neurons may render these cells 
particularly vulnerable to PD. In accordance with this, dopaminergic neurons in the 
ventral tegmental area (VTA), which do not rely upon L-type Ca2+ channels for 
pacemaking, are relatively intact in PD patients and in animal models of PD (Kish et al., 
1988; Chan et al., 2007). Another supportive observation is the resilience of selected 
SNpc dopaminergic neuronal populations that express Ca2+-buffering proteins: 
expression of calbindin, calreticulin or parvalbumin is negatively correlated with 
degeneration in PD (Yamada et al., 1990; German et al., 1992; Mouatt-Prigent et al., 
1994; McMahon et al., 1998). 
 Other evidences further support a role for alterations in mitochondrial Ca2+ 
homeostasis in PD. A dramatic reduction in calbindin levels has been described in brains 
of PD patients (Iacopino and Christakos, 1990). In addition, PD cybrid cells exhibit lower 
mitochondrial Ca2+ uptake ability relatively to control cells (Esteves et al., 2010b), even 
following carbachol-induced Ca2+ entering (Sheehan et al., 1997). Similarly, cybrid cell 
lines expressing mtDNA polymorphisms have alterations in intracellular Ca2+ dynamics 
(Kazuno et al., 2006). In addition, MPP+, 6-OHDA and rotenone were found to stimulate 
mitochondrial Ca2+ release and cause increased cytosolic free Ca2+ levels in cultured cell 
lines (Frei and Richter, 1986; Sousa et al., 2003; Wang and Xu, 2005). Also, some 
oligomeric forms of α-synuclein exogenously applied to dopaminergic neurons evoked 
Ca2+ influx from the extracellular milieu through a pore-forming mechanism, leading to 
mitochondrial Ca2+ overload and apoptotic cell death (Danzer et al., 2007). Other studies 
have shown that α-synuclein can be associated to mitochondria and its accumulation is 
directly related to an increase in mitochondrial Ca2+ levels (Parihar et al., 2008), which in 
turn lead to increased levels of nitric oxide, oxidative stress, and cytochrome c release 
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(Parihar et al., 2009). However, these observations failed to be consistently reported, as 
further studies have shown no alterations in cellular Ca2+ homeostasis following 
overexpression of wild-type or mutant α-synuclein (Hettiarachchi et al., 2009). Moreover, 
evidence has suggested a role for PD-linked protein PINK1 in the regulation of 
mitochondrial Ca2+, although data is controversial. Initially, it was proposed that PINK1 
ablation in dopaminergic neurons causes an impairment of mitochondrial Ca2+ efflux, 
probably by affecting the mitochondrial Na+/Ca2+ exchanger activity, resulting in 
mitochondrial Ca2+ overload, increased production of mitochondrial ROS and impaired 
mitochondrial respiration (Gandhi et al., 2009). Afterward, PINK1 depletion has instead 
been shown to impair mitochondrial Ca2+ uptake, and consequently to affect energy 
metabolism (Heeman et al., 2011). Coherently, some reports have demonstrated that 
lack of PINK1 in cells impairs Δm and increases susceptibility to mitochondrial 
neurotoxins (Wood-Kaczmar et al., 2008) as well as enhances vulnerability to Ca2+ 
(Akundi et al., 2011). Supporting a role for Ca2+ overload in PD-related cell death, 
pharmacological or genetic inhibition of Ca2+-sensitive proteases, such as calpains, has 
been shown to attenuate caspase-3 dependent cell death in mitochondrial deficient cells 
(Esteves et al., 2010a) and overall dopaminergic neurodegeneration in a MPTP mouse 
model of PD (Crocker et al., 2003). 
 
1.2.4.2 Mitochondria and programmed cell death 
Programmed cell death, or apoptosis, is a naturally occurring process of cell “suicide” 
that plays a crucial role in the development and maintenance of all pluricellular 
organisms by eliminating superfluous or unwanted cells. However, massive or abnormal 
activation of apoptosis in adulthood can lead to neurodegeneration. Because apoptosis 
is involved in the maintenance of tissue and organ homeostasis, it is strictly controlled at 
multiple levels (Green and Kroemer, 2004). 
 In numerous models, mitochondria represent a central checkpoint of apoptosis 
control by integrating various signals, including endogenous factors (e.g., cytosolic and 
organellar concentrations of protons Ca2+, Mg2+, K+, and Na+, metabolites such as ATP, 
ADP, NADP+, glutathione, lipid second messengers, and multiple proteins including 
kinases and phosphatases) as well as exogenous factors (e.g., specific viral proteins or 
xenobiotics) (Kroemer et al., 2007). These organelles integrate the sum of death-
inducing and life-preserving signals at the level of their membranes and, when the lethal 
signals predominate over the vital ones, mitochondria proceed with “its intrinsic” or 
mitochondrial pathway. Here, in response to an apoptotic stimuli, the initiator caspase-9, 
is activated by multimerization on the adapter molecule apoptosis protease activating 
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factor 1 (APAF-1) and assemble within a multiprotein complex called apoptosome. The 
release of cytochrome c (which normally resides only in the IMS) into the cytosol 
following mitochondrial outer membrane permeabilization (MOMP) is crucial for the 
generation of the apoptosome and subsequent processing and activation of effector 
caspases such as caspase-3. Hence, MOMP is the critical event responsible for caspase 
activation and represents the point of no return in a cell's commitment to die, being 
regulated by many proteins of the Bcl-2 family which either prevent (e.g., Bcl-2 and Bcl-
xL) or promote (e.g., Bax and Bak) the apoptotic cascade of cell death. 
 Relevant to PD pathology, dopaminergic cell death appears to occur, at least in 
part, through the activation of mitochondria-dependent apoptotic pathways. Analysis of 
PD patient post mortem brains revealed a great increase in apoptotic neuronal nuclei 
accompanied of raised immunoreactivity to caspase-3 and Bax (Tatton, 2000). In 
addition, data from transmitochondrial cybrids have shown that PD mitochondria are 
more likely than healthy mitochondria to activate the intrinsic apoptotic cascade, when 
exposed to a mitochondrial toxin, such as MPP+ (Swerdlow et al., 1996; Esteves et al., 
2008). Similarly, MPTP-treated mice were found to develop marked apoptotic features, 
as caspase-3 and caspase-9 activation (Hartmann et al., 2000), calpain activation 
(Crocker et al., 2003), downregulation of Bcl-2 levels and strong upregulation of Bax 
levels in nigrostriatal dopaminergic neurons (Vila et al., 2001). Further supporting the 
involvement of mitochondria-dependent apoptotic pathway in PD, nigrostriatal 
degeneration in MPTP-treated mice can also be prevented by targeting some molecules 
of this pathway, such as caspase-9 or APAF-1 (Mochizuki et al., 2001; Viswanath et al., 
2001), or by overexpressing Bcl-2 (Offen et al., 1998; Yang et al., 1998).  
 In addition, some mutated genes associated with familial forms of PD were found 
to affect mitochondria-dependent cell death. For instance, overexpression of α-synuclein 
in vivo and in several cell types triggered apoptosis (Saha et al., 2000; Stefanova et al., 
2001; Kim et al., 2004). Several apoptotic markers were also observed in yeast models 
of α-synuclein toxicity (Flower et al., 2005). α-Synuclein toxicity can be rescued by 
caspase inhibitors or knock down of caspase-12 (Smith et al., 2005). Activation of 
caspase-3 has been observed in transgenic mice (Martin et al., 2006) and caspase-9 
has been reported in viral models in mice (St Martin et al., 2007) and rats (Yamada et al., 
2004). In cell lines, PD-associated mutant LRRK2 led to mitochondria-dependent 
apoptosis through the release of cytochrome c and caspase-3 activation (Iaccarino et al., 
2007). The genetic ablation of Apaf1 abrogated the caspase-3 activation and the 
neuronal death. In addition, overexpression of wild-type PINK1, but not of mutant PD-
linked PINK1, reduced cytochrome c release, caspase activation, and apoptosis induced 
by mityochondrial neurotoxins in cultured cells (Petit et al., 2005). Likewise, 
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overexpression of Parkin was shown to prevent ceramide-induced mitochondrial swelling 
and subsequent cytochrome c release, caspase-3 activation, and apoptotic cell death in 
vitro (Darios et al., 2003). Together, these data suggest that activation of mitochondria-
dependent apoptotic pathways contributes to SNpc dopaminergic neuronal cell death in 
PD. 
 
1.3 ER, protein folding and misfolding 
The ER is a subcellular organelle comprised of a reticular membranous network that 
extends throughout the cytoplasm and that can be contiguous with the nuclear envelope. 
In highly elongated and polarized cells such as neurons, ER spreads from the cell body 
throughout the dendrites and axons (Aridor et al., 2004). The ER organizes its large 
amount of membrane by folding it into tubular or lamellar structures, generating a 
complex architecture that varies in response to functional requirements (Borgese et al., 
2006). This complex architecture makes ER a primed site for protein folding, and 
supports a variety of other key activities including Ca2+ storage, and steroid, cholesterol 
and lipid biosynthesis.  
 Proteins enter the ER as unfolded polypeptide chains and are then correctly folded 
and assembled prior to transit to the cell surface or to intracellular organelles. The 
acquisition of the native structure of a protein in vivo takes place within the crowded 
environment of the ER. In principle, crowding could interfere with folding by favouring the 
aggregation of unfolded proteins. This effect can be overcome by the action of a complex 
and dynamic network of protein chaperones, foldases and cofactors that assist the 
folding and maturation of proteins, preventing their abnormal aggregation or misfolding. 
Nonetheless, protein folding in the ER is inherently imperfect and errors made at any 
step on the way to the final product decrease the fraction of proteins that reach their 
proper conformation. Transient accumulation of unfolded proteins initiates an adaptive 
coordinated signaling cascade known as the unfolded protein response (UPR). 
Appropriate adaptation to misfolded protein accumulation within the ER requires 
regulation at all levels of gene expression including transcription, translation, 
translocation into the ER lumen or induction of protein degradation in a process termed 
ER-associated degradation (ERAD) or through autophagy (Malhotra and Kaufman, 
2007). Synchronized regulation of these processes is required to restore proper protein 
folding and ER homeostasis. On the other hand, if protein folding is not repaired, 
persistent activation of UPR signaling occurs, which eventually induces an apoptotic 
response. 
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1.3.1 ER, protein folding and quality control 
ER protein folding consists in a complex interplay between a polypeptide primary 
structural information and associated cellular networks. Folding begins as protein 
synthesis initiates on ribosomes and ends when native proteins are packaged for ER exit 
(Brodsky and Skach, 2011).  
 Relative to cytosol, ER is an oxidizing environment which facilitates several co-
translational and post-translational modifications that do not occur in the cytosol 
[disulfide bond formation, glycosylation and glycophosphatidylinositol (GPI) anchor 
addition], further stabilizing and conferring specific functionality to proteins (Dorner et al., 
1990; Braakman et al., 1992). Thus, secreted and membrane proteins, which transit 
through the secretory pathway, must first complete their folding in the ER. The ER 
therefore constitutes a protein folding factory that entails an exquisite quality control (QC) 
on its products, ensuring that only properly assembled and functional proteins are 
delivered to their final destinations in the cell (Ellgaard and Helenius, 2003). 
Consequently, proteins entering the ER immediately encounter a network of chaperone 
systems that minimize aggregation, facilitate native structure conformation and ensure 
the fidelity of oligomeric assembly (Jonikas et al., 2009) (Figure I.5). 
 Chaperones and folding enzymes reside in the ER in high concentrations and 
participate in all steps of folding and in QC. Key chaperones and folding sensors include 
the glucose regulated protein GRP78, also known as immunoglobulin binding protein 
(BiP) and 94 (GRP94), the lectins calnexin and calrecticulin, and the thiol-disulfide 
oxidoreductases. BiP/GRP78 belongs to the heat shock protein (Hsp)70 family and is 
one of the molecular chaperones first encountered by most newly synthesized 
polypeptides (Figure I.5). In mammalian cells, BiP is present at the translocon where it 
serves to maintain the permeability barrier of the ER during the early stages of targeting 
nascent chains into the translocon. BiP binds to the hydrophobic patches of unfolded 
proteins via a substrate-binding domain and facilitates folding through conformational 
changes evoked by the hydrolysis of ATP by the ATPase domain. 
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Figure I.5. Protein folding in the ER.  
Schematic overview of a nascent polypeptide entering the ER lumen cotranslationally, where it 
engages folding machinery to obtain its final conformation (folding cycle). Quality control 
checkpoint(s) establish the folding status of the polypeptide which then either proceeds to its final 
destination or is selectively degraded, either via the dislocation pathway or via a bulk degradation 
mechanism (e.g. autophagy) [Adapted from (Claessen et al., 2012)]. 
 
 
1.3.2 Protein misfolding and the ER stress response in Parkinson’s disease 
As mentioned above, disturbance in the function or loss of integrity of ER therefore 
disrupts folding and leads to the accumulation of unfolded proteins. Unfolded or 
misfolded proteins expose amino-acid residues that should be located inside the protein 
and became prone to form aggregates in the ER as well as in the cytosol. As small 
aggregates are highly toxic, this potentially leads to ER stress. To alleviate such a 
stressful condition, cells activate a series of self-defense mechanisms referred 
collectively to as the ER stress response or UPR (Mori, 2000; Patil and Walter, 2001; 
Harding et al., 2002; Schroder and Kaufman, 2005).  
 In mammalian cells, ER stress response consists of four different pathways. The 
first is attenuation of protein synthesis that prevents any further accumulation of unfolded 
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proteins. The second is the transcriptional induction of ER chaperone genes to increase 
folding capacity, and the third is the transcriptional induction of ERAD component genes 
to increase ERAD ability. The fourth is the induction of apoptosis to safely dispose of 
cells injured by ER stress to ensure survival of the organisms. 
 Accumulating evidence strongly suggests the involvement of ER stress in PD. The 
parkinsonism-inducing neurotoxins 6-OHDA, MPP+, and rotenone have been shown to 
induce many genes involved in various aspects of the UPR including ER chaperones 
such as BiP, protein disulfide-isomerase (PDI) and calreticulin, the inositol requiring 
enzyme 1 alpha (IRE1-α), and the protein kinase RNA-like endoplasmic reticulum kinase 
(PERK) in neuronal cells (Ryu et al., 2002; Holtz and O'Malley, 2003). These effects 
were specific for these PD mimetics but not for other agents (Ryu et al., 2002). In 
addition, the expression of ER chaperones, such as PDI, was found to be up-regulated in 
the brain of PD patients and PDI accumulated in LBs (Conn et al., 2004). According with 
these observations, accumulation of polyubiquitinated proteins and UPR activation have 
also been observed in the SNpc dopaminergic neurons of post mortem tissue from 
sporadic PD patients (Hoozemans et al., 2007; Slodzinski et al., 2009), and in Multiple 
System Atrophy patients, other synucleinopathy (Makioka et al., 2010), indicating that 
UPR activation may be induced to prevent neurotoxicity associated with ER stress and 
protein misfolding. Also, PDI inactivation occurs in PD brains through oxidative 
modifications (Uehara et al., 2006).  
 More substantial evidence for a role of ER stress in PD pathogenesis comes from 
the study of juvenile onset forms of genetic PD that is caused by mutation in the Parkin 
gene, which compromise the ubiquitin ligase function of the protein (Shimura et al., 
2000). PD-related mutations in Parkin results in the accumulation of its substrate, Pael-
R, in the ER of SNpc dopaminergic neurons, leading to ER stress and cell death (Imai et 
al., 2001). On the other hand, Parkin expression has a prosurvival activity against ER 
stress due to modulation of ERAD/proteasome pathway (Imai et al., 2000; Wang et al., 
2007). In addition, overexpression of wild-type (Shimazawa et al., 2010) or mutant 
(Smith et al., 2005) α-synuclein induces chronic ER stress activation, inducing cell death. 
Reports in the complementary model of yeast demonstrated that the earliest effect 
following α-synuclein expression is a block in the ER to Golgi vesicular trafficking. 
Notably, the inhibition of the ER-Golgi trafficking by α-synuclein expression triggers ER 
stress (Cooper et al., 2006; Gitler et al., 2008) possibly due to the accumulation of cargo 
vesicles, triggering the accumulation of immature proteins at the ER (Ding and Yin, 
2008). α-Synuclein phosphorylation at serine 129 was found to be responsible for UPR-
mediated cell death in neuroblastoma cells even before any detectable mitochondrial 
dysfunction is observed (Sugeno et al., 2008). Similarly, downregulation and mutations in 
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DJ-1 have been shown to trigger ER-stress, thus suggesting that loss of DJ-1 protein 
activity makes neurons more vulnerable to ER-stress (Yokota et al., 2003). Furthermore, 
mutations in the P5 ATPase (ATP13A2, PARK9), responsible for an autosomal recessive 
form of early onset parkinsonism, were associated with its retention in the ER, where it 
may exert neurotoxicity (Ramirez et al., 2006). Finally, LRRK2 deficiency in C.elegans 
triggers hypersensitivity to ER stress (Samann et al., 2009). 
 
1.3.3 ER-mitochondria interorganelle crosstalk 
The ER and mitochondria are endowed with several functionalities, and among them is a 
recently emerged concept of a direct line of communication between these two 
organelles. Interestingly, mitochondria and the ER are physically and functionally 
interconnected, as the MOM can associate with the ER membrane, in a structure called 
mitochondrial-associated membrane (MAM), allowing some important cellular functions 
(Giorgi et al., 2009). For example, the exchange of metabolites between mitochondria 
and the ER that occur continuously during the life span of the cell is crucial for cellular 
functions. Here, ATP produced by oxidative phosphorylation is used by ATPases located 
in the ER (i.e. Ca2+ ATPases); in the opposite direction, products of ER metabolic 
pathways, such as phospholipids, are transferred continuously to the mitochondrial 
membranes. However, the best characterized aspect of functional interconnection 
between these organelles is undoubtedly the regulation of intracellular Ca2+ 
homeostasis. This is because Ca2+ exchange between ER and mitochondria not only has 
a role in regulating physical interactions between the two organelles, but also regulates 
different fundamental biological processes, including cell survival and apoptosis. 
 
1.3.3.1 The ER and mitochondria partnership in Ca2+ homeostasis 
The ER has taken a center stage in the machinery responsible for Ca2+ homeostasis 
(Berridge, 2002). As in other neurons, the ER network in SNpc dopaminergic neurons 
extends throughout the somatodendritic tree (Choi et al., 2006). High-affinity ATP-
dependent transporters move Ca2+ from the cytoplasm into the ER lumen and pump it 
back to the cytoplasm. The absence of high-affinity, anchored intraluminal Ca2+ buffers 
and the physical continuity of the lumen within the cell (Mogami et al., 1997; Park et al., 
2000) enables the ER to rapidly (~30 µm/s) redistribute Ca2+ between intracellular 
compartments, thus avoiding pro-apoptotic accumulations in the cytosol (Choi et al., 
2006). Thus, Ca2+ sequestered in the ER by sarco(endo)plasmic reticulum Ca2+ATPase 
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(SERCA) is further released at sites where it can be pumped back across the plasma 
membrane or where it can be used to modulate cellular functions (Rose and Konnerth, 
2001; Verkhratsky, 2005; Park et al., 2008).  
 However, the storage capacity of the ER is limited. Ca2+ released from the ER 
through inositol-1,4,5-triphosphate receptor (IP3R) or ryanodine receptors (RyR) can 
enter mitochondria at points of close apposition between the organelles which form 
functional Ca2+ microdomains (Csordas et al., 2006; Rizzuto and Pozzan, 2006). 
Therefore, mitochondria play an important role in shaping the Ca2+ fluxes released from 
the ER. Mitochondria assist with the recovery phase by rapidly sequestering Ca2+ and 
then later returning it to the ER. During normal signaling, there is a continuous ebb and 
flow of Ca2+ between these two organelles. The normal situation is for most of the Ca2+ to 
reside within the ER lumen, except during Ca2+ signaling when a small part is periodically 
released to the cytoplasm and is then recaptured by mitochondria. Because the channels 
through which Ca2+ enters mitochondria are of low affinity, it has been proposed that 
regions of close proximity between mitochondria and the ER are necessary for Ca2+ entry 
into the mitochondrial matrix (Rizzuto et al., 1998). Thus, a major determinant of the ER-
mitochondria interface is the distance between their surfaces, controlled by the 
movement of these organelles along the cytoskeleton (Hollenbeck and Saxton, 2005; 
Boldogh and Pon, 2006). Ca2+ modulates this distance, as its release from ER channels 
is a signal that locally arrests mitochondrial motility and promotes their docking at the ER 
surface, enhancing Ca2+ transfer (Yi et al., 2004). Mitochondria respond promptly to 
physiological rises in Ca2+ with very rapid and large increases in their matrix Ca2+, as 
shown clearly in different cell types [reviewed in (Rizzuto and Pozzan, 2006)]. Thus, no 
kinetic limitations are apparent in the capacity of mitochondria to uptake and release 
Ca2+ rapidly. The uptake of Ca2+ released from the ER into the mitochondrial matrix has 
important regulatory roles, such as the modulation of the spatio-temporal pattern of Ca2+ 
signaling within the cell and therefore many Ca2+-dependent cellular processes, 
matching aerobic metabolism to energy demand. In addition, by buffering local Ca2+ 
and/or by returning it back to the cytosol after sequestration, mitochondria have a 
fundamental role in enabling the maintenance of cytosolic Ca2+ oscillations (Ishii et al., 
2006; Vay et al., 2007). Also, by functioning as high-capacity Ca2+-sinks, mitochondria 
modulate the propagation of Ca2+ waves and act in restricted microenvironments 
influencing the allosteric modulation by Ca2+ of the ER-release channels, such as the 
IP3R and the RyR (Rizzuto and Pozzan, 2006)  
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1.3.3.2 The ER-mitochondria coupling in apoptosis 
Numerous studies point to the ER as a third subcellular compartment implicated in 
apoptotic execution (Rao et al., 2004). Indeed, several molecules either present on the 
ER surface or in the soluble compartment have been implicated as effectors that cause 
cell death in response to prolonged ER stress. Caspase-12 (a murine caspase 
unequivocally identified in human tissue as caspase-4), which is associated with the ER, 
was implicated in apoptosis triggered by ER stress (Nakagawa et al., 2000; Rao et al., 
2001; Rao et al., 2002). However, further studies demonstrated that caspase-12/capase-
4 are not required for ER-stress induced apoptosis and that caspase-4-like activity is not 
always associated with an initiating event (Obeng and Boise, 2005). Caspase 2, which 
appears to be partially in the ER, has been proposed to have an important role in the 
initiation of ER-induced apoptosis, integrating the ER and the Golgi complex with the 
apoptotic pathway, acting as an upstream trigger to permeabilize the MOM (Cheung et 
al., 2006). 
Similar to mitochondria, the ER is also a repository of apoptotic and antiapoptotic 
molecules. The known antiapoptotic molecules include GRP78, calreticulin, PDI and the 
150-kDa oxygen-regulated protein (ORP-150) (Liu et al., 1997; Ozawa et al., 1999; 
Tanaka et al., 2000). Also, a significant fraction of endogenous Bcl-2 family members 
including Bcl-2, Bcl-xL, Bax, Bak and Bik have been shown to be associated with the ER, 
suggesting that Bcl-2 family proteins operate at the ER (at least in part) to regulate Ca2+ 
homeostasis and apoptotic cell death (Wei et al., 2001; Germain et al., 2002; Germain 
and Shore, 2003; Scorrano et al., 2003). For example, Bcl-2 overexpression results in a 
decrease of ER luminal Ca2+ content and this effect has been attributed to an increase in 
the Ca2+ leak from the organelle (Foyouzi-Youssefi et al., 2000; Pinton et al., 2000; 
Palmer et al., 2004; White et al., 2005). Moreover, knockdown of Bax and Bak increases 
the interaction of Bcl-2 with the type-1 IP3Rs and promotes both the phosphorylation of 
the IP3R and a constitutive Ca
2+ leak through the IP3Rs under basal conditions (Scorrano 
et al., 2003; Oakes et al., 2005). A reduced ER Ca2+ content, as in the case of Bcl-2 
overexpression or knockdown of Bax/Bak, reduces the amount of Ca2+ that can be 
released from the ER owing to an apoptotic stimulus and thus decreases the probability 
of a Ca2+-dependent MPTP opening (reviewed in (Oakes et al., 2006; Pinton and 
Rizzuto, 2006; Giacomello et al., 2007). In addition, released Ca2+ from the ER, acting on 
mitochondria fusion/fission proteins [dynamin-related protein 1 (DRP-1), hFis1, optic 
atrophy 1 (OPA1) and mitofusins (MFNs)], can also influence mitochondrial cristae 
remodeling and thus the amount of cytochrome c that can be released in the cytosol 
(Breckenridge et al., 2003a). 
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 The ER–mitochondria crosstalk therefore amplifies ER-initiated apoptotic pathways 
or other pathways. In any case, the balance between these various Bcl-2 family 
members determines an “apoptotic rheostat” that modulates ER-mitochondria-dependent 
cell survival versus death (Korsmeyer et al., 1993). 
 
 
Figure I.6. Local ER–mitochondria interactions and apoptotic signalling at the ER–
mitochondria interface.  
A representation is depicted of ER–mitochondria relationships and of some of the proteins 
involved in the crosstalk between the organelles. Ca
2+
 released from the ER through IP3Rs is 
taken up by mitochondria through the mitochondria Ca
2+
 uniporter (MCU). Within mitochondria, 
Ca
2+
 modulates mitochondrial dehydrogenase activity and thus ATP production. Moreover, 
mitochondrial Ca
2+
 uptake regulates the spatio-temporal pattern of the cytosolic Ca
2+
 signal and, 
therefore, many Ca
2+
-dependent cellular processes. Massive and/or a prolonged accumulation of 
Ca
2+
 in the mitochondria can lead to the opening of the permeability transition pore (PTP) in the 
MIM and swelling of the organelle or, acting on mitochondria-shaping proteins [DRP-1, hFis1, 
OPA1, mitofusins (MFNs)], to mitochondrial cristae remodeling and modulation of apoptosis. The 
concerted action of the two organelles in cell death is further supported by the presence on both 
the ER membrane and the MOM of different components of the Bcl-2 family that have either a 
pro- (BIK, BAX, BAK) or an anti-apoptotic role (Bcl-2, Bcl-XL) [Adapted from (Pizzo and Pozzan, 
2007)]. 
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1.4 Autophagy and protein homeostasis: more than just a 
cellular cleaning mechanism in Parkinson’s disease 
Autophagy refers to a set of evolutionarily conserved and strictly regulated process 
whereby intracytoplasmic material of any kind is delivered to lysosomes (Mizushima et 
al., 2008; Yang and Klionsky, 2010). This pathway was first described by Christian De 
Duve in the 1960’s as a simple cellular process in which a double-membrane vesicle, the 
autophagosome, delivers cytoplasmic constituents to lysosomes for degradation and 
recycling (De Duve, 1963). A substantial progress on the molecular dissection of 
autophagy has taken place during only the past 15 years, uncovering the main 
components that are involved in the different autophagic processes, their regulation and 
contribution to different cellular functions. Autophagy is induced by different adverse 
conditions such as limited nutrients, low oxygen levels, and decreased energy supply, 
and its action results in the release of degradation products, especially amino acids, 
back into the cytoplasm to be used in essential biosynthetic pathways. According to the 
different pathways by which cargo is delivered to the lysosome, autophagy can be 
divided into three major distinct types in mammalian cells: macroautophagy, 
microautophagy, and chaperone-mediated autophagy (CMA) (Figure I.7). 
 Macroautophagy involves the sequestration of a complete region of the cytosol, 
including whole organelles, by a double-membrane vesicle known as the 
autophagosome. The latter acquires the enzymes required for the degradation of its 
content after fusion with a lysosome. Macroautophagy is activated in response to nutrient 
deprivation, where degradation of intracellular components by this pathway provides 
cells with the amino acids no longer obtained by the diet, but required for the synthesis of 
proteins essential for survival (Mizushima et al., 2004). Physical and chemical stressors, 
as well as infectious agents, have also been shown to activate macroautophagy (Levine 
and Klionsky, 2004). Activation of autophagy under these conditions is aimed at the 
removal of the aggressor itself (i.e., invading microorganisms) or of the intracellular 
components that were damaged during exposure to stress. However, some level of 
basal macroautophagy is detected in almost all cells, and this basal activity plays an 
important role in the continuous turnover of organelles and clearance of misfolded and 
damaged proteins (Komatsu et al., 2005; Hara et al., 2006; Komatsu et al., 2006). 
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Figure I.7. Autophagic pathways.  
Cytosolic proteins can reach the lysosomal lumen for degradation via autophagy through three 
different mechanisms. A. In macroautophagy, a whole region of the cytosol is sequestered into a 
double membrane vesicle that fuses with lysosomes for cargo delivery. B. In microautophagy, the 
lysosomal membrane invaginates to trap regions of the cytosol that are internalized into the 
lysosomal lumen as single membrane vesicles. C. In chaperone-mediated autophagy (CMA), a 
targeting motif in the substrate proteins is recognized by a cytosolic chaperone that delivers it to 
the surface of the lysosome. Once there, the substrate protein binds to a lysosomal receptor that 
multimerizes to form a translocation complex. A luminal chaperone mediates the translocation of 
the substrate protein into the lumen where it is rapidly degraded [Adapted from (Wong and 
Cuervo, 2010)]. 
 
 
 Microautophagy is somewhat similar to macroautophagy, but in this case the 
lysosomal membrane invaginates or generates protrusions and tubulations to sequester 
the cytosolic content “in bulk.” Microautophagy is a constitutively active pathway that 
contributes to the continuous, slow turnover of cytosolic proteins (Mortimore et al., 1988). 
 In contrast to “in bulk” degradation, cytosolic proteins can also be transported one-
by-one into lysosomes for degradation by CMA. The intrinsic selectivity associated with 
this pathway permits the removal of damaged proteins without affecting normal proteins 
in the vicinity. Through CMA just cystosolic proteins containing the pentapeptide 
targeting motif KFERQ (Dice, 1990) are selectively recognized by a chaperone complex 
in the cytosol, including the heat shock cognate (HSC70) and its associated co-
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chaperones (Chiang et al., 1989). This complex is targeted to the lysosome-associated 
membrane protein type 2A (LAMP-2A), the lysosomal receptor for this pathway (Cuervo 
and Dice, 1996). After unfolding, substrate proteins cross the lysosomal membrane and 
are assisted by a luminal chaperone (Lys-hsc70) to be degraded within the lysosomal 
lumen. Although some level of basal CMA activity is detectable in almost all cell types, 
this pathway is maximally activated under conditions of stress. Stressors known to 
activate this pathway include prolonged starvation, mild oxidative stress, and exposure to 
toxic compounds that alter the conformation of particular proteins (Massey et al., 2004). 
 Among the three main types of autophagy, macroautophagy is the best 
characterized process and will henceforth be referred to as autophagy. 
 
1.4.1 Molecular orchestration of autophagy 
1.4.1.1 Autophagy-related proteins: the basic core machinery  
The molecular understanding of autophagy was initiated by the pioneering work in yeast 
utilizing genetic screenings that led to the discovery of more than 30 autophagy-related 
(Atg) genes, followed by the identification of homologs in mammals (Noda et al., 2002; 
Nakatogawa et al., 2009). Although autophagy occurs at basal levels in all cells, basal-
level autophagy is very low under normal conditions, therefore an efficient mechanism of 
induction is crucial for organisms to adapt to stress and extracellular signals (He and 
Klionsky, 2009).  
 A central negative regulator of autophagy is the serine/threonine protein kinase 
mTOR (mammalian target of rapamycin) (Kamada et al., 2004; Neufeld, 2010). mTOR 
integrates input information from multiple upstream signal transduction pathways and 
negatively regulates other downstream serine/threonine kinases. Thus, under nutrient-
rich conditions, mTOR inhibits autophagy through phosphorylation and inactivation of 
key targets, the Unc-51-like kinase 1 (ULK1) and -2 (ULK2) (Atg1 in yeast), mammalian 
Atg13 (mAtg13), and the focal adhesion kinase family-interacting protein of 200 kD 
(FIP200, Atg17 in yeast), which seem to form a stable complex regardless of nutritional 
conditions in mammalian cells (Kamada et al., 2000; He and Klionsky, 2009; Hosokawa 
et al., 2009). In contrast, upon mTOR inhibition by starvation or rapamycin, ULK1 and 
ULK2 undergo autophosphorylation that is conducive to a conformational change 
essential for their activation (Chan et al., 2009b), and further phosphorylate mAtg13 and 
FIP200, forming a complex essential for autophagy activity (Hosokawa et al., 2009; Jung 
et al., 2009) (Figure I.8). 
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Figure I.8. Basic molecular machinery of autophagy. 
There are at least three steps in the formation of autophagosomes: initiation, nucleation, and 
elongation/closure. Autophagy is initiated by the ULK1 complex. This complex is formed by ULK1 
Ser/Thr protein kinase, Atg13, and FIP200. Among the initial steps of vesicle nucleation is the 
activation of the phosphatidylinositol 3-kinase class III (Vps34) to generate phosphatidylinositol 3-
phosphate (PtdIns(3)P). This activation depends on the formation of a multiprotein complex that 
includes Beclin-1, p150 (Vps15), mAtg14 (Atg14-like protein), and Ambra1. Beclin-1 constitutively 
interacts with Bcl-2 or its close homolog Bcl-XL and autophagy induction requires the dissociation 
of Beclin-1 from its inhibitors Bcl-2 or Bcl-XL. The membrane formed elongates and closes on 
itself to form an autophagosome. Two conjugation systems are successively involved. The first 
involves the covalent conjugation of Atg12 to Atg5, with the help of Atg7 and Atg10. This 
conjugate is organized into a complex by associating with Atg16 to form the Atg16–Atg5–Atg12 
complex. The second involves the conjugation of phosphatidylethanolamine (PE) to LC3 by the 
sequential action of the Atg4, Atg7, and Atg3. This lipid conjugation leads to the conversion of the 
soluble form of LC3 (named LC3-I) to the autophagic vesicle-associated form (LC3-II), allowing 
for the closure of the autophagic vacuole. Abbreviations: Ambra1, activating molecule in Beclin-1-
regulated autophagy; Atg, autophagy genes; Bcl, B-cell leukemia/lymphoma; FIP200, 200-kDa 
focal adhesion kinase family-interacting protein; LC3, microtubule-associated protein light chain 3; 
mTOR, mammalian target of rapamycin; PI3K, phosphatidylinositol 3-kinase; ULK1, 
uncoordinated 51-like kinase 1; Vps, vacuolar protein sorting. [Adapted from (Rautou et al., 
2010)].  
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In addition, the activation of autophagy in response to starvation requires the dissociation 
of Beclin-1 (Atg6 in yeast) from its binding partner Bcl-2 in the cytosol (Wei et al., 2008). 
Beclin is then free to complex with the phosphatidylinositol 3-kinase class III (Vps34 in 
yeast), p150 (Vps15 in yeast) and mAtg14 (Atg14 in yeast) to form the active class III 
phosphatidylinositol 3-kinase (PtdIns3K) complex (Backer, 2008; Itakura et al., 2008). 
The lipid kinase activity of the class III PtdIns3K produces phosphatidylinositol 3-
phosphate (PtdIns(3)P) and is involved in the targeting of a number of Atg proteins 
essential to generate the nucleation complex or the phagophore (in yeast), which gives 
rise to the pre-autophagosomal membrane. Various sources, including the ER, 
mitochondria, the plasma membrane, and the Golgi complex have been proposed to be 
the origins of the autophagosomal membrane (Arstila and Trump, 1968; Geng et al., 
2010; Hailey et al., 2010; Ravikumar et al., 2010; Bodemann et al., 2011). The PtdIns3K 
complex, in part together with the above Atg proteins, further recruits two interrelated 
ubiquitin-like (Ubl) conjugation systems, the mAtg12–Atg5-Atg16 and the light chain-3 
(LC3, Atg8 in yeast), to the autophagosomal membrane (Suzuki et al., 2007; Geng and 
Klionsky, 2008; Sou et al., 2008), which play an essential role in regulating the 
membrane elongation and expansion of the forming autophagosome. Then, both Atg12 
and LC3 undergo conjugation and are activated by the ubiquitin E1-like ligase, mAtg7. In 
addition, the shuttling and self-multimerization of mAtg9, the only identified integral 
membrane protein required for autophagosome formation, to the site of autophagosome 
formation facilitates membranes supply for the elongation of the limiting membrane (Mari 
et al., 2010). When autophagosome formation is completed, LC3 attached to the outer 
membrane is cleaved from phosphatidylethanolamine (PE) by Atg4 and released back to 
the cytosol (Kirisako et al., 2000). The mechanism of autophagosome formation is such 
that the sequestering membrane can accommodate basically any sized cargo. After 
fusion, degradation of the inner vesicle components and cargo is dependent on a series 
of lysosomal acid hydrolases, including cathepsins B, D, and L (Tanida et al., 2005). The 
resulting small molecules from the degradation, particularly amino acids, are transported 
back by permeases to the cytosol for de novo protein synthesis and maintenance of 
cellular functions under starvation conditions. 
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1.4.1.2 Microtubule network: a crucial component required for autophagy 
Besides the aforementioned Atg proteins, certain subcellular systems, including the MT 
network, may also carry out essential functions during autophagy, such as facilitating 
autophagosome transport and enabling clearance of autophagic substrates. 
 Within neurons, autophagosomes are actively formed in synapses and along 
neurites but the proper clearance of these compartments involve their retrograde 
transport towards the neuronal cell body, where lysosomes are concentrated. Several 
lines of evidence suggest that, in mammals, autophagosomes associate with MT tracks, 
move towards the microtubule-organizing centre (MTOC), and fuse with endosomes or 
lysosomes, and the dynamic process is driven by the dynein motors. Indeed, pioneering 
studies demonstrated that autophagic flow is MT-dependent since disruption of MT 
network using agents such as nocodazole and vinblastine, which interfere with MT 
polymerization, blocks fusion of autophagosomes with endosomes and lysosomes (Aplin 
et al., 1992; Seglen et al., 1996; Webb et al., 2004). Also, disruption of the MT network 
results in a decreased clearance of autophagy substrates (Ravikumar et al., 2005). 
However, a number of more recent studies revealed that, in mammalian cells, 
compromised functional integrity of MTs provoke a delay in autophagy rather than a 
complete block in this process (Fass et al., 2006; Kochl et al., 2006). In addition, it was 
shown that knockdown of dynein leads to similar effects (Jahreiss et al., 2008) 
corroborating that dyneins are the key motor proteins that mediate the transport of 
autophagosomes along MTs towards lysosomes (Kimura et al., 2008). 
 In addition, proteins associated to familial forms of PD, such as α-synuclein, 
LRRK2, PINK1 or Parkin have been reported to interact with, and potentially impair MT-
mediated trafficking (Schon and Przedborski, 2011). In fact, misfolded and aggregated 
proteins are also transported to, and deposited in the pericentriolar region via the MT 
system (Johnston et al., 1998; Kopito, 2000). These MT dependent deposits of 
aggregates are called aggresomes and may explain the biogenesis of the LBs found in 
PD. Therefore, impairment of MT system is being increasingly associated with abnormal 
accumulation of α-synuclein (Lee et al., 2006). Although the mechanism whereby α-
synuclein accumulates in LBs is not fully understood, evidence suggests that defective 
axonal transport of α-synuclein itself may contribute to the process. Mutant forms of α-
synuclein but not wild-type were found to exhibit reduced axonal transport in transfected 
cultured neurons (Saha et al., 2004). Further evidence revealed that overexpression of 
α-synuclein causes disruption of MT network and impairment of MT-dependent trafficking 
(Lee et al., 2006). In addition, Kim et al. demonstrated that exposing yeast cells to a MT 
assembly inhibitor or by deleting genes involved in MT biogenesis, α-synuclein 
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aggregation and toxicity increases, suggesting that tubulin can stimulate α-synuclein 
fibrillization in yeast (Kim et al., 2008a). Therefore, there are two possible mechanisms 
underlying the crosstalk between α-synuclein and MT function and, interestingly, they 
seem to be not exclusive from each other. Consistent with this observation, wild-type α-
synuclein has also been considered a functional MT-associated protein able to induce 
the polymerization of purified tubulin into MTs whereas mutant forms of α-synuclein lose 
this potential (Alim et al., 2002; Alim et al., 2004).  
 With long axons and elaborated dendrites, neurons require a more coordinated 
and widespread regulation of the MT network and membrane trafficking system. 
Potentially important mechanisms for controlling MT dynamics are the post-translational 
modifications of tubulin subunits. Acetylation is the major post-translational modification 
of α-tubulin and occurs on Lys40 (L'Hernault and Rosenbaum, 1985; LeDizet and 
Piperno, 1987; Edde et al., 1991) which, according to structural data, is localized to the 
luminal face of the microtubule (Nogales, 1999; Draberova et al., 2000). The acetylation 
of α-tubulin could regulate the presence of MTs in specific intracellular spaces by 
selective stabilization, promoting the scafold indispensable for an efficient mobilization of 
cargos within neurons. Indeed, α-tubulin acetylation results from dynamic processes 
targeting a MT subset that may restrict to stable MTs (Webster and Borisy, 1989) in most 
cell types, but that may also extend to the whole MT network (Belmadani et al., 2004). 
Like other post-translational modifications of α-tubulin, the level of acetylation is 
regulated by the balance of tubulin acetyltransferase and tubulin deacetylase activities 
(Laurent and Fleury, 1996). As acetylation of tubulin most often compartmentalizes on 
the stable MT subset, it was widely accepted that deacetylases would act preferentially 
on soluble tubulin and that acetylases operate on stable polymers.  
 Although α-tubulin acetylation was firstly described more than 25 years ago, the 
enzymes that control α-tubulin deacetylation and acetylation were identified only in the 
past decade. The first discovery came from the finding that histone deacetylase 6 
(HDAC6), a member of the class II histone deacetylases, which is mainly cytoplasmic 
(Bertos et al., 2004), associates with MTs and deacetylates α-tubulin both in vitro on 
preassembled MTs and in cells (Hubbert et al., 2002; Matsuyama et al., 2002; Zhang et 
al., 2003) Interestingly, and in contrast with the “classical” view of α-tubulin post-
translational modifications, HDAC6 does not deacetylate soluble tubulin dimers in vitro 
(Hubbert et al., 2002). HDAC6 was also found to deacetylate Hsp90, a chaperone that 
was known for a long time to associate with MTs (Redmond et al., 1989; Bali et al., 
2005) and with soluble tubulin (Garnier et al., 1998), and was recently described to bind 
MTs in a tubulin acetylation-dependent manner (Giustiniani et al., 2009). The links 
between HDAC6 and the cytoskeleton also extend to actin microfilaments as HDAC6 
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binds to and deacetylates cortactin (Zhang et al., 2007; Lee et al., 2010b; Lee and Yao, 
2010). Its deacetylation has an impact on actin dynamics by enhancing the interaction of 
cortactin and F-actin thus leading to an increased actin polymerization (Zhang et al., 
2007). Therefore, HDAC6 is seen as a cytoplasmic regulator of cell motility and protein 
transport. 
 A recently emerging aspect is the direct involvement of HDAC6 in autophagy 
progression and clearance, which is of great interest for revealing disease mechanisms 
in neurodegeneration. HDAC6 facilitates the MT and dynein motor-based transport of 
ubiquitinated proteins to aggresomes (Kawaguchi et al., 2003; Pandey et al., 2007). A 
central role for HDAC6 for misfolded protein clearance is further supported by the recent 
study of Lee et al., which shed some light on the question how HDAC6 is linked to 
autophagic clearance mechanistically, and described the fusion of the autophagosome 
with the lysosome as a HDAC6-dependent step in autophagy, depending on the HDAC6 
substrate cortactin and assembly of the actin network (Lee et al., 2010b). In addition, the 
crucial role of HDAC6 in manageing cytotoxic protein overload was also demonstrated in 
a Drosophila model where ectopic expression of HDAC6 could rescue proteasome 
impairment as well as a neurodegenerative phenotype in an autophagy-dependent 
manner (Pandey et al., 2007). The role of HDAC6 in the degradation of protein 
aggregates suggests its involvement in the formation of LBs in PD. In fact, HDAC6 was 
found to colocalize with α-synuclein and ubiquitin in brain sections of PD patients, 
demonstrating that HDAC6 is also a component of LBs (Kawaguchi et al., 2003). In cell 
culture, the association of HDAC6 with polyubiquitinated mutant DJ-1, a protein involved 
in an early onset form of PD, promoted the formation of aggresomes containing DJ-1 
upon proteasome inhibition (Olzmann et al., 2007). This study further demonstrates that 
HDAC6 preferentially binds K63-linked polyubiquitinated DJ-1 in vivo. DJ-1 ubiquitination 
recruits HDAC6, which facilitates the transport of DJ-1 to the MTOC, forming the 
inclusion body. This observation suggests that K63-linked polyubiquitination of DJ-1 may 
act as a novel signal for the dynein-mediated transport and sequestration of misfolded 
proteins in the aggresome. Moreover Parkin, an ubiquitin E3 ligase (often mutated in 
PD), tightly binds to HDAC6 and is also transported by HDAC6 in a MT motor-dependent 
manner to the forming aggresome. There may be ongoing Parkin-mediated ubiquitination 
of misfolded proteins during transport along the MTs (Jiang et al., 2008). 
 The second tubulin deacetylase that was identified is the sirtuin SIRT2, a class III 
histone deacetylase which depends on NAD+ as a cofactor (North et al., 2003). Like 
HDAC6, it mainly resides in the cytoplasm as a result of an active nuclear exportation 
mechanism (North and Verdin, 2007). In contrast to HDAC6, it may use both soluble and 
polymerized tubulin as substrates (North et al., 2003). HDAC6 and SIRT2 do not only 
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share tubulin as a common substrate but they were found to interact in a complex that 
also comprises α-tubulin (Nahhas et al., 2007). Like HDAC6 does, SIRT2 may also 
deacetylate non-tubulin substrates like the transcription factors FOXO1(Jing et al., 2007; 
Wang and Tong, 2009) and p53 (an activity that also requires SIRT1) (Peck et al., 2010) 
or it may control the self-acetylation of the histone acetylase p300 that functions as a 
broad coactivator in regulating gene expression (Black et al., 2008). Conversely, p300 
may also acetylate SIRT2 to down-regulate its enzyme activity (Han et al., 2008). 
 Relevant to PD, inhibition of SIRT2 prevented α-synuclein cytotoxicity and 
modulated its aggregation in cultured cells; ameliorated mutant α-synuclein neurotoxicity 
in rat primary dopamine-positive neurons and rescued degeneration of dopaminergic 
neurons from α-synuclein toxicity in a Drosophila animal PD model (Outeiro et al., 2007). 
However, the mechanisms by which SIRT2 inhibition protects neurons from cell death 
remain uncertain. In addition, it was demonstrated that SIRT2-mediated tubulin 
deacetylation abolished degeneration resistance in the Wallerian mouse model 
subjected to axonal injury induced by MT depolymerizing drugs, suggesting that tubulin 
deacetylation promotes axonal MT destabilization (Suzuki and Koike, 2007). 
 
1.4.2 Selective autophagy and protein turnover 
Although autophagy had been primarily considered a nonselective degradative pathway 
induced by starvation, constitutive basal autophagic activity has now emerged as a main 
QC process that selectively dispose aberrant protein aggregates and damaged 
organelles for degradation (Lee et al., 2010b; Lee et al., 2010a). In fact, several 
autophagy selective processes have been described in recent years based on the nature 
of the cargo degraded by each of them: mitophagy (autophagy of mitochondria), 
pexophagy (autophagy of peroxisomes), lipophagy (autophagy of lipid droplets), and 
aggregophagy (autophagy of aggregates). A specific subset of proteins, known as cargo-
recognition proteins, is involved in each of these subtypes of autophagy, concurring for 
their selectivity (Klionsky et al., 2003; Yang and Klionsky, 2010). All of these proteins, 
including among others p62, the neighbor of Brca1 gene (NBR1) and NIX, contain a 
region that binds to components of the autophagic system (LC3) and a second region 
that recognizes specific tags in the cargo (Lamark et al., 2009). In addition, ubiquitin can 
target organelles such as mitochondria, peroxisomes and protein aggregates for 
autophagic degradation (Bjorkoy et al., 2005; Kim et al., 2008b), making autophagy an 
alternative mechanism to degrade superfluous material that cannot be processed by the 
proteasome. Thus, it is not surprising that malfunction of autophagy could contribute to 
neurodegeneration associated to PD as efficient sequestration and clearance of 
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unneeded or damaged cellular or nonself components is crucial for cell survival and 
function. 
 The most compelling evidence supporting a significant role for autophagy 
dysfunction in PD came from the demonstration that α-synuclein is degraded either by 
macroautophagy and CMA (Webb et al., 2003; Cuervo et al., 2004; Vogiatzi et al., 2008; 
Xilouri et al., 2009). Actually, although α-synuclein can be degraded by the UPS, it also 
contains the KFERQ targeting motif that mediates its degradation through CMA (Webb et 
al., 2003; Cuervo et al., 2004). However, A53T and A30P α-synuclein mutants, that 
cause autosomal dominant PD, are unsuccessfully degraded by CMA because they 
cannot be internalized into lysosomes, despite their higher binding affinity to the 
lysosomal receptor LAMP-2A compared with wild type α-synuclein (Cuervo et al., 2004). 
In addition, due to their tight binding to the lysosomal receptor, α-synuclein mutants often 
end up clogging the CMA translocation system and inhibit their own degradation and that 
of other CMA substrates, leading to a “wide-range” CMA blockage (Cuervo et al., 2004). 
Inhibition of CMA by α-synuclein mutants is accompanied by a compensatory activation 
of macroautophagy that could help alleviate that conditions (Wong and Cuervo, 2010), 
although the physiological significance of this event is not completely understood. In 
addition to the rare α-synuclein mutations, phosphorylated, ubiquitinated, nitrated and 
oxidized forms of α-synuclein impair, to some extent, further degradation of α-synuclein 
by CMA, but not degradation of other substrates (Cuervo et al., 2004; Engelender, 
2008). However, modification of the protein via a noncovalent interaction with oxidized 
dopamine gives a phenotype that more closely resembles the point mutations (Maguire-
Zeiss et al., 2005; Norris et al., 2005). Dopamine-modified α-synuclein is not only poorly 
degraded by CMA, but also blocks degradation of other substrates, thereby increasing 
cellular vulnerability to stressors (Martinez-Vicente et al., 2008). This is especially 
relevant because oxidized metabolites of dopamine such as dopamine quinone 
derivatives are thought to play a critical role in the preferential loss of dopaminergic 
neurons in PD (Martinez-Vicente et al., 2008). The blockage of CMA activity with mutant 
forms of α-synuclein not only results in the direct buildup of toxicity in the neuron through 
the formation of aggregates, but it also prevents the protective activity of the protein 
myocyte enhancer factor 2D (MEF2D), a transcription factor required for neuronal 
survival, and CMA substrate (Yang et al., 2009). Interestingly, it was demonstrated that 
both wild-type and A53T mutant α-synuclein interfere with the binding of MEF2D to the 
chaperone HSC70 in the CMA degradation machinery. Consistent with this observation, 
the cytoplasmic pool of MEF2D is increased in A53T α-synuclein transgenic mice and in 
postmortem brain tissue from PD patients (Smith et al., 2006), and a similar increase of 
inactive MEF2D in the cytoplasm has been found in neurons upon inhibition of CMA 
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(Yang et al., 2009). These findings rise up two interesting possibilities: (1) α-synuclein 
promotes neuronal cell death through the formation of aggregates, but also by the 
inhibition of cell survival proteins; (2) compromised neuronal viability observed in PD 
results, at least in part, from CMA dysfunction. 
 As abovementioned, inhibition of CMA by aberrant α-synuclein leads to an 
increase in autophagy. This appears to be a compensatory response, but rather than 
leading to cell survival, the induction of autophagy can be detrimental causing 
autophagic cell death. For example, alterations in macroautophagy have been 
associated with wild-type α-synuclein accumulation, suggesting that this lysosomal 
pathway is also involved in normal α-synuclein turnover (Vogiatzi et al., 2008). 
Nevertheless, blocking autophagy by knocking down the autophagy protein Atg5 in cells 
expressing the A53T a-synuclein mutant can rescue the cell from toxicity-induced cell 
death (Xilouri et al., 2009). More recently, it was also demonstrated that α-synuclein 
overexpression not only impairs CMA but also macroautophagy through RAB1A and 
omegasome formation as observed in both cell and mouse models (Winslow et al., 
2010). α-Synuclein blocks autophagy by inhibiting the activity of RAB1A, a GTPase 
involved in the early secretory pathway, specifically in the ER-to-Golgi transport. These 
data show an Atg9 mislocalization and consequent inhibition of autophagosome 
formation (Winslow et al., 2010). 
 
1.4.3 Mitophagy: the autophagic mitochondria removal 
The role of autophagy dysfunction in PD is not restricted to the removal of cytosolic PD-
related or other damaged proteins but also involve removal of dysfunctional organelles, 
such as mitochondria. Accumulating data suggests that mitochondrial dysfunction by 
itself triggers mitophagy. Changes in the MPT that result in loss of mitochondria 
membrane potential were initially found to be a selective marker for mitochondria 
degradation (Lemasters et al., 1998; Kim et al., 2007). More recently, a predicted 
mitochondrial targeting signal (MTS) was identified in the N-terminus of PINK1 after 
mitochondria depolarization (Jin et al., 2010), which can determine the selective 
recruitment and the binding of cytosolic proteins to the surface of the dysfunctional 
mitochondria (Narendra et al., 2008; Narendra et al., 2010). Additionally, other studies 
have also revealed the involvement of α-synuclein, Parkin, PINK1 and LRRK2 in the 
regulation of mitochondrial degradation and homeostasis. Overexpression of α-
synuclein, Parkin and PINK1 results in enhanced mitochondrial fragmentation, followed 
by activation of mitophagy (Kamp et al., 2010; Kawajiri et al., 2010; Vives-Bauza et al., 
2010), supporting an essential role of autophagy in the clearance of defective 
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mitochondria in PD. In cells expressing the A53T α-synuclein mutant, an increased 
colocalization of autophagosomes with normal and polarized mitochondria occurs. In 
addition, there is a decrease in the number and length of mitochondria in these cells 
(Choubey et al., 2011). The increase in mitochondria clearance in these cell lines is 
dependent on mitochondrial fragmentation and on the protein Parkin. Parkin is 
selectively recruited to dysfunctional mitochondria with low membrane potential in 
mammalian cells (Narendra et al., 2008) and relies on the expression of wild-type PINK1, 
but not PD related PINK1 mutants, due to a decreased physical binding of PINK1 to 
Parkin (Geisler et al., 2010b). This occurs via phosphorylation-dependent regulation of 
Parkin (Sha et al., 2010), suggesting a pathogenic role of PINK1 and Parkin loss-of-
function mutations in PD. Once in mitochondria, Parkin activates the UPS, that will 
mediate the ubiquitination of VDAC-1 (Geisler et al., 2010a), mitofusins Mfn1 and Mfn2, 
among other mitochondrial proteins (Gegg et al., 2010), and serve to recruit the 
ubiquitin-binding histone deacetylase HDAC6 and p62, which assemble the autophagic 
machinery (LC3) for efficient degradation of impaired mitochondria (Geisler et al., 2010a; 
Chan et al., 2011). In addition, Parkin was recently shown to interact with Ambra 1, an 
autophagy/Beclin-1 regulator, that critically determines the final step of Parkin-mediated 
mitochondrial clearance (Van Humbeeck et al., 2011) 
 The role of LRRK2 in regulating autophagy was also addressed. Interestingly, it 
was demontrated that LRRK2 specifically localizes to specific membrane subdomains 
and endosomal-autophagic structures, suggesting a functional relationship between 
LRRK2 and mitophagy (Alegre-Abarrategui et al., 2009). Furthermore, increased 
autophagic activity upon LRRK2 knockdown was observed, which indicates that LRRK2 
may normally act as a negative regulator of autophagy (Alegre-Abarrategui et al., 2009). 
Alternatively, LRRK2 regulation in neurite blunting and remodeling requires autophagy 
(Plowey et al., 2008). Thus, by impairing this pathway, mutations in parkin, PINK1, and 
LRRK2 may alter autophagy-dependent mitochondrial turnover which, in turn, may cause 
the accumulation of defective mitochondria and, ultimately, neurodegeneration in PD.   
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1.5 Aims and thesis outline 
Understanding the molecular basis of sPD has proven to be a major challenge in the 
field of neurodegenerative diseases. Although several hypotheses have been proposed 
to explain the molecular mechanisms underlying the pathogenesis of sPD, growing 
evidence has highlighted the role of mitochondrial dysfunction and the disruption of 
mechanisms which rely on mitochondrial bioenergetics in sPD. But the role of 
mitochondria in sPD extends beyond defective mitochondrial respiratory chain and may 
involve mitochondrial dynamics, intracellular trafficking, protein quality control, or redox 
homeostasis. 
 Data from human genetics and studies in model organisms, as well as from 
biochemical and biophysical characterization of the proteins involved in PD, have 
demonstrated that most cases of PD can be considered as arising from protein 
misfolding, protein aggregation, or defective degradation and clearance, and that 
proteostasis network pathways are also altered in sPD. However, it remains an open 
question whether alterations of these pathways lead to different aspects of PD or 
whether they converge at a point that is the common denominator of sPD pathogenesis. 
In addition, clear insights of exactly how and when mitochondria and proteostasis 
network pathways interconnect, overlap or converge to produce nigral neuronal 
degeneration will be crucial to understanding the pathogenesis of sPD. 
 In this work, we aim to address the potential implications of an altered structural 
and functional crosstalk between mitochondria and the ER, two important metabolic 
organelles for the maintenance of cellular protein homeostasis. In addition, we will 
assess the role of mitochondrial metabolism in the regulation of the autophagy-lysosomal 
pathway, a major cellular homeostatic process essential for bulk and/or selective 
degradation of cytoplasmic contents. 
 The data obtained will be presented according with the following specific aims: 
 
- Address the molecular mechanism underlying the interplay between 
mitochondria and ER dysfunctions under particular stressfull conditions of 
sPD; 
 
- Investigate whether the modulation of ER-mitocondria interaction, as well as 
the Ca2+ shuttling between ER and mitochondria, has repercursions to the 
intracellular homeostasis and consequently to lowering the cell's threshold to 
survival; 
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- Establish a molecular framework between deregulation of the autophagy 
pathway observed in PD patients brains and mitochondrial dysfunction; 
 
- Explore the hypothesis that dysfunctional mitochondria lead to impaired 
vesicular trafficking and protein turnover; 
 
- Unravel the mechanistic link between mitochondria-, autophagy-, and 
microtubule network dysfunctions. 
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2.1 Materials 
2.1.1 Chemicals and cell media  
The most common chemicals and media used were as categorized in the Table II.1. 
Table II.1 Chemicals and cell media, with the corresponding company. 
 
CHEMICAL COMPANY 
Antibodies  
Alexa Fluor
®
 488-conjugated goat anti-rabbit Molecular Probes (Eugene, OR, USA) 
Alexa Fluor
® 
594-conjugated goat anti-mouse Molecular Probes (Eugene, OR, USA) 
Goat alkaline phosphatase-conjugated anti-
mouse 
GE Healthcare (Buckinghamshire, UK) 
Goat alkaline phosphatase-conjugated anti-
rabbit 
GE Healthcare (Buckinghamshire, UK) 
Mouse mAb* anti-Beclin BD Biosciences (San Diego, CA, USA) 
Mouse mAb anti-BiP/GRP78 BD Biosciences (San Diego, CA, USA) 
Mouse mAb anti-class III β -tubulin (clone TU-
20) 
Cell Signaling (Danvers, MA, USA) 
Mouse mAb anti-class III β-tubulin (clone TUJ) Covance Inc. (Princeton, NJ, USA) 
Mouse mAb anti-GAPDH AbCam (Cambridge, UK) 
Mouse mAb anti-Hsp60 Millipore (Billerica, MA, USA) 
Mouse mAb anti-LAMP-1 (clone H4A3) Developmental Studies Hybridoma Bank 
(University of Iowa, Iowa, USA) 
Mouse mAb anti-MAP2 Sigma-Aldrich Co. (St. Louis, MO, USA) 
Mouse mAb anti-TATA binding protein TBP AbCam (Cambridge, UK) 
Mouse mAb anti-α-synuclein (clone LB509) Invitrogen Corporation (Camarillo, CA, USA). 
Rabbit mAb anti-LC3B (D11) XP
®
 Cell Signaling (Danvers, MA, USA) 
Rabbit mAb anti-α-tubulin (clone 11H10) Cell Signaling (Danvers, MA, USA) 
Rabbit pAb* anti-Bcl-2 Cell Signaling (Danvers, MA, USA) 
Rabbit pAb anti-Beclin Cell Signaling (Danvers, MA, USA) 
Rabbit pAb anti-COX IV Cell Signaling (Danvers, MA, USA) 
Rabbit pAb anti-LC3B Cell Signaling (Danvers, MA, USA) 
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Rabbit pAb anti-NDUFA2 Generous gift of Dr. Leo Nijtmans (Radboud 
University Nijmegen Medical Center, The 
Netherlands) 
Rabbit pAb anti-SIRT2 Cell Signaling (Danvers, MA, USA) 
Rabbit pAb anti-SQSTM1/p62 Cell Signaling (Danvers, MA, USA) 
Rabbit pAb anti-TOM20 Santa Cruz Biotechnology (Santa Cruz, CA, 
USA) 
Rabbit pAb anti-VDAC/Porin AbCam (Cambridge, UK) 
Rabbit pAb anti-Vimentin Cell Signaling (Danvers, MA, USA) 
  
Cell culture chemicals and media  
5-fluoro-2’-deoxyuridine (FUdR) Sigma-Aldrich Co. (St. Louis, MO, USA) 
all-trans retinoic acid (ATRA) Sigma-Aldrich Co. (St. Louis, MO, USA) 
B-27 supplement Gibco
TM
, Invitrogen Corporation (Camarillo, 
CA, USA). 
Bovine serum albumin (BSA) fatty acid free Sigma-Aldrich Co. (St. Louis, MO, USA) 
Cytosine β-D-arabinofuranoside (araC) Sigma-Aldrich Co. (St. Louis, MO, USA) 
Deoxyribonuclease I (DNAse I) Sigma-Aldrich Co. (St. Louis, MO, USA) 
Dialyzed fetal bovine serum (FBS) Gibco
TM
, Invitrogen Corporation (Camarillo, 
CA, USA). 
Dulbecco's Modified Eagle (DMEM) Medium Gibco
TM
, Invitrogen Corporation (Camarillo, 
CA, USA). 
L-glutamine Sigma-Aldrich Co. (St. Louis, MO, USA) 
Minimum Essential Medium (S-MEM) Gibco
TM
, BRL, Life Technologies (Scotland, 
UK) 
Neurobasal medium Gibco
TM
, Invitrogen Corporation (Camarillo, 
CA, USA). 
Non-dialyzed FBS Gibco
TM
, Invitrogen Corporation (Camarillo, 
CA, USA). 
Opti-MEM
®
 I Reduced Serum Medium Gibco
TM
, BRL, Life Technologies (Scotland, 
UK) 
Penicillin Gibco
TM
, Invitrogen Corporation (Camarillo, 
CA, USA). 
Poli-D-lysine, Sigma-Aldrich Co. (St. Louis, MO, USA) 
Poli-L-lysine Sigma-Aldrich Co. (St. Louis, MO, USA) 
Polyethylene glycol 1000 (PEG 1000) Merck (Darmstadt, Germany) 
Sodium pyruvate solution Sigma-Aldrich Co. (St. Louis, MO, USA) 
Streptomycin Gibco
TM
, Invitrogen Corporation (Camarillo, 
CA, USA). 
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Trypsin/Ethylenediamine tetraacetic acid 
(EDTA) solution 
Sigma-Aldrich Co. (St. Louis, MO, USA) 
Uridine (Urd) Sigma-Aldrich Co. (St. Louis, MO, USA) 
  
Enzyme inhibitors  
3-Methyladenine (3-MA) Sigma-Aldrich Co. (St. Louis, MO, USA) 
AK-1 Sigma-Aldrich Co. (St. Louis, MO, USA) 
Chymostatin Sigma-Aldrich Co. (St. Louis, MO, USA) 
Leupeptin Sigma-Aldrich Co. (St. Louis, MO, USA) 
Pepstatin A Sigma-Aldrich Co. (St. Louis, MO, USA) 
Phenylmethylsulfonyl fluoride (PMSF) Sigma-Aldrich Co. (St. Louis, MO, USA) 
Rapamycin Sigma-Aldrich Co. (St. Louis, MO, USA) 
Trypsin inhibitor type-II soybean Sigma-Aldrich Co. (St. Louis, MO, USA) 
Tubastatin A BioVision Inc. (Milpitas, CA, USA) 
  
Enzyme substrates  
N-Ac-Asp-Glu-Val-Asp-pNA (NAc-DEVD-pNA) Calbiochem, Merck KGaA (Darmstadt, 
Germany) 
N-Ac-Leu-Glu-His-Asp-pNA (NAc-LEDH-pNA) Calbiochem, Merck KGaA (Darmstadt, 
Germany) 
N-Ac-Leu-Glu-Val-Asp-pNA (NAc-LEVD-pNA) MBL International Corporation (Woburn, MA, 
USA) 
N-Ac-Val-Asp-Val-Ala-Asp-pNA (NAc-VDVAD-
pNA) 
Sigma-Aldrich Co. (St. Louis, MO, USA) 
  
Fluorescent dyes  
Acetoxymethyl ester of Fura-2 (Fura-2, AM) Molecular Probes
®
, Invitrogen (Eugene, OR, 
USA) 
Acetoxymethyl ester of Rhod-2 (Rhod-2, AM) Molecular Probes
®
, Invitrogen (Eugene, OR, 
USA) 
Hoechst 33342 Molecular Probes
®
, Invitrogen (Eugene, OR, 
USA) 
Mitotracker Green Molecular Probes
®
, Invitrogen (Eugene, OR, 
USA) 
Rhodamine 123 Sigma Chemical Co (St. Louis, MO, USA) 
  
Western blotting purpose  
Enhanced chemifluorescence (ECF) reagent 
Hybond
TM
-P PVDF membrane 
GE Healthcare (Buckinghamshire, UK) 
GE Healthcare (Buckinghamshire, UK) 
Immobilon
TM
-P PVDF membrane Millipore (Billerica, MA, USA) 
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Low range all blue prestained protein standard Bio-Rad (Hercules, CA, USA) 
  
Others  
1-methyl-4-phenylpyridinium (MPP
+
) Sigma-Aldrich Co. (St. Louis, MO, USA) 
Ammonium chloride (NH4Cl) Merck KGaA (Darmstadt, Germany) 
Brefeldin Sigma-Aldrich Co. (St. Louis, MO, USA) 
BSA (Fraction V, Low heavy metals) Calbiochem
TM
, Merck (Darmstadt, Germany) 
Calimycin (A23187) Sigma-Aldrich Co. (St. Louis, MO, USA) 
Carbonyl cyanide-p 
trifluoromethoxyphenylhydrazone (FCCP) 
Sigma-Aldrich Co. (St. Louis, MO, USA) 
Dantrolene Sigma-Aldrich Co. (St. Louis, MO, USA) 
Dithiothreitol (DTT) Sigma-Aldrich Co. (St. Louis, MO, USA) 
Histopaque – 1077 Sigma-Aldrich Co. (St. Louis, MO, USA) 
Nocodazole Sigma-Aldrich Co. (St. Louis, MO, USA) 
Oligomycin Sigma-Aldrich Co. (St. Louis, MO, USA) 
Paclitaxel (Taxol) Sigma-Aldrich Co. (St. Louis, MO, USA) 
Pluronic F-127 Molecular Probes
®
, Invitrogen (Eugene, OR, 
USA) 
Potassium cyanide (KCN) Sigma-Aldrich Co. (St. Louis, MO, USA) 
Thapsygargin Sigma-Aldrich Co. (St. Louis, MO, USA) 
Tunicamycin Sigma-Aldrich Co. (St. Louis, MO, USA) 
Ubiquinone Sigma-Aldrich Co. (St. Louis, MO, USA) 
*mAb: monoclonal antibody; pAb: polyclonal antibody 
 
All other chemicals were of the best analytical grade and were purchased from Merck 
(Darmstadt, Germany) or Sigma-Aldrich Co. (St. Louis, MO, USA). 
 
2.1.2 Biological materials 
2.1.2.1 Human subjects’ characteristics 
Sporadic PD (sPD) patients and healthy individuals were all recruited after approval by 
the University of Kansas School of Medicine Institutional Review Board. Individuals in the 
PD group were followed regularly in a tertiary referral movement disorders clinic at the 
Kansas University Medical Center and met criteria commonly used to diagnose PD in 
clinical and research settings (Litvan et al., 2003). None of the patients were believed to 
have alternative diagnoses, degeneration of related systems, drug-induced 
Parkinsonism, or any other serious medical illness. Enrollment was also contingent on 
the absence of a diagnosis for another neurodegenerative disease. 
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 The control (CT) subjects were participants of a longitudinal “normal ageing” cohort 
that is characterized serially by the Brain Ageing Project at the University of Kansas 
School of Medicine. These CT subjects have not been diagnosed with a 
neurodegenerative or pre-neurodegenerative disease condition. The age of the PD 
subjects who participated in this study was 64±12.8 years, and for the CT subjects it was 
74.3±5.5 years.  
 After informed consent was given, sPD (n=9) and age-matched CT (n=5) subjects 
underwent a 10 ml phlebotomy using tubes containing acid-citrate-dextrose, as an 
anticoagulant, to provide the platelets needed for cell fusions. 
 
2.1.2.2 Animals 
Experiments involving animals were approved by and performed in accordance with the 
University of Coimbra Institutional Animal Care and Use Committee guidelines and 
European Community Council Directive for the Care and Use of Laboratory Animals 
(86/609/ECC). 
 
2.2 Cell Culture 
2.2.1 Human Cell Lines Culture 
2.2.1.1 Parental Teratocarcinoma (NT2 Rho+) cell line  
The NT2 (Ntera2/ clone D1) cells, from a neuronally committed human teratocarcinoma 
cell line (Pleasure and Lee, 1993; Sodja et al., 2002), were purchased from Stratagene 
Cloning Systems (La Jolla, CA, USA) and were cultured as described previously 
(Cardoso et al., 2001). Briefly, cells were grown in 75 cm2 tissue culture flasks in Opti-
MEM® medium (a modification of Eagle's Minimum Essential Medium) supplemented 
with 10% heat-inactivated fetal bovine serum (FBS), 10,000U/mL penicillin and 10 µg/mL 
streptomycin. Cells were maintained under a humidified atmosphere of 95% air, 5% CO2, 
at 37ºC and and were split by incubating them in 0.05% (v/v) trypsin solution whenever 
flasks were 80-100% confluent. In early passages, cells were split 1:4; at later passages, 
cells were split 1:5 or 1:6 because cell growth rate increase at later passages. 
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2.2.1.2 mtDNA depleted (NT2 Rho0) cell line  
The mtDNA-free Rho0 cell-line used for these studies was kindly provided by Dr. RH 
Swerdlow (University of Kansas School of Medicine, Kansas City, Kansas, USA). This 
cell line was created in the NT2 cells background by long-term exposure (at least 150 
days) to 5 µg/mL ethidium bromide (Sigma-Aldrich Co., St. Louis, MO, USA) in growth 
medium to deplete selectively mitochondrial DNA (mtDNA) (Swerdlow et al., 1996).  
 Cells were grown in 75 cm2 tissue culture flasks in Opti-MEM® medium, 
supplemented with 10% heat-inactivated FBS, 10,000 U/mL penicillin and 10 µg/mL 
streptomycin, 150 µg/mL uridine and 200 µg/mL pyruvate. Cells were maintained under 
a humidified atmosphere of 95% air, 5% CO2, at 37ºC and and were split by incubating 
them in 0.05% (v/v) trypsin solution whenever flasks were 80-100% confluent. In early 
passages, cells were split 1:2; at later passages, cells were split 1:4 because cell growth 
rate increase at later passages. 
 
2.2.1.3 Generation of transmitochondrial hybrid (cybrids) cell lines  
Cybrid approach consists of the transfer of sPD or healthy subjects’ platelet mitochondria 
to mtDNA-depleted recipient cells (Rho0 cells), generating hybrid cell lines (cybrids). 
Platelets (which contain mtDNA but not nDNA) from PD subjects are known to have 
reduced complex I activity relatively to control subjects’ (Parker et al., 1989). We used 
platelet mitochondria to generate cybrid cell lines from both sPD and disease-free control 
subjects. Thus, the resulting cybrid cell lines express the nuclear genes of the recipient 
Rho0 cell line and the mitochondrial genes of the platelet donor (Figure II.1). 
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Figure II.1 Generation of cybrid cell lines.  
Tumor or immortalized cell lines are grown in the presence of ethidium bromide, which effectively 
eliminates functional mtDNA to result in a Rho0 cell line. Rho0 cells are then fused with patient 
platelets, which contain mitochondria but not nuclei. This creates cytoplasmic hybrid (cybrid) cells 
that can be isolated and expanded. The expanded cybrid cell cultures are biochemically analyzed. 
Differences in function between cell lines mostly likely arise through differences in their mtDNA. 
 
 
 The preparation and fusion of donor and host cells and selection of repopulated 
cybrid cell lines was as detailed subsequently: 
 
 Isolation of platelets 
Previously, platelets were isolated from the individual blood sample which was drawn 
aseptically into a tube containing 2.2% citrate, 0.8% citric acid, and 2.45% dextrose. Ten 
milliliters of blood were separated over three mL of Histopaque-1077-1 in a 12 mL 
AccuspinTM tube (Sigma-Aldrich Co., St. Louis, MO, USA) by centrifugation at 1000 ×g 
for 10 min, at room temperature. The platelet (top) layer was washed with 15 mL of 
Minimum Essential Medium (S-MEM). Platelets were counted, then washed again, and 
resuspended to 1×108 cells/mL. Aseptic blood drawing and sample collection were 
essential to eliminate the propagation of mycoplasma and other organisms. 
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 Fusion 
Fusion of human platelets with NT2 Rho0 cells was facilitated by the presence of dilute 
polyethylene glycol 1000 (PEG 1000). Autoclaved PEG was melted and mixed 1:1 (w/v) 
with S-MEM and pH was adjusted to 7.2 with sterile 0.1 N NaOH. Then, one mL of 
platelets (1×108) and one mL Rho0 cells (1.5×106) were mixed and allowed to adhere at 
room temperature for 10 min. The mixture was then centrifuged at 200 ×g for 5 min and 
supernatant was removed. To fuse cells, 150 µL S-MEM-diluted pH 7.2 PEG solution 
was added to the pellet and allowed to penetrate for 10 s. This mixture was then gently 
ressuspended 10 times with a wide bore pipet tip until smooth. At 90 s, 12 mL growth 
medium was added to the pellet and the whole content was transferred to a 75 cm2 flask. 
Media were changed at 24 h after cells have adhered to the flask. As a control, “mock 
fusions”, in which NT2 Rho0 cells were not co-incubated with platelets, were performed 
in parallel with the proper fusions. The resulting cybrids were maintained for one week or 
until cells were 90% confluent in Rho0 growth medium, that was changed every 2–3 
days. 
 
 Cybrid selection 
NT2 Rh0 cells lack intact mtDNA, do not possess a functional mitochondrial electron 
chain, and are auxotrophic for pyruvate and uridine. Maintaining cells in selection 
medium removes Rh0 cells that have not repopulated their mtDNA with platelet mtDNA.  
The cybrid selection process began by substituting Rho0 growth medium (with pyruvate 
and uridine) for the selection medium (growth medium that lacked pyruvate and uridine 
and contained dialyzed heat-inactivated serum). After 4 days in selection medium, Rho0 
cells that had not fused with platelets began to die. Cybrids were typically split every 5 
days. Cells in the mock fusion were always split 1:1 and decreased in numbers over 
time. Selection was considered complete when the mock fusion flask contained fewer 
than 20 cells. 
 After selection was complete, the cybrids were changed to cybrid growth medium. 
Flasks were maintained in this medium at 37ºC, 5% CO2 for 24 hours prior to harvesting. 
Afterward, cybrids were maintained in growth medium under a humidified atmosphere of 
95% air, 5% CO2 at 37ºC and were split by incubating them in 0.05% (v/v) trypsin 
solution whenever flasks were 80-100% confluent. In early passages, cybrids were split 
1:4; at later passages, cells were split 1:6 or 1:8 because cell growth rate increase at 
later passages. 
 
 
 
Materials & Methods  
 
55 
2.2.1.4 Cybrid cell line neuronal differentiation and culture 
Cybrid cell lines with an NT2 background present a commited neuronal precursor stage 
of differentiation. NT2 precursor cells can be induced by all-trans retinoic acid (ATRA) to 
differentiate in vitro into post mitotic central nervous system neurons. 
 Cybrid cell lines were induced to form process-bearing neuronal cells according to 
the procedure of Paquet-Durand et al. (Paquet-Durand et al., 2003). Cells were allowed 
to form free floating conglomerates in non-tissue culture plastic, 10 cm diameter dishes 
in growth medium supplemented with 10 µM ATRA, renewed every 2 days. After 8 days 
in culture, the conglomerates were seeded in 75 cm2 cell culture flasks and cultures were 
kept for 10 days to completely generate a large number of cell aggregates. A single-cell 
suspension was then derived from the conglomerates by trypsinization and transferred to 
175 cm2 culture flasks. Cells were cultured for 4 days to expand the culture and to further 
obtain conditioned medium. After that, cells were selectively trypsinized and transferred 
again to 75 cm2 culture flasks, where they were kept for 2 weeks to eliminate persistent 
undifferentiated cells by adding mitotic inhibitors (AraC 1 μM, FudR 10 μM, Urd 10 μM) in 
the growth medium. Finally, neuron-like cells (1×105 per coverslip) were plated onto 
glass coverslips (16 mm diameter) pre-coated with poly-D-lysine in 50:50 conditioned 
medium and were allowed to improve neurite outgrowth for 4 days for further 
immunocytochemical experiments.  
 The enrichment and purity of neuronal-like cultures was evaluated by comparing 
the number of cells staining positively with antibodies directed against neuronal marker 
β-tubulin III (clone TU20), with the number of nuclei stained with Hoechst 33342 dye. 
The number of β-tubulin III-positive cells and Hoechst 33342-positive nuclei were 
counted in 10 randomly selected visual fields. This was performed for two independent 
experiments. 
 
2.2.2 Isolation of human peripheral blood mononuclear cells (PBMCs)  
Data obtained using cell lines were corroborated in human PBMCs obtained from control 
and sPD patients. PBMCs were composed of 90% of lymphocytes and 10% monocytes 
and in this study were considered as a lymphocytic population. 
 For this purpose, 20 ml of venous blood from both sPD and disease-free CT 
subjects were collected by venipuncture in K2EDTA-containing tubes. PBMCs were 
isolated by Histopaque-1077 density gradient centrifugation, according to the 
manufacturer’s instruction. Briefly, blood samples were diluted with the same amount of 
Hanks's balanced salt solution (HBSS), layered on Histopaque-1077-1 and centrifuged 
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for 30 min at 300 ×g, at room temperature. PBMCs were collected from the interface 
between serum and Histopaque-1077-1 gradients and washed once with HBSS.  
 
2.2.3 Mouse primary cortical neurons isolation and culture 
Primary neuronal cultures were prepared as described previously (Agostinho and 
Oliveira, 2003), with minor modifications. Cerebral cortices were removed from 
embryonic day 15-16 of Wistar rats and were aseptically dissected and combined in 
Ca2+- and Mg2+-free Krebs buffer [10 mM HEPES (pH 7.4), 1.2 mM KH2PO4, 120 mM 
NaCl, 4.8 mM KCl, 13 mM glucose] and then incubated in Krebs solution supplemented 
with 0.3 g/L BSA containing 0.5 g/L trypsin and 0.04 g/L DNase I for 10 min, at 37ºC. 
Tissue digestion was stopped by the addition of trypsin inhibitor (type II-S; 0.75 g/L) in 
Krebs buffer containing 0.04 g/L DNase I, followed by a centrifugation at 140 ×g for 5 
min. After washing the pellet once with Krebs buffer, the cells were dissociated 
mechanically and resuspended in fresh Neurobasal medium supplemented with 2 mM L-
glutamine, 2% (v/v) B-27 supplement, 100,000 U/L penicillin, and 100 mg/L 
streptomycin. The cells were seeded on poly-L-lysine (0.1 g/L)-coated dishes at a 
density of 0.75×106 cells/mL for Western blotting. For immunofluorescence studies, 
neurons were mounted on poly-L-lysine-coated glass coverslips at a density of 1.6×106 
cells/mL. The cultures were maintained in serum-free Neurobasal medium supplemented 
with B-27 at 37ºC in a humidified atmosphere of 5% CO2, 95% air for 6 days before 
treatment, in order to allow neuronal differentiation. After 6 days in vitro (6 DIV), cultured 
neurons were treated with 50 µM MPP+, 24h before fixation or harvesting. Where 
indicated, 20 mM ammonium chloride and 20 μM leupeptin, and 10 mM 3-MA or 10 nM 
rapamycin were added in the culture medium in the last 4 h of MPP+ treatment. The 
composition of the cultures was determined by immunolabeling in addition to 
physiological characterization. The majority of cells (90–95%) were positive for neuronal 
markers (MAP2, TUJ1), whereas <10% of cells showed immunolabeling for the 
astrocytic marker glial fibrillary acidic protein (GFAP). 
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2.3 Evaluation of mitochondrial structure and function 
2.3.1 Mitochondrial ultrastructure  
Cybrids and Rho0 cells were grown in 75 cm2 culture flasks till 90% confluence and 
growth medium was changed 1–3 h before harvesting. Then cellular suspensions from 
each cell lines were obtained and were fixed with 2.5% gluteraldehyde/2% 
paraformaldehyde in 100 mM sodium cacodylate (SC), pH 7.43, and post-fixed in 1% 
osmium tetroxide in SC followed by 1% uranyl acetate. After ethanol dehydration and 
embedding in LX112 resin (LADD Research Industries), ultrathin sections were stained 
with uranyl acetate followed by lead citrate. Grids were viewed on a JEOL JEM 1400 
transmission electron microscope operated at 80 kV. For the quantification of 
mitochondria in cells, 10-15 different electronmicrographs for each cell line were 
analyzed. 
 
2.3.2 Mitochondrial morphology 
Cybrid cells growing in 75 cm2 flasks were replated on treated glass coverslips (16 mm 
diameter) in 12-well plates at the concentration of 1.0×105 cells/mL. After 24 h, cells were 
washed twice with serum-free growth medium and once with (1:1) serum-free growth 
medium: 4% (v/v) paraformaldehyde in PBS solution, for 10 min. Then cells were fixed 
with 4% (v/v) paraformaldehyde in PBS solution for 20 minutes, at room temperature. 
The fixed cells were washed again with PBS, permeabilized with 0.2 % (v/v) Triton X-100 
in PBS and incubated with 3% (w/v) BSA in PBS, for 30 min, to prevent nonspecific 
binding. Then, cells were incubated with the primary rabbit polyclonal anti-TOM-20 
(1:200) antibody overnight followed by washing with PBS and incubation with the 
secondary antibody Alexa Fluor® 488-conjugated goat anti-rabbit for 1 h. After washing 
twice with PBS, nuclei were counterstained with 5 µg/mL Hoechst 33342 dye in PBS. 
After a final wash, the coverslips were immobilized on a glass slide with mounting 
medium (DakoCytomation, Dako, Glostrup, Denmark). Negative CTs omitting primary 
antibody were performed in each case, and no staining was seen (data not shown). 
Images were acquired on a Zeiss LSM 510 meta-confocal microscope (63 × 1.4NA plan-
apochromat oil immersion lens) by using the Zeiss LSM510 v3.2 software (Carl Zeiss, 
Inc., Thornwood, NY, USA) and analyzed using Zeiss LSM Image Examiner. 
 Fluorescence microscopy images were optimized by adjusting the contrast and 
afterwards binarized by conversion to 8-bit images. After unspecific noise of the 
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fluorescence signal was reduced, a spatial filter (convolution filter) as well as a threshold 
was applied to the images to define mitochondrial structures. Using a custom-written 
macro containing plug-ins (Dagda et al., 2009) from ImageJ1.46e software (Wayne 
Rasband; National Institutes of Health, USA), every single mitochondrion of the 
investigated cells was marked to analyze morphological characteristics such as its area, 
perimeter, major and minor axes. The area/perimeter ratio was employed as an index of 
mitochondrial interconnectivity, and inverse circularity was used as a measure of 
mitochondrial elongation. 
 
2.3.3 Mitochondrial content 
Cybrid cell lines growing in 75 cm2 flasks were replated into 10 cm petri-dishes at the 
concentration of 3.0×105 cells/mL. After 24 h in culture, individual cell lines were washed 
once with ice-cold PBS, scraped and harvested on ice with a 1% (v/v) Triton X-100 
containing hypotonic lysis buffer [25 mM HEPES (pH 7.5), 2 mM MgCl2, 1 mM EDTA and 
1 mM EGTA, supplemented with 2 mM DTT, 0.1 mM PMSF and a 1:1000 dilution of a 
protease inhibitor cocktail]. The cellular suspension was frozen/thawed three times on 
liquid nitrogen and centrifuged at 20,000 ×g, for 10min at 4ºC. The resulting supernatant 
was collected and assayed for protein concentration using the Bio-Rad Protein Assay 
(Bio-Rad, Hercules, CA, USA). 
 For each sample, 50 µg of protein were separated under reducing conditions on 
12% sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) after 
denaturation at 100ºC, for 5 min, in a 6 × concentrated sample buffer [100 mM Tris-HCl 
(pH 6.8), 100 mM DTT, 4% (w/v) SDS, 0.2% (w/v) bromophenol blue and 20% (v/v) 
glycerol]. Proteins were then transfered to a ImmobilonTM-P PVDF (polyvinylidene 
difluoride) membrane, which was further blocked with 5% (w/v) non fat milk in Tris-
buffered saline buffer [50 mM Tris (pH 7.6), 150 mM NaCl], 0.1% (v/v) Tween 20 (TBS-
T), for 1h, at room temperature. After blocking, membranes were subjected to an 
overnight incubation with the anti-Hsp60 (1:1000), anti-VDAC/Porin (1:800), anti-COXIV 
(1:1000), anti-TOM20 (1:1000), anti-NDUFA2 (1:200) or anti-α-tubulin (1:10,000) primary 
antibodies, at 4ºC. Membranes were further washed three times with TBS-T and then 
incubated with the corresponding alkaline phosphatase-conjugated secondary antibody 
(1:15,000) for 1h, at room temperature. The membranes were washed again three times 
and bound antibodies detected using the enhanced chemifluorescence reagent (ECF) 
according to the manufacturer’s instructions.  
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 Blots were visualized using a VersaDoc imageing system (Bio-Rad, Hercules, CA, 
USA) and protein bands densitometry quantified using the Quantity-One software (Bio-
Rad, Hercules, CA, USA). 
 
2.3.4 mtDNA screening 
Total DNA was extracted from three PD and three CT cybrids by using standard 
methods and quantified by UV spectrophotometry (λ=260 nm). Automated sequencing 
analysis was used, according to the manufacturer's instructions (3130 ABI Prism 
sequencing system), with BigDye® Terminator Ready Reaction Mix v3.1 (Applied 
Biosystems), for the investigation of the seven mtDNA genes coding for complex I 
subunits, corresponding to ND1, ND2, ND3, ND4L, ND4, ND5 and ND6, allowing the 
screening of confirmed pathogenic mutations, reported mutations, polymorphisms and 
novel sequence variations in these genes, according to MITOMAP (www.mitomap.org). 
All sequences were analysed using Sequencing Analysis v5.4 and SeqScape v.2.5 
software, by comparison with reference sequence obtained from GenBank database. 
 In silico analysis was performed for unpublished sequence variations found, using 
PolyPhen-2® and ClustalW2® for evolutionary conservation analysis among species. 
 
2.3.5 Analysis of mitochondrial membrane potential 
NT2 Rho+ cells growing in 75 cm2 flasks were replated into 24-well plates at the 
concentration of 2.1×105 cells/mL. Where indicated, cell treatment conditions included 1 
mM MPP+; 2 M brefeldin A and 2 M tunicamycin added to the growth medium for 2, 4, 
6 and 24 h. For all experimental procedures, controls were performed in the absence of 
the stress agents. 
 The distribution and subsequent quenching of the fluorescent lipophilic cation 
rhodamine 123 (Rh123) was used to monitor changes in Δm. An increase in Rh 123 
fluorescence indicates depolarization of Δm, as shown by the observation that 
mitochondrial uncouplers increase the Rh123 fluorescence signal (Duchen, 1992; 
Duchen and Biscoe, 1992). This is interpreted in terms of the well-established biophysics 
of a variety of lipophilic cations in response to partitioning into negatively charged 
organelles. The concentration of the dye by mitochondria leads to the forced aggregation 
of dye molecules and to an associated quenching of the fluorescence signal (Emaus et 
al., 1986; Bunting, 1992). Some dye must remain in the cytosol, prevented from leaving 
the cell by the plasma membrane potential. Thus, hyperpolarization of Δm will increase 
the partitioning of dye into the mitochondria, and increase the concentration-dependent 
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quenching. Depolarization of Δm allows dye to redistribute from the mitochondria into 
the cytosol, increasing the signal. 
 Cells were loaded with 0.5 μM Rh123 in Krebs buffer [10 mM HEPES, 10 mM 
NaHCO3 (pH 7.4), 132 mM NaCl, 4 mM KCl, 1.4 mM MgCl2, 6 mM glucose, 1 mM CaCl2] 
at 37°C, in the dark. Simultaneously, the fluorescence (λex = 505 nm and λem= 525 nm) 
was recorded for 45 min before, and 10 min after mitochondrial depolarization, using a 
Spectramax Plus 384 spectrofluoremeter (Molecular Devices, Sunnyvale, CA, USA). 
Maximal mitochondrial depolarization (Δm collapse)
 was performed in every individual 
experiment by adding 1 µM carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone 
(FCCP, protoionophore), which was always preceded by oligomycin (2 µg/mL) to prevent 
ATP synthase reversal. 
 Rh123 retention was determined by the difference between total fluorescence 
(after depolarization) and the initial value of fluorescence. Since positively charged 
Rh123 is retained by functional mitochondria with a high Δm, a decrease of cellular 
retention of Rh123 has been associated with a decrease in Δm. 
 
2.3.6 Evaluation of mitochondrial respiratory chain NADH–ubiquinone 
oxidoreductase activity 
NT2 Rho+ cells growing in 75 cm2 flasks were replated into 10 cm petri-dishes at the 
concentration of 3.0×105 cells/mL. Cell treatment conditions were as mentioned in the 
section 2.3.2. 
 The activity of mitochondrial NADH-ubiquinone oxidoreductase (complex I: EC 
1.6.99.3) was determined by using a modified version of the method of Ragan et al. 
(Ragan, 1987). Briefly, after treatments, cells were harvested on ice with a low 
stringency lysis buffer [20 mM HEPES (pH 7.4), 250 mM sucrose, 1 mM EDTA, 1 mM 
EGTA]. Then, protein lysates of homogenated cells were prepared using a Teflon-fitted 
glass hand homogenizer and assayed for protein concentration using the Bio-Rad 
Protein Assay (Bio-Rad, Hercules, CA, USA). Complex I activity was measured by 
following the decrease in NADH absorbance at 340 nm (=6.81mM-1cm-1) that occurs 
when ubiquinone is reduced to form ubiquinol. The reaction was initiated by adding 50 
µM ubiquinone to the reaction mixture, containing 30 µg of protein lysate suspended in 
potassium phosphate buffer [25 mM K2HPO4, 25mM KH2PO4 (pH 7.2)], in the presence 
of 2.5 mg/mL BSA (which increases rotenone sensitivity), 4 mM MgCl2, and 1 mM KCN 
at 30ºC. After 5 min, 10 µM rotenone was added and the reaction was monitored for a 
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further 5 min period. Complex I specific activity was expressed in nanomoles per minute 
per milligram of protein and represents the rotenone sensitive rates. 
 
2.3.7 Quantitative determination of total NAD levels 
Total nicotinamide adenine dinucleotide (NAD+ plus NADH) levels were determined 
using the NAD+/NADH colorimetric assay kit (MBL International Corporation, Woburn, 
MA, USA) according to the manufacturer's instructions. Standard curves generated with 
known amounts of purified NADH were used to whole cell concentrations. 
 
2.3.8 Evaluation of mitochondrial Ca2+ uptake ability 
NT2 Rho+ cells growing in 75 cm2 flasks were replated into 12-well plates at the 
concentration of 2.1×105 cells/mL. Cells treatment conditions included 1 mM MPP+, 2 M 
brefeldin A and 2 M tunicamycin added to the growth medium for 2, 4, 6 and 24 h. 
 To monitor mitochondrial Ca2+ levels we used the fluorescent cell permeant probe 
Rhod-2, AM (λex= 552 nm and λem= 581 nm). In its AM form, Rhod-2 carries a 
delocalized positive charge that causes preferential accumulation of this probe in 
mitochondrial matrix driven by Δm according to the Nernst equation. After 
deesterification, this dye remains trapped in the mitochondria and reports Ca2+ levels 
variations in the mitochondrial lumen. 
 Treated and CT cells were washed twice with Krebs buffer [10 mM HEPES, 10 mM 
NaHCO3 (pH 7.4), 132 mM NaCl, 4 mM KCl, 1.4 mM MgCl2, 6 mM glucose, 1 mM CaCl2] 
and loaded with 10 μM Rhod-2 in Krebs buffer, supplemented with 0.01% (v/v) Pluronic 
F-127 (Molecular Probes, Eugene, OR, USA) and 1% (w/v) BSA, for 40 min, at 37 °C. To 
assure a selective loading of Rhod-2, AM into mitochondria, probe loading procedure 
was performed at low temperature followed with warm incubation at 37ºC. After loading, 
cells were washed three times in calcium-free Krebs buffer and were kept in Ca2+ and 
dye free-medium at 37°C, for 30 min, thereby permitting the cells to hydrolyze the 
acetoxymethyl ester completely. From the entire loading process onwards, cells were 
shielded from ambient light. Then, recordings were carried out. After establishment of a 
stable fluorescence baseline, mitochondrial maximal Ca2+ uptake ability was further 
assessed by challenging mitochondria with the subsequent addition of 5 µM Ca2+ 
ionophore A23187 as described previously by Deniaud et al. (Deniaud et al., 2008). The 
variations of fluorescence were monitored using a Spectramax Plus 384 
spectrofluorometer (Molecular Devices, Sunnyvale, CA, USA).  
 The ratio between mitochondrial matrix Ca2+ before and after challenging with 
A23187 was taken as an indirect measure of mitochondrial Ca2+ content. 
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2.3.9 Evaluation of mitochondrial distressing on cell-death related events 
Induction of apoptic cell death mechanisms was determined by caspase activation 
assays that were performed by using the method described by Cregan et al. (Cregan et 
al., 1999), with minor modifications.  
 NT2 Rho+ cells growing in 75 cm2 flasks were replated into 6-well plates at the 
concentration of 2.5×105 cells/mL. Where indicated, cells were treated with 1 mM MPP+ 
added in the culture medium for 24 h. In another set of experiments, cells were 
preincubated for 1h with 10 M dantrolene, an inhibitor of ryanodine receptors of ER. 
After treatments, cells were washed once in ice-cold PBS and harvested on ice with a 
hypotonic lysis buffer [25 mM HEPES (pH 7.5), 2 mM MgCl2, 1 mM EDTA and 1 mM 
EGTA, supplemented with 2 mM DTT, 0.1 mM PMSF and a 1:1000 dilution of a protease 
inhibitor cocktail]. The cellular suspension was frozen/thawed three times on liquid 
nitrogen and centrifuged at 20,000 ×g, for 10min, at 4ºC. The resulting supernatant was 
collected and assayed for protein concentration using the Bio-Rad Protein Assay (Bio-
Rad, Hercules, CA, USA).  
 To evaluate caspases activation, in parallel sets of assays, whole cellular extracts 
containing 50 μg or 100 μg of protein were individually incubated, for 2 h, at 37ºC in a 
reaction buffer [25mM HEPES (pH 7.5), 0.1% (w/v) 3[(3-cholamidopropyl) 
dimethylammonio]-propanesulfonic acid (CHAPS), 10% (w/v) sucrose, 2 mM DTT] with 
100 M Ac-VDVAD-pNA, 100M Ac-DEVD-pNA, 50 M Ac-LEVD-pNA and 50 M Ac-
LEDH-pNA, specific colorimetric substrates for caspase-2, -3, -4 and -9, respectively. 
 The enzymatic cleavage of the chromophore p-nitroaniline (pNA) from the 
substrate was detected at 405 nm using a Spectramax Plus 384 spectrophotometer 
(Molecular Devices, Sunnyvale, CA, USA). 
 
 
2.4 Evaluation of ER stress and UPR activation 
2.4.1 Analysis of Bip/GRP78 levels  
NT2 Rho+ cells growing in 75 cm2 flasks were replated into 6-well plates at the 
concentration of 2.5×105 cells/mL. Cells treatment conditions included 1 mM MPP+, 2 M 
brefeldin A and 2 M tunicamycin added to the growth media for 2, 4, 6 and 24 h. 
 After treatments, cells were washed once in ice-cold PBS and harvested on ice 
with a 1% (v/v) Triton X-100 containing hypotonic lysis buffer [25 mM HEPES (pH 7.5), 2 
mM MgCl2, 1 mM EDTA and 1 mM EGTA, supplemented with 2 mM DTT, 0.1 mM PMSF 
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and a 1:1000 dilution of a protease inhibitor cocktail]. The cellular suspension was 
frozen/thawed three times on liquid nitrogen and centrifuged at 20,000 ×g, for 10min at 
4ºC. The resulting supernatant was collected and assayed for protein concentration 
using the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA, USA). 
 For each sample, 40 µg of protein were separated under reducing conditions on 
12% SDS-PAGE gel after denaturation at 100ºC, for 5 min, in a 6 × concentrated sample 
buffer [100 mM Tris-HCl (pH 6.8), 100 mM DTT, 4% (w/v) SDS, 0.2% (w/v) bromophenol 
blue and 20% (v/v) glycerol]. Proteins were then transfered to a Hybond-P PVDF 
membrane, which was further blocked with 5% (w/v) non fat milk in TBS-T, for 1 h, at 
room temperature. After blocking, membranes were subjected to an overnight incubation 
with the anti-BiP/GRP78 (1:500) or anti-α-tubulin (1:10,000) primary antibodies, at 4ºC. 
Membranes were further washed three times with TBS-T and then incubated with the 
corresponding alkaline phosphatase-conjugated secondary antibody (1:20,000) for 2 h, 
at room temperature. The membranes were washed again three times and bound 
antibodies detected using the enhanced chemifluorescence reagent (ECF) according to 
the manufacturer’s instructions.  
 Blots were visualized using a VersaDoc imageing system (Bio-Rad, Hercules, CA, 
USA) and protein bands densitometry quantified using the Quantity-One software (Bio-
Rad, Hercules, CA, USA). 
 
2.4.2 Evaluation of ER Ca2+ content 
Measurement of ER Ca2+ content was assessed according to the method described by 
Nutt et al. (Nutt et al., 2002), with some modifications. Briefly, 2.1×105 cells/mL were 
seeded in 12-well plates and treated with 1 mM MPP+, 2 M brefeldin A and 2 M 
tunicamycin added in the growth medium for 2, 4, 6 and 24 h. 
 Afterward, treated and control cells were washed twice in Krebs buffer [10 mM 
HEPES, 10 mM NaHCO3 (pH 7.4), 132 mM NaCl, 4 mM KCl, 1.4 mM MgCl2, 6 mM 
glucose, 1 mM CaCl2] and loaded with 5 μM Fura-2, AM in Krebs buffer, supplemented 
with 0.01% (v/v) Pluronic F-127 and 1% (w/v) BSA, for 40 min, at 37 °C. After loading, 
cells were washed three times in Ca2+-free Krebs buffer and they were kept in Ca2+ and 
dye free-medium at 37°C, for 30 min, thereby permitting the cells to hydrolyze the 
acetoxymethyl ester completely. From the entire loading process onwards, the cells were 
shielded from ambient light. Then, recordings were carried out. After fluorescence 
baseline stabilization, cells were stimulated with 5 μM thapsigargin, in the absence of 
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extracellular Ca2+, to empty Ca2+ from ER. Fura-2, AM fluorescence was recorded at 
340/380 nm excitation and 512 nm emission.  
 The variations of fluorescence were monitored using a Spectramax Plus 384 
spectrofluoremeter (Molecular Devices, Sunnyvale, CA, USA). The peak amplitude of 
Fura-2, AM fluorescence (ratio at 340/380 nm) was used to evaluate ER Ca2+ levels.  
 
2.4.3 Evaluation of ER stress on apoptosis induction 
NT2 Rho+ cells growing in 75 cm2 flasks were replated into 6-well plates at the 
concentration of 2.5×105 cells/mL. Cells treatment conditions included 2 M brefeldin A 
and 2 M tunicamycin added in the growth media for 24 h.  
 Induction of apoptic mechanisms was determined by caspase -2, -4 and -9 
activation assays performed as described in the section 2.3.9. 
 
2.5 Assessment of the autophagy-lysosomal pathway  
2.5.1 Autophagic vacuole ultrastructural analysis 
Cybrids and Rho0 cells were grown in 75 cm2 culture flasks till 90% confluence and 
growth medium was changed 1–3 h before harvesting. Then cellular suspensions from 
each cell line were obtained and were fixed with 2.5% gluteraldehyde/2% 
paraformaldehyde in 100 mM sodium cacodylate (SC), pH 7.43, and post-fixed in 1% 
osmium tetroxide in SC followed by 1% uranyl acetate. After ethanol dehydration and 
embedding in LX112 resin (LADD Research Industries), ultrathin sections were stained 
with uranyl acetate followed by lead citrate. Grids were viewed on a JEOL JEM 1400 
transmission electron microscope operated at 80 kV. For the quantification of autophagic 
vacuoles in cells, 10-15 different electronmicrographs for each cell line were analyzed. 
Autophagic vacuoles were identified using previously established criteria (Nixon et al., 
2005). 
 
2.5.2 Evaluation of autophagic flux and turnover  
2.5.2.1 Western blotting 
NT2 Rho+, Rho0 and cybrid cells growing in 75 cm2 flasks were replated into 10 cm petri-
dishes at the concentration of 3.0×105 cells/mL. Cell lines treatment conditions included 
normal-nutrient (serum +) and serum-starvation (hereafter simply starvation) by culturing 
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cells in serum-free medium (serum -) for 6 h before harvesting. Compounds included 1 
mM MPP+, 5 µM AK-1 or 10 µM Tubastatin A added in the growth medium for 24 h 
before harvesting. Where indicated, 20 mM ammonium chloride and 100 μM leupeptin 
were added in the culture medium in the last 4 h of fed/starved cells. 
 Regarding primary neuronal cultures, after 6 DIV, cultured cortical neurons were 
treated with 50 µM MPP+, 24 h before harvesting. Where indicated, 20 mM ammonium 
chloride and 20 μM leupeptin, 10 mM 3-MA or 10 nM rapamycin were added in the 
culture medium in the last 4 h of MPP+ treatment. 
 After cell treatments, individual cell lines or cultured cortical neurons were washed 
once with ice-cold PBS, scraped and lysed on ice in RIPA buffer [50 mM Tris-HCl (pH 
7.4), 150 mM NaCl, 1% (v/v) NP40, 0.1% (v/v) SDS, 0.5% (v/v) sodium deoxicholate 
(DOC), supplemented with 0.1 mM PMSF, 2 mM DTT and a 1:1000 dilution of a 
protease inhibitor cocktail]. Cell suspensions were incubated on ice for 15 min and 
centrifuged at 20,000 ×g for 15 min. Cleared lysates were assayed for protein 
concentration using the Pierce® BCA Protein Assay Kit (Thermo Fisher Scientific Inc., 
Rockford, IL, USA).  
 Regarding PBMCs, protein extracts were obtained by using 1% Triton X-100 
containing hypotonic lysis buffer [25 mM HEPES (pH 7.5), 2 mM MgCl2, 1mM EDTA and 
1mM EGTA, supplemented with 2 mM DTT, 0.1 mM PMSF and a 1:1000 dilution of a 
protease inhibitor cocktail]. The cellular suspension was frozen/thawed three times on 
liquid nitrogen and centrifuged at 20,000 ×g, for 10 min at 4ºC. The resulting supernatant 
was collected and assayed for protein concentration using the Bio-Rad Protein Assay 
(Bio-Rad, Hercules, CA, USA). 
 For each sample, equal amounts of protein (50 µg) were separated under reducing 
conditions on 15% SDS-PAGE gels. Following electrophoretic transfer onto a 
ImmobilonTM-P PVDF membrane and blocking with 5% (w/v) BSA in TBS-T solution, 
membrane was incubated overnight with the rabbit polyclonal anti-LC3B (1:1000) 
antibody, at 4ºC with gentle agitation. Membranes were further washed three times with 
TBS-T and then incubated with the corresponding alkaline phosphatase-conjugated 
secondary antibody (1:15,000), for 2h at room temperature. The membranes were 
washed again three times and bound antibodies detected using ECF according to the 
manufacturer’s instructions.  
 Blots were visualized using a VersaDoc imageing system (Bio-Rad, Hercules, CA, 
USA) and protein bands densitometry performed using the Quantity-One software (Bio-
Rad, Hercules, CA, USA). 
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2.5.2.2 Immunocytochemistry 
Rho0 and cybrid cells growing in 75 cm2 flasks were replated on treated glass coverslips 
(16 mm diameter) in 12-well plates at the concentration of 1.0×105 cells/mL. Cybrid 
neuron-like cells (1×105 per coverslip) were plated onto glass coverslips (16 mm 
diameter) pre-coated with poly-D-lysine in 50:50 conditioned medium and were allowed 
to improve neurite outgrowth for 4 days, for further immunocytochemical experiments. 
Cortical neurons were mounted on poly-L-lysine-coated glass coverslips (16 mm 
diameter) at a density of 0.75×106 cells/mL. Cell treatment conditions were as mentioned 
in the section 2.5.2.1.  
 Following treatments, cells were analyzed by indirect immunofluorescence as 
described in the section 2.3.2, using the primary rabbit polyclonal anti-LC3B (1:200) 
antibody overnight and the secondary antibody Alexa Fluor® 488-conjugated goat anti-
rabbit for 1 h. LC3 puncta number and size were quantified using the ‘analyze particles’ 
function of the ImageJ v1.46e software (Wayne Rasband; National Institutes of Health, 
USA) after thresholding of images with size settings from 0.2–10 pixel2 and a circularity 
of 0–1. At least 20 cells were examined for each condition. 
 
2.5.3 Autophagy induction and nucleation complex 
2.5.3.1 Beclin and Bcl-2 levels 
Cybrid cells growing in 75 cm2 flasks were replated into 10 cm petri-dishes at the 
concentration of 3.0×105 cells/mL. Cell line treatment conditions included normal nutrient 
(serum +) and starvation for 6 h before harvesting. Where indicated, 20 mM ammonium 
chloride and 100 μM leupeptine were added in the culture medium in the last 4 h of 
fed/starved cells. 
 Following treatments, individual cell lines were washed once with ice-cold PBS, 
scraped and lysed on ice in RIPA buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% 
(v/v) NP-40, 0.1% (v/v) SDS, 0.5% (v/v) sodium deoxicholate (NaDOC), supplemented 
with 0.1mM PMSF, 2 mM DTT and a 1:1000 dilution of a protease inhibitor cocktail]. Cell 
suspensions were incubated on ice for 15 min and centrifuged at 20,000 ×g for 15 min. 
Cleared lysates were assayed for protein concentration using the Pierce® BCA Protein 
Assay Kit (Thermo Fisher Scientific Inc., Rockford, IL, USA). For each sample, equal 
amounts of protein (50 µg) were separated under reducing conditions on 12% SDS-
PAGE gels. 
 Following electrophoretic transfer onto a ImmobilonTM-P PVDF membrane and 
blocking with 5% (v/v) non fat milk TBS-T solution, membrane was incubated overnight 
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with the rabbit polyclonal anti-Bcl-2 (1:1000) or the mouse monoclonal anti-Beclin 
(1:1000) primary antibodies, at 4ºC, with gentle agitation. Membranes were further 
washed three times with TBS-T and then incubated with the corresponding alkaline 
phosphatase-conjugated secondary antibody (1:15,000) for 2 h at room temperature. 
The membranes were washed again three times and bound antibodies detected using 
ECF, according to the manufacturer’s instructions.  
 Blots were visualized using a VersaDoc imageing system (Bio-Rad, Hercules, CA, 
USA) and protein bands densitometry performed using the Quantity-One software (Bio-
Rad, Hercules, CA, USA). 
 
2.5.3.2 Beclin and Bcl-2 subcompartmentalization 
Cybrid cells were grown in 75 cm2 flasks and were treated under the conditions 
mentioned in the section 2.5.3.1. Following treatments, mitochondria- and cytosol-
enriched fractions were obtained by using the ProteoExtract Subcellular Proteome 
Extraction Kit (CalbiochemTM, Merck KGaA, Darmstadt, Germany). Cells were harvested 
and subcellular fractions were prepared according to the manufacturer’s specifications. 
To prepare samples for Western blotting, protein concentrations were determined using 
the Pierce® BCA Protein Assay Kit (Thermo Fisher Scientific Inc., Rockford, IL, USA) 
according to the manufacturer’s instructions for plate reader. 
 For each sample, equal amounts of protein (20 µg) were separated under reducing 
conditions on 12% SDS-PAGE gels and analyzed by Western blotting using the rabbit 
polyclonal anti-Bcl-2 (1:1000) and the rabbit polyclonal anti-Beclin (1:1000) primary 
antibodies, as described in the section 2.5.3.1. The rabbit monoclonal anti-α-tubulin 
(clone 11H10) (1:1000) and the rabbit polyclonal anti-TOM20 (1:1000) primary 
antibodies were used as loading controls for cytosol- and mitochondria-enriched 
fractions, respectively. 
 
2.5.3.3 Beclin/Bcl-2 physical interaction  
Cybrid cells were grown in 75 cm2 flasks and were treated under the conditions 
mentioned in the section 2.5.3.1. After starvation conditions, cells were scraped and 
lysed on ice in a non-denaturing lysis buffer [20 mM Tris-HCl (pH 7.0), 100 mM NaCl, 2 
mM EDTA, 2 mM EGTA, supplemented with 0.1% (v/v) SDS, 1% (v/v) Triton X-100, 2 
mM DTT, 0.1 mM PMSF and a 1:1000 dilution of a protease inhibitor cocktail]. Cellular 
suspensions were centrifuged at 20,000 ×g, for 10 min at 4ºC and whole lysates were 
assayed for protein concentration as mentioned in the section 2.5.3.1.  
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 Afterward, 500 μg of each sample were precleared with Protein A Sepharose 
beads (GE Healthcare Bio-Sciences, Uppsala, Sweden) for 1 h, at 4ºC, and then 
incubated with the primary rabbit polyclonal anti-Beclin (1:100) antibody, overnight at 4ºC 
and with nutation. Protein A-Sepharose beads were then added to samples followed by 2 
h incubation. The beads were spun down and washed seven times with the previously 
referred washing buffer (each time centrifuging at 4°C and discarding the supernatant). 
For the first two washes the buffer was supplemented with 1% (v/v) Triton X-100. For the 
next three washes the buffer was supplemented with 1% (v/v) Triton X-100 and 500 mM 
NaCl. The final two washes were performed using unsupplemented buffer. The last 
supernatant was collected and 25 μl of 2 × concentrated sample buffer was added. The 
samples were boiled at 95-100°C for 5 min to denature the protein and to separate it 
from the protein-A beads. The boiled proteins were centrifuged at 20,000 ×g for 5 min at 
room temperature and the supernatants collected. Samples including the input, flow 
trough and immunoprecipitated complex, were separated by SDS–PAGE and analyzed 
by Western blotting using the rabbit polyclonal anti-Bcl-2 (1:1000) and the rabbit 
polyclonal anti-Beclin (1:1000) primary antibodies, as mentioned in the section 2.5.3.1. A 
shift < 5 kDa is observed in the molecular weight of Bcl-2 in the IP, which might be due to 
different salt concentrations between the lysis buffer and the IP buffer. 
 
2.5.4 Clearance of autophagic substrates  
2.5.4.1 p62 levels  
Cybrid cells growing in 75 cm2 flasks were replated into 10 cm petri-dishes at the 
concentration of 3.0×105 cells/mL. Cell lines treatment conditions included normal 
nutrient (serum +) and starvation for 6 h before harvesting. Where indicated, 20 mM 
ammonium chloride and 100 μM leupeptin were added in the culture medium in the last 4 
h of fed/starved cells.  
 Following cell treatments, cells were harvested and samples were processed and 
subjected to SDS-PAGE and immunoblotting analysis using the rabbit polyclonal anti-
SQSTM1/p62 (1:1000) antibody, as described in the section 2.5.2.1. 
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2.5.4.2 α-Synuclein oligomerization patterns  
Cybrid cells were grown in 75 cm2 flasks and were treated under the conditions 
mentioned in the section 2.5.2.1. 
 For the analysis of α-synuclein oligomerization patterns, a detergent solubility 
fractionation was performed by using 1% (v/v) Triton X-100 containing hypotonic lysis 
buffer [25 mM HEPES (pH 7.5), 2 mM MgCl2, 1 mM EDTA and 1 mM EGTA, 
supplemented with 2 mM DTT, 0.1 mM PMSF and a 1:1000 dilution of a protease 
inhibitor cocktail] and incubating cells suspensions for 15 min on ice followed by 
ultracentrifugation (163,400 ×g, 15 min, 4°C). The supernatant was designated Triton X-
100-soluble fraction, and the pellet was redissolved in 1% (v/v) SDS-containing lysis 
buffer and sonicated for 10 s (Triton X-100-insoluble fraction). Seventy-five micrograms 
of each cell lysate was loaded onto 10% SDS-PAGE gels under non-reducing and non-
denaturating conditions and subjected to SDS-PAGE and immunoblotting analysis using 
the mouse monoclonal anti-α-synuclein [clone LB509, (1:100)] antibody, as described in 
the section 2.5.2.1. 
 
2.5.4.3 Autophagosome-lysosome fusion 
Autophagosome-lysosome fusion can be visualized via immunofluorescence imageing 
as the co-localization of LC3 positive vesicles with a lysosome marker (e.g., LAMP-1) 
(Bains and Heidenreich, 2009).  
 Cybrid cells growing in 75 cm2 flasks were replated on treated glass coverslips (16 
mm diameter) in 12-well plates at the concentration of 1.0×105 cells/mL. To modulate 
microtubule dynamic instability 5 nM taxol and 1 µM nocodozole were added in the 
culture medium for 24 h, and 20 mM ammonium chloride and 100 μM leupeptin in the 
last 4 h.  
 Following treatment, cells were analyzed by indirect immunofluorescence as 
mentioned in the section 2.3.2, using the rabbit monoclonal anti-LC3 XP® (1:400) and the 
mouse monoclonal anti-LAMP-1 [clone H4A3, (1:100)] primary antibodies. Colocalization 
of the two antibodies (LC3/LAMP-1) was quantified in thresholded images with the 
JACoP plug-in of the ImageJ software, according to Bolte and Cordelières (Bolte and 
Cordelieres, 2006).  
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2.5.5 Evaluation of autophagy modulation on cell death-related events 
NT2 Rho+, Rho0 and cybrid cells growing in 75 cm2 flasks were replated into 6-well 
plates at the concentration of 2.5×105 cells/mL. Cells treatment conditions included 20 
mM ammonium chloride and 100 μM leupeptin, 10 mM 3-MA or 0.5 μM rapamycin added 
in the culture medium in the last 4 or 6 h before harvesting, respectively. 
 Induction of apoptic cell death related mechanisms was determined by the 
caspase-3 activation assay as described in the section 2.3.9. 
 
 
2.6 Microtubule network status and intracellular trafficking 
 
2.6.1 Microtubule network morphology  
Cybrid cells growing in 75 cm2 flasks were replated on treated glass coverslips (16 mm 
diameter) in 12 well plates at the concentration of 1.0×105 cells/mL. Where indicated, 
cells were treated with 5 µM AK-1 and 10 µM Tubastatin A added in the culture medium 
for 24 h. Following treatment, cells were analyzed by indirect immunofluorescence as 
described in the section 2.3.2, using the mouse polyclonal anti-α-tubulin (1:1000) primary 
antibody. 
 
2.6.2 Microtubule network postranslational modifications: acetylation 
Cybrid cells growing in 75 cm2 flasks were replated into 10 cm petri-dishes at the 
concentration of 3.0×105 cells/mL. Cell line treatment conditions were as described in the 
section 2.6.1. Following cell treatments, cells were harvested and samples were 
processed and subjected to SDS-PAGE and immunoblotting analysis using the mouse 
polyclonal anti-acetyl-α-tubulin (1:2000) primary antibody, as described in the section 
2.5.2.1. 
 
2.6.3 Microtubule network structural integrity 
Cybrid cells growing in 75 cm2 flasks were replated into 10 cm petri-dishes at the 
concentration of 3.0×105 cells/mL. Cell lines treatment conditions were as described in 
the section 2.6.1.  
 Following cell treatments, soluble and polymeric fractions of cell tubulin were 
prepared according to the method described by Joshi and Cleveland (Joshi and 
Cleveland, 1989), with slight modifications. Cells were washed twice, very gently, with a 
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microtubule stabilizing buffer (0.1 M N-morpholinoethanesulfonic acid, pH 6.75, 1 mM 
MgSO4, 2 mM EGTA, 0.1 mM EDTA, 4 M glycerol). Soluble proteins were extracted at 
37°C for 4-6 min in 100 μl of microtubule stabilizing buffer containing 0.1% Triton X-100. 
The soluble extract was removed and centrifuged for 2 min in order to pellet any 
cytoskeletal material dislodged from the culture dish during extraction. The remaining 
cytoskeletal fraction in the culture dish was scraped in 100 μl of 25 mM Tris (pH 6.8) and 
0.5% SDS. This suspension was frozen three times in liquid nitrogen. Then, samples 
were processed and subjected to SDS-PAGE and immunoblotting analysis using the 
mouse polyclonal anti-α-tubulin (1:10,000) primary antibody, as described in the section 
2.5.2.1. 
 
2.6.4 SIRT2 tubulin deacetylase subcompartmentalization 
Cybrid cells were grown in 75 cm2 flasks and were treated under the conditions 
mentioned in the section 2.6.1. Following treatments, mitochondria-, cytosol-, nuclei-, 
and cystoskeleton-enriched fractions were obtained as described in 2.5.3.2.  
 For each sample, equal amounts of protein (50 µg) were separated under reducing 
conditions on 12% SDS-PAGE gels and analyzed by Western blotting using the rabbit 
polyclonal anti-SIRT2 (1:1000) antibody, as described in the section 2.5.2.1. The rabbit 
monoclonal anti-α-tubulin (clone 11H10, 1:1000), the rabbit polyclonal anti-TOM20 
(1:1000), the mouse monoclonal anti-TATA binding protein (1:1000), and the rabbit 
polyclonal anti-Vimentin (1:1000) primary antibodies were used as loading controls for 
cytosol-, mitochondria-, nuclei-, and cystoskeleton-enriched fractions, respectively. 
 
2.6.5 Intracellular transport of mitochondria and autophagosomes 
2.6.5.1 Modulation of microtubule-dependent trafficking of autophagosomes 
Cybrid cells growing in 75 cm2 flasks were replated into 10 cm petri-dishes at the 
concentration of 3.0×106 cells/mL. To modulate microtubules dynamic instability 5 nM 
taxol and 1 µM nocodozole were added in the growth medium in normal nutrient 
conditions for 24h. Following cell treatments, cells were harvested and samples were 
processed and subjected to a SDS-PAGE and immunoblotting analysis using the rabbit 
polyclonal anti-LC3B (1:1000) antibody, as described in the section 2.5.2.1. 
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2.6.5.2 Live-cell imaging of mitochondria movement 
Cybrid cells growing in 75 cm2 flasks were replated into ibidiTreat µ-Slide eight-well 
plates at the concentration of 2.0×104 cells/mL. Cells treatment conditions included 
normal nutrient (serum +) and starvation for 6h. To modulate microtubule dynamic 
instability 5 nM taxol and 1 µM nocodozole were used in normal nutrient conditions for 24 
h. Where indicated, 20 mM ammonium chloride and 100 μM leupeptin, were added in the 
culture medium in the last 4h of fed/starved cells.  
 Following treatments, cells were washed twice with HBSS, and to label 
mitochondria, cells were then incubated with 100 nM MitoTracker Green in HBSS for 30 
min, at 37°C, in the dark, according to Du et al. (Du et al., 2010). After a gentle wash 
cells were kept in HBSS, and were imaged for mitochondrial movements. Time-lapse 
images were captured under a Zeiss LSM 510 meta confocal microscope with a stage-
based chamber (5% CO2, 37°C). The inverted microscope was driven by the LSM 
software and images were taken every 2 s for a total of 4 min under 63 × magnification 
(Zeiss Plan-ApoChromat 63 ×, 1.4NA). 
 For transport analysis, mitochondria were considered not mobile if they remained 
stationary for the entire recording period. Movement was counted only if the 
displacement was more than the length of the mitochondrion (~2 μm). 
 For each time-lapse movie, mitochondria were manually tracked and transport 
parameters of mitochondria movements were generated using the ImageJ software plug-
in Multiple Kymograph, submitted by J. Rietdorf and A. Seitz (European Molecular 
Biology Laboratory, Heidelberg, Germany). Mitochondrial movement velocity data were 
determined from the kymographic images and were calculated based on the slope 
(v=dx/dt) obtained for each mitochondrion movement profile along the recording time. 
Each series of images was recorded for at least three randomly selected MitoTracker 
Green-labeled cells per culture and three independent cultures per condition. 
 
2.6.5.3 Live-cell imaging of autophagosome movement 
Cybrid cells growing in 75 cm2 flasks were replated into ibidiTreat µ-Slide eight-well 
plates at the concentration of 2.0×104 cells/mL. To modulate microtubule dynamic 
instability 5 nM taxol and 1 µM nocodozole were used in normal nutrient conditions for 24 
h. Where indicated, 20 mM ammonium chloride and 100 μM leupeptin, were added in the 
culture medium in the last 4h.  
 Following treatments, cells were washed twice with HBSS and late 
autophagosomes and earlier vacuoles in the autophagy pathway were labeled using the 
Cyto-ID™ Green detection reagent provided in the Cyto-ID™ Autophagy detection kit 
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(Enzo, Lausen, Switzerland) according to the manufacturer’s instructions. After a gentle 
wash, cells were kept in HBSS and were imaged for autophagosome movements. Time-
lapse images acquisition and transport analysis were performed as described in the 
section 2.6.5.2. Movement was counted only if the displacement was more than the 
length of the autophagosome (~500 nm). Each series of images was recorded for at 
least three randomly selected Cyto-ID™ Green-labeled cells per culture and three 
independent cultures per condition. 
 
 
2.7 Data Analysis 
All data were expressed as mean ± SEM of at least three independent experiments. 
Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, San 
Diego, CA, USA). Differences between two data sets were evaluated by two tailed 
unpaired Student’s t-test. Statistical tests between multiple data sets and conditions were 
carried out using a one way or two-way analysis of variance (ANOVA) followed by 
Bonferroni post hoc test or the Newman-Keuls multiple comparison test to determine 
statistical significance, as appropriate. A P-value<0.05 was considered statistically 
significant. 
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3.1 Summary 
Sporadic Parkinson’s disease (sPD) is a progressive neurodegenerative disease 
characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta. 
Many cellular mechanisms are thought to be involved in the death of these specific 
neurons in sPD, including oxidative stress, changes in intracellular calcium (Ca2+) 
homeostasis, and mitochondrial dysfunction. In addition, recent studies have revealed 
that also the endoplasmic reticulum (ER) stress in conjunction with abnormal protein 
degradation can contribute to the sPD pathophysiology. 
 Here, we investigated the molecular mechanisms underlying the interplay between 
the ER and mitochondria and its relevance for the control of neuronal cell death in sPD. 
We observed that 1-methyl-4-phenylpyridinium (MPP+) induces changes in the 
mitochondrial function, affecting the mitochondrial membrane potential and the electron 
transport chain function. Likewise, it was also evident the activation of the unfolded 
protein response by the overexpression of the chaperone BiP/GRP78. 
 Moreover, MPP+ stress stimuli caused the release of Ca2+ from the ER, which 
consistently induced mitochondrial Ca2+ uptake, with a rise in the mitochondrial matrix 
free Ca2+. Besides, inhibition of Ca2+ release from the ER prevented the activation of 
mitochondria-dependent caspases induced by MPP+.  
 Our findings show that the ER and mitochondria are in a close communication, 
establishing a dynamic ER-Ca2+-mitochondria interconnection that can play a prominent 
role in the neuronal cell death induction under particular stressful circumstances of sPD 
pathology. 
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3.2 Introduction 
 
Sporadic Parkinson’s disease (sPD) is a severe and progressive neurodegenerative 
disease of unknown cause, characterized by a selective and profound loss of 
dopaminergic neurons in the substantia nigra pars compacta (SNpc) and 
norepinephrinergic neurons of the locus coeruleus. The most prominent histopathological 
hallmark of sPD is the intracellular accumulation of insoluble fibrous material, named 
Lewy bodies (LBs), found in the cytoplasm of neurons (Cardoso et al., 2005). LBs are 
formed by aggregates of several proteins, including α-synuclein, ubiquitin, synphilin and 
tubulin (Shimura et al., 2000).  
 Several reports support a link between the endoplasmic reticulum (ER) stress and 
sPD. Thus, it has been demonstrated the up-regulation of ER chaperones, such as 
protein disssulfide isomerase (PDI), in postmortem brain tissues and cell culture models 
of sPD, and the accumulation of PDI in LBs (Conn et al., 2004). Other evidences come 
from studies of certain neurotoxins that are used as model compounds to mimic the 
disease process both in neuronal cells and in vivo (Ryu et al., 2002; Holtz and O'Malley, 
2003). Compounds, such as 6-hydroxydopamine (6-OHDA) and N-methyl-4-phenyl-
1,2,3,6 tetrahydropyridine (MPTP), or its active metabolite, 1-methyl-4-phenylpyridinium 
(MPP+), induce oxidative stress and impair mitochondrial respiration and energy 
metabolism. Recent studies in cultured cells, including dopaminergic neurons, have 
demonstrated that these compounds trigger ER stress and are also involved in the up-
regulation of diverse components of the unfolded protein response (UPR) (Ryu et al., 
2002; Holtz and O'Malley, 2003). It has also been well-established that mitochondrial 
function is altered in the course of sPD, particularly at the mitochondrial NADH-
ubiquinone oxidoreductase (complex I) level (Cardoso et al., 2005). The complex I 
deficiency in the SNpc and platelets of patients with sPD has been consistently noticed 
(Parker et al., 1989; Schapira et al., 1989; Mann et al., 1994; Haas et al., 1995). 
Accordingly, it seems that sPD has a mitochondrial component and that probable factors 
which directly or indirectly modulate normal mitochondrial functions could compromise 
neuronal survival.  
 The fundamental contribution of mitochondria and ER to the cellular fate has been 
increasingly recognized. Moreover, mitochondria are often closely associated with the 
ER providing the conditions for a local and privileged communication between the two 
organelles (Csordas et al., 2006).  
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 Therefore, it seems worthwhile to unveil the molecular mechanisms that coordinate 
the interplay between mitochondrial dysfunction and the ER stress and its relevance for 
the control of neuronal cell death in a sPD context. 
 In the present work, we report that an altered mitochondrial function renders cells 
more susceptible to develop an ER stress response. We propose that calcium (Ca2+) is 
the main intervenient in the ER and mitochondria crosstalk, functioning as a key 
modulator of cell death signals triggered by the ER and mitochondria. 
  
Chapter III 
 
80 
3.3 Results  
3.3.1 Characterization of mitochondrial function  
Concentrations of high micromolar or millimolar range of MPP+ are usually used to study 
its neurotoxic effects and apoptosis induction (Bando et al., 2005; Domingues et al., 
2008a; Esteves et al., 2008). We have previously reported that MPP+ triggers apoptotic 
cell death, upon 24 h, in different PD cellular models (Arduino et al., 2008; Domingues et 
al., 2008a; Esteves et al., 2008).  
 In this study, to characterize the mitochondrial function in the NT2 cell line after 
short- (2, 4, 6 h) and long-term (24 h) periods of MPP+ exposure, we have evaluated the 
mitochondrial respiratory chain complex I activity and changes in the mitochondrial 
membrane potential (Δm). As expected, results detailed in Table III.1 demonstrate that 
MPP+ induced a statistically significant decrease of this mitochondrial respiratory chain 
complex activity.  
 
Table III.1. Mitochondrial respiratory chain NADH-ubiquinone oxidoreductase (complex I) 
activity (nmol.min
-1
.mg
-1
). Data represent mean ±SEM. 
 
Condition Complex I activity (nmol.min
-1
.mg
-1
) 
 2h 4h 6h 24h 
Control 5.60±0.232 5.32±0.521 5.23±0.547 4.72±0.540 
MPP
+
 1.44±0.155*** 1.45±0.084*** 1.35±0.119*** 1.21±0.014*** 
*** p<0.001 relative to the corresponding control. 
  
 
Nevertheless, as shown in the Figure III.1, we were unable to observe a significant 
alteration in rhodamine 123 (Rh123) retention induced by MPP+ for the first 6 h.  
 These results suggest that, although NT2 cells harbour deficits in mitochondrial 
respiratory chain complex I and show an increase in reactive oxygen species (ROS) 
production during the first 6 h period (Domingues et al., 2008b), they are able to maintain 
m until 24 h. 
Mitochondria – ER interplay in Parkinson’s disease 
 
81 
 
Figure III.1. Mitochondrial function is affected in NT2 neuron-like cells after long-term 
exposure to MPP
+
.  
Changes in mitochondrial membrane potential (Δm) induced by MPP
+
 were estimated using the 
fluorescent cationic dye Rh123 as depicted in Chapter II. Rh123 retention was determined by the 
difference between total fluorescence (after mitochondrial membrane depolarization) and the 
initial value of fluorescence. Data are expressed as a percentage of the untreated cells values 
(control) and are mean±SEM (n=3; *** p<0.001, relative to control). 
 
 
3.3.2 MPP+ activates UPR in an early phase 
Our next step was to clarify the effect of a decreased activity of the mitochondrial 
respiratory chain complex I on the ER stress induction. The initial cellular response 
following ER stress, also called UPR, protects the cell through adaptive mechanisms that 
re-establish normal ER function (Xu et al., 2005; Boyce and Yuan, 2006). For this 
purpose, we have analyzed the expression levels of a specific UPR marker, BiP/GRP78, 
a chaperone known to be localized in the ER lumen and that function in Ca2+ 
sequestration or that assist to the correct folding and assembly of nascent proteins 
(Nigam et al., 1994; Lievremont et al., 1997). 
 Overall, Figure III.2 shows a representative BiP/GRP78 immunoblot (Figure III.2A) 
and the corresponding protein levels (Figure III.2B) in cells treated with MPP+ for the 
different time points (2, 4, 6 and 24 h) . 
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Figure III.2. The unfolded protein response is activated in an early phase by MPP+ in NT2 
neuron-like cells.  
A. Whole-cell lysates from untreated and MPP
+
-treated cells were prepared as described in 
Chapter II and the levels of BiP/GRP78 were determined by immunobloting analysis for 2, 4, 6 
and 24 h. The blots were reprobed for α-tubulin to confirm equal protein loading. The data are 
from representative blots. B. Quantification of BiP/GRP78 levels by densitometric analysis of each 
time point corresponding blots. Data are reported as the fold increase over the untreated cell 
values (control) (n=3-10; ***p<0.001, relative to control). 
 
 
Surprisingly, the levels of this ER chaperone was extensively up-regulated by MPP+ 
treatment upon 2 h, being observed a suppression of its expression pattern along the 
time course studied. 
 We suggest that, eventually, an increase in ROS production elicited by 
mitochondrial deficits at respiratory chain level potentiated this ER stress response. 
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3.3.3 Ca2+ is the mediator in the ER and mitochondria communication 
Mitochondria and the ER form two intertwined endomembrane networks and their 
dynamic physical interactions control metabolic flow, protein transport and intracellular 
Ca2+ homeostasis (Ferri and Kroemer, 2001; Berridge et al., 2003; Levine and Rabouille, 
2005). Therefore, we appointed Ca2+ as a potential mediator in the communication 
between these two organelles in the context of sPD pathology.  
 To investigate this point, we determined the ER Ca2+-content after cell treatment 
with MPP+ for the different time points studied. The ER Ca2+-content was evaluated by 
changes in cytosolic Ca2+, monitored using the Fura-2AM probe. Cytosolic Ca2+ was 
measured before and after the addition of thapsigargin (TPG), which evokes Ca2+ release 
from the ER (Figures III.3A-D). Overall, Figure III.3E shows that MPP+ promoted a 
gradual and sustained decrease of Ca2+ content in the ER.  
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Figure III.3. MPP
+ 
triggers Ca
2+
 release from ER stores.  
Untreated (control) and MPP
+
-treated cells were loaded with 5 µM of Fura-2,AM for the 
fluorescence measurement of the ER Ca
2+
-content. A-D Representative traces of the fluorometric 
measurement of cytosolic Ca
2+ 
levels for the indicated time points. Cytosolic Ca
2+ 
was measured 
before and after the addition of 5 µM thapsigargin (TPG) to evoke ER Ca
2+ 
release (denoted as an 
arrow on the graphs). E. Measurement of ER Ca
2+
 released after TPG stimulation. The 
measurement of Ca
2+
 released was obtained by subtracting the fluorescence after to the 
fluorescence before TPG addition (n=4; *p<0.05, relative to control).  
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 We further investigated whether the observed ER Ca2+ changes are accompanied 
by changes in mitochondrial Ca2+-content. Mitochondria, by virtue of their membrane 
potential (Figure III.1) provide a sink for the buffering of cytoplasmic Ca2+ after the 
ionophore calimycin (A23187) stimuli. Therefore, we have also evaluated Ca2+ clearance 
by mitochondrial uptake and subsequent Ca2+ accumulation in the mitochondrial 
compartment following MPP+ treatment. After establishment of a stable baseline, cells 
were challenged with A23187, which rapidly increased the Rhod-2AM fluorescence, 
demonstrating Ca2+ accumulation in the mitochondrial matrix (Figures III.4 A-D).  
 We have also abserved that MPP+ led to an accumulation of Ca2+ in the 
mitochondrial matrix after 4 h treatment, which is in accordance with the decrease in the 
ER compartment for the same time point (Figures III.3E and III.4E). 
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Figure III.4. MPP
+ 
triggers Ca
2+
 uptake by mitochondria from cytosolic pools.  
Untreated (control) and MPP
+
-treated cells were loaded with 10 µM of Rhod-2, AM for the 
fluorescence measurement of mitochondrial Ca2+-content. A-D Representative traces of the 
fluorometric measurement of mitochondrial matrix Ca
2+ 
levels for the indicated time points. 
Mitochondrial matrix Ca
2+ 
was measured before and after the addition of 5 µM of calimycin 
(A23187, A23) to take the mitochondrial maximal uptake ability (denoted as an arrow on the 
graphs). E. Measurement of Ca
2+ 
uptake by mitochondria. The measurement of mitochondrial 
Ca
2+
 uptake was obtained by the ratio of fluorescence before over total fluorescence after A23187 
addition (n=4; *p<0.05, relative to control). 
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 Taken collectively, these results demonstrate that Ca2+ release from the ER incited 
by MPP+ invariably induces mitochondrial Ca2+ uptake with a rise in mitochondrial matrix 
free Ca2+ after MPP+ treatment for 4 h. This suggests a qualitative inverse relationship 
between Ca2+ changes in the ER and mitochondria compartments. 
 Besides, these findings are consistent with the m data (Figure III.1), which 
pointed that m is not affected by the presence of MPP
+ until 24 h and that there is a 
correlation between the maintenance of m and the ability of mitochondria to take up 
Ca2+. 
 
3.3.4 Mitochondria stress initiates ER and mitochondria caspase-dependent 
cell death 
We next decided to examine the mechanisms that the ER and mitochondria use to 
initiate and propagate cell death signals and its involvement in the control of neuronal 
death in a sPD context. 
 Firstly, following the cascade of death signalling downstream of the ER, we have 
analyzed the involvement of caspase-4 induced by MPP+. As shown in Figure III.5A, an 
increase in Ac-LEVD-pNA cleavage (caspase-4 activation) was only observed upon 
treatment with MPP+ for 24 h.  
 We have also analyzed caspase-2 and caspase-9 activities, which are thought to 
be involved in the cell death signals propagation triggered by mitochondria (Slee et al., 
1999; Susin et al., 1999; Guo et al., 2002). As shown in Figures III.5B and C, the 
activation pattern of caspase-2 (Ac-VDVAD-pNA cleavage) was similar to caspase-9 
(Ac-LEDH-pNA cleavage) and it was more marked in later stages following the 
treatments with MPP+.  
 Additionally, since caspase-3 is an effector caspase in the apoptotic process, and 
to better characterize the cell death mechanisms mediated by MPP+, it was also our 
interest to analyze its effects on caspase-3 activation. We observed an increase in Ac-
DEVD-pNA cleavage (caspase-3 activation) within 6 h, which was detectable till to 24 h 
treatment with MPP+ (Figure III.5D). To confirm the involvement of the ER Ca2+ in the 
activation of this caspase-cascade, we analyzed caspase-3 activation by MPP+ in cells 
exposed previously to dantrolene. We have observed that dantrolene, which blocks the 
ER Ca2+ release, was able to prevent MPP+-mediated caspase-3 activation (Figure 
III.5E). 
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Figure III.5. MPP
+
-induced ER and mitochondria stress activates ER and mitochondria-
dependent apoptotic pathways. A-D Effect of MPP
+
 on caspase 4-like activity (Ac-LEVD-pNA 
cleavage) (A), caspase 2-like activity (Ac-VDVAD-pNA cleavage) (B), caspase 9-like activity (Ac-
LEDH-pNA) (C), and caspase 3-like activity (Ac-DEVD-pNA cleavage) (D), respectively. Caspase 
activation was evaluated spectrophotometrically at 405 nm as described in Chapter II. Data are 
expressed relative to the basal activity observed in the untreated NT2 cells (n=4-8; **p<0.01, 
***p<0.001 relative to control). E. Protective effect of dantrolene on MPP
+
-induced caspase-3 
activation. Data are expressed relative to the basal activity observed in the untreated NT2 cells 
(n=3; **p<0.01; ***p<0.001, relative to control; 
###
p<0.001, relative to MPP
+
-treated cells). 
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3.4 Discussion 
In this study, we have investigated the molecular mechanisms underlying the crosstalk 
between the ER and mitochondria and their relevance to the sPD pathology. We provide 
some lines of direct evidence indicating that mitochondria and the ER can establish a 
dynamic signaling pathway, which is crucial for the activation of a cascade of cellular 
signals that culminates in apoptotic cell death.  
 First, we have characterized mitochondrial function upon MPP+ treatments. Our 
results demonstrate that MPP+, as expected, led to a steady decrease in the complex I 
oxidoreductase activity as soon as 2 h, but only induced considerable changes in Δm at 
24 h. Second, our results also indicate that an altered mitochondrial respiratory chain 
complex I activity seems to play an essential role in the ER-induced stress response. 
UPR as a consequence of ER stress was elicited by MPP+ at 2 h, indicating that 
mitochondria complex I activity may regulate an ER response. These results are in 
agreement with previous ones that reported the activation of UPR induced by 6-OHDA 
and MPP+ in cellular models of PD and in dopaminergic neurons of the SNpc of PD 
patients (Ryu et al., 2002; Holtz and O'Malley, 2003; Cooper et al., 2006; Hoozemans et 
al., 2007). MPP+ is thought to induce oxidative stress by mitochondrial function inhibition. 
The consequent accumulation of oxidized proteins that hinder the cellular protein 
degradation mechanisms leads to an accumulation of misfolded proteins into the ER 
(Friedlander et al., 2000). Interestingly, we have previously demonstrated, in the same 
cellular model, that MPP+-treatment for 2 h induces an increased generation of ROS 
(Domingues et al., 2008).  
 Moreover, changes in the redox state and the presence of ROS also affect the 
Ca2+ homeostasis by modulating the functionality of ER-based channels and buffering 
chaperones [for review see (Gorlach et al., 2006)]. In such instance, we suggest that a 
close relationship exists between ROS generation mediated by MPP+ and the ER stress, 
further contributing to the disruption of the mitochondrial function. 
 Our hypothesis is that the ER and mitochondria communicate via Ca2+ exchanges 
facilitated by the close proximity of their membranes that easily exchange lipids, Ca2+ 
and glycoproteins (Chandra et al., 1998; Rizzuto et al., 1998). 
 Ca2+ is one of the most important elements in cellular signaling. The ER, besides 
playing a major role in regulating synthesis, folding and transport of proteins, functions 
also as a dynamic Ca2+ store. The dynamic changes in free-cytosolic and in the ER Ca2+ 
are regulated by a number of factors including intracellular Ca2+ buffers (Ca2+ binding 
proteins, nucleotides and phosphate) and Ca2+-transporting systems (Ca2+ channels and 
Ca2+-ATPases). Moreover, mitochondria have been postulated to play an important role 
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as Ca2+ buffers participating in the intracellular Ca2+ handling machinery in stimulated 
cells (Hoth et al., 1997; Hajnoczky et al., 1999; Hoth et al., 2000). More recently, 
mitochondria have been considered not only as high-capacity Ca2+ buffers but also as 
active elements of the intracellular signaling system (Parekh, 2003; Butow and Avadhani, 
2004).  
 In this work, we have found that MPP+ evokes a gradual decrease in the ER Ca2+ 
content, concomitantly to an Ca2+ increase into the mitochondrial matrix. These results 
demonstrate that a net flux of Ca2+ from the ER to mitochondria occurs under ER and 
mitochondria stress conditions.  
 In fact, Ca2+ release from the ER has been implicated as a key signaling event in 
many apoptotic models and it may sensitize mitochondria to trigger apoptotic cell death. 
Furthermore, a growing number of ER proteins have been described to influence 
apoptosis by either interacting with Bcl-2 family members or altering ER Ca2+-responses, 
whereas several ER proteins are caspase substrates that may regulate the execution 
phase of apoptosis [for review see (Breckenridge et al., 2003b)]. 
 Our results revealed that stress in the ER and the subsequent ER Ca2+-release 
triggers a caspase-4 dependent pathway and also a mitochondrial-dependent apoptotic 
pathway, which leads to the activation of caspase-2 and -9. We propose that these two 
components of the ER and mitochondria stress can apparently work together to activate 
caspase-3, an executer caspase of the apoptotic process. Moreover, we proved, by 
inhibiting ryanodine receptors-mediated Ca2+ release with dantrolene, that ER Ca2+ 
fluxes evoked by MPP+ were able to induce caspase-3 activation. 
 Our results highlight the inevitable role of ER to mitochondria Ca2+ fluxes and their 
requirement to mitochondria-dependent cell death induction, enclosing a feedback loop 
whereas mitochondria signal ER, ER induces further mitochondrial alterations, like Δm 
loss, leading to the activation of a cascade of signals that culminates in apoptotic cell 
death. 
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4.1 Summary 
Recent studies have revealed that endoplasmic reticulum (ER) disturbance is involved in 
the pathophysiology of neurodegenerative disorders contributing to the activation of the 
ER stress-mediated apoptotic cell death pathway.  
 Here, we investigated the molecular mechanisms underlying the interplay between 
the ER and mitochondria, focusing on calcium as a potential mediator and its relevance 
for the control of cell death signals. 
 Using NT2 cells treated with brefeldin A or tunicamycin, two ER stressors, we 
observed that ER stress induced changes in the mitochondrial function, affecting the 
mitochondrial membrane potential and the electron transport chain function. Moreover, 
stress stimuli at ER level evoked calcium fluxes between the ER and mitochondria. 
Under these conditions, ER stress activated the unfolded protein response by the 
overexpression of BiP/GRP78, although this chaperone was unable to prevent 
mitochondria-dependent caspases activation.  
 Our findings show that ER and mitochondria interconnection play a prominent role 
in the neuronal cell death induction under particular ER stress circumstances. 
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4.2 Introduction 
The endoplasmic reticulum (ER) has several important functions including the regulation 
of intracellular calcium (Ca2+) homeostasis, protein glycosylation, and formation of 
disulfide bounds and folding and assembly of newly synthesized secretory proteins.  
 Under various conditions, ER function is disturbed leading to the accumulation of 
unfolded proteins and activation of a sporadic ER stress response, also known as 
unfolded protein response (UPR). In an attempt to survive, cells develop self-protective 
mechanisms, whereby conditions within the ER are communicated to the protein 
translation machinery and to the nucleus in order to restore cellular homeostasis. When 
cells are subjected to severe or prolonged ER stress, the transcriptional factor 
CHOP/Gadd153 is activated and apoptotic cell death may occur (Kaufman, 1999a, b; 
Paschen et al., 2001). ER stress has been implicated in many important diseases, 
including neurodegenerative disorders. We have recently demonstrated that the 
Alzheimer’s disease-associated amyloid-β peptide induces ER stress contributing to Ca2+ 
release through ryanodine (RyR) and inositol 1,4,5-triphosphate (IP3R) receptors, with 
subsequent increase in intracellular Ca2+ levels and induction of apoptosis (Ferreiro et 
al., 2006). Moreover, it has been demonstrated the up-regulation of ER chaperones, 
such as protein disulfide isomerase (PDI) in postmortem brain tissues and cell culture 
models of Parkinson’s disease (PD), accumulating preferentially in Lewy bodies (Conn et 
al., 2004). Recent studies in cultured cells, including dopaminergic neurons, have 
demonstrated that PD-related neurotoxins, such as 6-hydroxydopamine (6-OHDA) and 
N-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) or even its active metabolite 1-
methyl-4-phenylpyridinium (MPP+), trigger ER stress and are also involved in the up-
regulation of diverse components of the UPR (Ryu et al., 2002; Holtz and O'Malley, 
2003; Arduino et al., 2009a). Moreover, mitochondria are often closely associated with 
the ER providing the conditions for a local and privileged communication between the 
two organelles (Csordas et al., 2006).  
 Therefore, it seems worthwhile to unveil the molecular mechanisms that coordinate 
the interplay between the ER stress and mitochondrial function and their relevance for 
the control of cell death.  
 In the present work, we report that mitochondrial function is sensitive to ER stress 
stimuli and identify Ca2+ fluxes in the ER and mitochondria axis as key factors for cell 
death signals triggered by the ER and mitochondria stress. 
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4.3 Results and Discussion 
 
4.3.1 Brefeldin A and tunicamycin activate the unfolded protein response 
To induce ER stress, we used two pharmacological agents, employed as ER stress 
inducers, that block ER to Golgi protein trafficking (brefeldin A, BFA) or that inhibit N-
linked glycosylation reactions (tunicamycin, TUN).  
 Upon stress induction, ER activates the UPR by the induction of ER resident stress 
proteins, referred to as the glucose-regulated proteins (GRPs) (Lee, 1992). GRPs are 
Ca2+-binding chaperone proteins with protective properties. The best characterized GRP 
is GRP78, a 78-kDa protein also referred to as BiP. BiP/GRP78 is an essential regulator 
of the ER function due to its role in protein folding and assembly, ER Ca2+ binding and 
controlling the activation of transmembrane ER stress inducers (Little et al., 1994; Lee, 
2001). The cytoprotective function of BiP/GRP78 has been well recognized in several 
experimental systems (Rao et al., 2002; Reddy et al., 2003; Lee, 2005). 
 Figure IV.1 shows a representative BiP/GRP78 immunoblot (Figure IV.1A) and 
the corresponding protein levels (Figure IV.1B) in cells treated with BFA or TUN. Results 
show that the levels of this protein were up-regulated by BFA and TUN, indicating that 
BFA and TUN elicit ER stress.  
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Figure IV.1. Induction of UPR after exposure of NT2 cells to ER stress.  
A. Expression of BiP/GRP78 was determined by immunoblot analysis from untreated (control) 
and ER stressors (BFA, TUN)-treated cells. The blots were reprobed for α-tubulin to confirm equal 
protein loading. The data are representative blots. B. Quantification of BiP/GRP78 levels by 
densitometric analysis of the corresponding blots. Data are reported as the fold increase over the 
untreated cell values (n=8; ***p<0.001, relative to control).  
 
 
4.3.2 Ca2+ is the link in the ER to mitochondria communication axis 
ER, besides playing a major role in regulating synthesis, folding, and transport of 
proteins, functions also as a dynamic Ca2+ store. The dynamic changes in free/cytosolic 
and in ER Ca2+ are regulated by a number of factors, including intracellular Ca2+ buffers 
and Ca2+ transporting systems (channels and ATPases). Moreover, mitochondria have 
been suggested to play an important role as Ca2+ buffers, participating in the intracellular 
Ca2+ handling machinery in stimulated cells (Hajnoczky et al., 1999; Hoth et al., 2000; 
Butow and Avadhani, 2004). More recently, mitochondria have been considered not only 
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as high-capacity Ca2+ buffers but also as active elements of the intracellular signaling 
system (Parekh, 2003; Sadek et al., 2004).  
 Therefore, we appointed Ca2+ as a potential mediator in the communication 
between these two organelles. To investigate this point, we determined ER Ca2+ content 
after cell treatment with ER stressors. ER Ca2+ content was assessed by changes in 
cytosolic Ca2+, monitored using Fura-2, AM. Cytosolic Ca2+ was measured before and 
after the addition of thapsigargin to evoke ER Ca2+ release. The difference in cytosolic 
Ca2+calcium before and after thapsigargin addition was taken as a measure of ER Ca2+ 
store. As shown in Figure IV.2, both ER stressors were able to induce Ca2+ release from 
the ER lumen (Figure IV.2A), demonstrated by the very low levels of ER Ca2+ content 
(Figure IV.2B).  
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Figure IV.2. Cellular Ca
2+
 fluxes upon ER stress in NT2 cells.  
Untreated (control), BFA or TUN treated cells were loaded with 5 μM Fura-2, AM for the 
fluorescence measurement of ER Ca2+ content. A. Representative trace of the fluorometric 
measurement of cytosolic Ca
2+ 
levels for the indicated time points. Cytosolic Ca
2+ 
was measured 
before and after the addition of 5 µM TPG to evoke ER Ca
2+ 
release (denoted as an arrow on the 
graph). B. Measurement of ER Ca2+ released after TPG stimulation. The measurement of Ca2+ 
released was obtained by subtracting the fluorescence after to the fluorescence before TPG 
addition Data are reported in relation to untreated cells values (control) (n = 4, ***P ＜0.001, 
compared to control). 
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We further investigated whether the observed ER Ca2+ changes are accompanied by 
changes in mitochondrial Ca2+ content. The mitochondria, by virtue of their sustained 
membrane potential, provide a sink for the buffering of cytoplasmic Ca2+ after the calcium 
ionophore calimycin (A23187) stimuli. Thus, we evaluated Ca2+ clearance by 
mitochondrial uptake and subsequent Ca2+ accumulation in the mitochondrial 
compartment following the treatments indicated before. After establishment of a stable 
baseline, as a measure of basal mitochondrial Ca2+ stores, cells were challenged with 
the A23187, which rapidly increased the Rhod-2, AM fluorescence, demonstrating a 
mitochondrial matrix calcium accumulation (Figure IV.3A). The ratio between 
mitochondrial matrix calcium before and after challenging with A23187 was taken as an 
indirect measure of mitochondrial calcium content.  
In accordance with calcium fluxes release from ER (Figure IV.2), we detected a 
significant increase in mitochondrial calcium content induced by both ER stressors 
(Figure IV.3B).  
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Figure IV.3. Mitochondrial Ca
2+
 uptake fluxes upon ER stress induction in NT2 cells. 
Untreated (control) and BFA or TUN treated cells were loaded with 10 µM Rhod-2, AM for the 
fluorescence measurement of mitochondrial calcium content. A. Representative trace of the 
fluorometric measurement of mitochondrial matrix Ca
2+ 
levels. Mitochondrial matrix Ca
2+ 
was 
measured before and after the addition of 5 µM A23187 (A23) to take the mitochondrial maximal 
uptake ability (denoted as an arrow on the graph). B. Measurement of Ca
2+ 
uptake by 
mitochondria. The measure of mitochondrial Ca
2+
 uptake was obtained by the ratio of 
fluorescence before over the total fluorescence after A23187 addition (n=4; *p<0.05, compared to 
the control). 
 
 
A
B
Control BFA TUN
0.00
0.25
0.50
0.75
1.00
1.25
1.50
*
*
M
it
o
c
h
o
n
d
ri
a
 c
a
lc
iu
m
 l
e
v
e
ls
 (
re
la
ti
v
e
 t
o
 c
o
n
tr
o
l)
0 200 400 600 800 1000
160
200
240
280
320
360  Control
 BFA
 TUN
F
5
8
1
 n
m
Time (s)
A23
The ER – mitochondria axis in Parkinson’s disease 
 
 
101 
 These results lead us to presume that ER and mitochondria are in a close 
communication, establishing a dynamic signalling pathway. 
 
4.3.3 Brefeldin A and tunicamycin-evoked Ca2+ fluxes affect mitochondrial 
function 
Although we have demonstrated that ER induced stress potentiates mitochondrial Ca2+ 
uptake, we hypothesized that ER and mitochondria communication via Ca2+exchanges 
could stimulate alterations in mitochondrial function. 
 Therefore, we have investigated the functional significance of ER stress induction 
on mitochondrial function and its contribution to the initiation of cell death. We evaluated 
changes on m. As shown in Figure IV.4A, a slight decrease in rhodamine 123 (Rh123) 
retention induced by ER stress inducers was observed, suggesting that these 
compounds did not incite a substantial mitochondrial depolarization.  
In addition, we have also evaluated the mitochondria respiratory chain NADH-ubiquinone 
oxidoreductase (complex I) activity. Results shown in Figure IV.4B demonstrate that 
both BFA and TUN provoked a statistically significant decrease in mitochondrial 
respiratory chain complex I activity.  
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Figure IV.4. Effects of BFA and TUN on mitochondrial function.  
A. Changes in mitochondrial membrane potential induced by BFA and TUN stressors were 
estimated using the fluorescent cationic dye Rh123. Data are expressed as a percentage of the 
untreated cells values (control) (n=3; *p<0.05, relative to control). B. Mitochondrial respiratory 
chain complex I activity was determined as described in Chapter II. Data are reported in 
nmol/min/mg as the mean±SEM (n=4; ***p<0.001, relativel to control).  
 
 
Overall, these results indicate that mitochondrial respiratory chain activity is sensitive to 
the effects induced by brefeldin A and tunicamycin at ER level. 
 
 
4.3.4 Brefeldin A- and Tunicamycin-induced stress activates ER- and 
mitochondria-dependent caspase cascades 
Ca2+ release from the ER has been implicated as a key signaling event in many 
apoptotic models and it may influence the sensitivity of mitochondria to apoptotic 
alterations. Moreover, a recent discovery that a subpopulation of BiP/GRP78 can exist as 
an ER transmembrane protein implies that it can potentially interact directly with the 
cytosolic components of the apoptotic pathway and regulate their activity (Rao et al., 
2002; Reddy et al., 2003). For instance, GRP78 has been reported to form complexes 
with procaspases, such as mouse caspase-12, which associates with the outer ER 
membrane (Reddy et al., 2003). The protective function of BiP/GRP78 against a wide 
variety of stresses suggests that BiP/GRP78 may also interfere with the activity of key 
upstream regulators of apoptosis. 
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 Thus, we decided to examine the mechanisms through which ER-induced stress 
initiate and propagate cell death signals and its involvement in the control of cell death. 
Firstly, following the cascade of death signalling downstream of ER, we analyzed the 
involvement of caspase-4. As shown in Figure IV.5A, a significant increase in Ac-LEVD-
pNA cleavage by activated caspase-4 was observed upon BFA treatment only.  
 Previously, it has been demonstrated that BFA and TUN promote the translocation 
of cytochrome c from the mitochondrial matrix to the cytosol (Elyaman et al., 2002; Izuta 
et al., 2008). In line with this, we further analyzed the caspase-2 activity, which appears 
to act upstream of cytochrome c release and to be involved in the ER stress-mediated 
death (Guo et al., 2002; Lassus et al., 2002; Seo et al., 2006b), and caspase-9 activity, 
which is thought to be involved in the cell death signals propagation triggered by 
mitochondria (Slee et al., 1999). As shown in Figure IV.5B, only TUN activated caspase-
2 (Ac-VDVAD-pNA cleavage). Both ER stressors activated caspase-9 (Ac-LEDH-pNA) 
(Figure IV.5C). 
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Figure IV.5. Effects of ER stress on caspase activation in NT2 cells.  
Effect of brefeldin A (BFA) and tunicamycin (TUN) on caspase 4-like activity (Ac-LEVD-pNA 
cleavage) (A), caspase 2-like activity (Ac-VDVAD-pNA cleavage) (B), and caspase 9-like activity 
(Ac-LEDH-pNA cleavage) (C). Data are expressed relative to the basal activity observed in the 
untreated NT2 cells (control) (n=3-6; **p<0.001, ***p<0.001, relative to control). 
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was shown to be activated by ER stress in a specific-manner and not by membrane- or 
mitochondria-targeted signals (Hitomi et al., 2004). 
 Our results revealed that stress in the ER and the subsequent ER Ca2+ release 
triggers a caspase-4 dependent pathway and also a mitochondrial-dependent apoptotic 
Control BFA TUN
0.0
0.5
1.0
1.5
2.0
2.5
***
A
c
-L
E
V
D
-p
N
A
 c
le
a
v
a
g
e
(r
e
la
ti
v
e
 t
o
 c
o
n
tr
o
l)
Control BFA TUN 
0
1
2
3
4
***
A
c
-L
E
D
H
-
p
N
A
 c
le
a
v
a
g
e
(r
e
la
ti
v
e
 t
o
 c
o
n
tr
o
l)
A B
C
Control BFA TUN 
0.0
0.5
1.0
1.5
2.0
2.5
3.0
***
A
c
-V
D
V
A
D
-p
N
A
 c
le
a
v
a
g
e
 (
re
la
ti
v
e
 t
o
 c
o
n
tr
o
l)
The ER – mitochondria axis in Parkinson’s disease 
 
 
105 
pathway, which leads to the activation of caspase-2 and -9. We suppose that these two 
components of the ER and mitochondria stress can apparently work independently. 
These results are consistent with a previous study which showed that BFA induces 
typical apoptosis features, such as mitochondrial breach and cell shrinkage, in follicular 
lymphoma cells (Guo et al., 2002). 
 First, our results demonstrated that ER stressors induced ER Ca2+ release to the 
cytosol. Second, perturbations at ER level by BFA and TUN potentiated Ca2+ uptake by 
mitochondria. Third, ER stress led to a low decrease of mitochondria membrane 
potential, with a substantial decline in the rotenone sensitive NADH oxidation.  
 Taken together, these results led us to infer the inevitable role of Ca2+ fluxes 
between the ER and mitochondria and subsequent caspase activation, representing a 
link between ER deregulation and mitochondria-dependent apoptotic pathways. 
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Mitochondrial metabolism in Parkinson’s disease 
impairs quality control autophagy by hampering 
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5.1. Summary 
 
Abnormal presence of autophagic vacuoles is evident in brains of patients with 
Parkinson’s disease (PD), in contrast to the rare detection of autophagosomes in a 
normal brain. However, the actual cause and pathological significance of these 
observations remain unknown. 
Here, we demonstrate a role for mitochondrial metabolism in the regulation of the 
autophagy-lysosomal pathway in ex vivo and in vitro models of PD. We show that 
transferring mitochondria from PD patients into cells previously depleted of mitochondrial 
DNA is sufficient to reproduce the alterations in the autophagic system observed in PD 
patient brains. Although the initial steps of this pathway are not compromised, there is an 
increased accumulation of autophagosomes associated with a defective autophagic 
activity. We prove that this functional decline was originated from a deficient mobilization 
of autophagosomes from their site of formation toward lysosomes due to disruption in 
microtubule-dependent trafficking. This contributed directly to a decreased proteolytic 
flux of α-synuclein and other autophagic substrates. 
Our results lend strong support for a direct impact of mitochondria in autophagy 
as defective autophagic clearance ability secondary to impaired microtubule trafficking is 
driven by dysfunctional mitochondria. We uncover mitochondria and mitochondria-
dependent intracellular traffic as main players in the regulation of autophagy in PD. 
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5.2. Introduction  
 
Parkinson’s disease (PD) is a common neurodegenerative movement disorder, 
characterized by a dramatic loss of midbrain dopaminergic neurons in the substantia 
nigra pars compacta (SNpc), and the presence of ubiquitylated α-synuclein-containing 
intracytoplasmic inclusions called Lewy bodies (LBs) in surviving SNpc neurons (Forno, 
1996). 
 Ageing is considered the greatest risk factor for sporadic PD (sPD). Accumulation 
of mitochondrial DNA (mtDNA) mutations and mitochondria-driven oxidative stress is 
thought to represent a bridge between sPD and the natural ageing process. 
Mitochondrial association with sPD was established when a mitochondrial NADH 
dehydrogenase (complex I) activity deficit was identified in the SNpc of post-mortem PD 
patient brains (Schapira et al., 1989) and in PD patient platelets (Parker et al., 1989). In 
addition, mtDNA involvement in complex I defects observed in PD platelets was further 
recognized after transference of platelet mitochondria into mtDNA-deficient cell lines and 
validated in the resultant cell lines known as ‘‘cybrids’’ (Swerdlow et al., 1996). Data 
obtained using this ex vivo cellular model have shown that several pathogenic features 
observed in PD subject brains are actually recapitulated by PD cybrids (Cardoso, 2011; 
Swerdlow, 2011). Moreover, the generation of fibrillar and vesicular protein inclusions in 
sPD cybrids replicating most antigenic and structural features of LBs was reported 
(Trimmer et al., 2004b; Esteves et al., 2009). 
 The presence of LBs-like structures in sPD cybrids suggests that mitochondrial 
dysfunction associated with defective protein handling may account for PD 
pathogenesis. Relevant to PD pathology, autophagy represents a major mechanism by 
which intracellular long-lived proteins, protein aggregates (such as α-synuclein 
oligomers) and entire cytoplasmic organelles (such as mitochondria) are directly 
degraded within lysosomes. It is now considered that constitutive basal autophagic 
activity is a main quality control (QC) process that selectively disposes aberrant protein 
aggregates and damaged organelles for degradation (Lee et al., 2010b; Lee et al., 
2010a). Thus, the regulation of QC autophagy may be critical to restrain the 
neurodegenerative process (Wong and Cuervo, 2010; Arduino et al., 2011b).  
 In line with this, growing evidence has suggested a role for autophagy deregulation 
in PD. Increased number of autophagosomes has been observed in cultured cells 
treated with mitochondrial complex I inhibitors such as 1-methyl-4-phenylpyridinium 
(MPP+), rotenone and 6-OHDA (Chen et al., 2007; Dagda et al., 2008), and in 
postmortem PD patient brains (Anglade et al., 1997). Although these changes have been 
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commonly interpreted as an abnormal induction of autophagy, the actual origin and 
significance of these observations for the disease pathogenesis remain elusive. 
 Here, we investigated cause-and-effect relationships between mitochondrial 
dysfunction, microtubule network disruption and accumulation of autophagosomes and 
autophagy substrates. Using sPD cybrid cells, mtDNA-depleted cells and MPP+-treated 
primary cortical neurons, we characterized basal and induced autophagic responses and 
the clearance of autophagy cargos. We found that changes in mitochondrial function per 
se have a severe impact on autophagy since autophagosomes are actually actively 
formed but inefficiently cleared in sPD cells. Molecular dissection of each of the steps 
revealed that microtubule disruption rather than abnormal induction of autophagy gives 
rise to the characteristic patterns of autophagic pathology observed in PD. 
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5.3. Results 
5.3.1. Hybrid cells harboring sPD patient mitochondria and mtDNA-depleted 
cells accumulate morphologically abnormal mitochondria and nonfused 
autophagic vacuoles 
To directly explore the functional consequences of an altered mitochondrial function over 
the autophagic-lysosomal system in the context of sPD, we modeled PD by creating 
transmitochondrial cytoplasmic hybrid cell lines (cybrids) in which endogenous 
mitochondrial DNA (mtDNA) from sPD or control (CT) subject platelets was transferred to 
human teratocarcinoma (NT2) cells after complete depletion of endogenous mtDNA 
(Rho0 cells). By this approach, it is possible to follow the effects of mtDNA heteroplasmy 
within a nuclear and environmentally controlled context, thus providing a rational basis 
for the propagation of PD-related mitochondrial dysfunction, including a decline in 
mitochondrial ATP synthesis capacity and other mitochondria-dependent processes. 
 In this study, we used the same cohort of cybrids that was previously characterized 
in terms of mitochondrial bioenergetics (Esteves et al., 2010c). In this cohort, sPD 
cybrids were found to have a reduced complex I function, though citrate synthase 
activity, a commonly used quantitative mitochondrial enzyme marker, was not altered. In 
addition, basal oxygen consumption between sPD and CT cybrids was comparable. 
However, when mitochondria were challenged via chemical-induced uncoupling into a 
state of maximum oxygen consumption, sPD cybrids revealed an increase in proton leak 
in conjunction with a reduced respiratory reserve capacity and ATP production, 
compared with CT cells. In addition, pathways influenced by aerobic metabolism were 
also altered in these sPD cybrids. sPD cybrids showed reduced sirtuin-1 (SIRT1) 
phosphorylation, reduced peroxisome proliferator-activated receptor-gamma coactivator-
1alpha (PGC-1α) levels and increased NF-kB activation (Esteves et al., 2010c). 
 In this study, to investigate potential sequence variations that may be functionally 
relevant and cause mitochondrial dysfunction in sPD, we sequenced cybrid mtDNA 
derived from three sPD patients and three CT subjects and performed an mtDNA 
screening analysis of seven mtDNA genes coding for complex I subunits. As shown in 
Table V.1, we identified different patterns of mtDNA variations, in both CT and sPD 
patients.  
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Table V.1. Summary of mtDNA investigation results. 
Sample mtDNA sequence 
variations 
Status (according to MITOMAP) Gene 
CT2 
3915G>A CRP MTND1 
4727A>G CRP MTND2 
11253T>C CRP; PM reported in LHON and PD MTND4 
CT3 
3915G>A 
4727A>G 
CRP 
CRP 
MTND1 
MTND2 
11253T>C CRP; PM reported in LHON and PD MTND4 
CT8 
10685G>A CRP MTND4L 
11467A>G CRP; PM reported in altered brain pH MTND4 
11719G>A CRP MTND4 
12070G>A CRP MTND4 
12372G>A CRP; SM in prostate tumor; PM reported in altered 
brain pH 
MTND5 
13617T>C CRP MTND5 
PD4 14470T>A CRP MTND6 
PD5 
3992C>T CRP; SM in thyroid tumor MTND1 
4025A>G CRP MTND1 
5004T>C CRP MTND2 
14365C>T CRP MTND6 
14582A>G CRP MTND6 
PD6 
3652A>G* UnP in Congenital Non-syndromic Deafness MTND1 
4216T>C CRP; SM in acute leukemia platelets, leukocytes 
and bone marrow; PM-haplogrup marker JT in 
LHON/Insulin Resistance 
MTND1 
4917A>G CRP; PM reported and haplogroup T marker in 
LHON/Insulin Resistance/AMD/NRTI-PN 
MTND2 
11251A>G CRP MTND4 
11719G>A CRP MTND4 
11812A>G CRP MTND4 
13368C>A CRP MTND5 
13965T>C CRP MTND5 
14233A>G CRP MTND6 
Notes: the nomenclature of genes is presented according to MITOMAP; CRP: coding region polymorphism; 
*heteroplasmy; SM: somatic mutation; PM: point mutation; UnP: unpublished polymorphism; LHON: Leber 
Hereditary Optic Neuropathy; AMD: Age-Related Macular Degeneration; NRTI-PN: Antiretroviral Therapy-
Associated Peripheral Neuropathy. 
However, no consistent differences were found in terms of mutation patterns or 
localizations and no PD-related mtDNA variations were detected in sPD cybrids. Our 
results do not rule out the possible involvement of mtDNA on mitochondrial dysfunction 
observed in sPD cybrids since other genes outside the regions investigated may be 
involved in the disease or that mtDNA involvement is related to either deletion events or 
copy number alterations. We then decided to evaluate whether the phenotypic 
biochemical changes found earlier in these cybrids are correlated with the mitochondrial 
content. We performed a comparative analysis for different mitochondrial markers in 
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order to assess the total mitochondrial pool of CT versus sPD cybrids. As shown in 
Figures V.1A and B, we have found variability among the levels of the proteins studied, 
but no statistically significant differences in sPD cybrids in comparison with CT cells were 
detected in the most significant structural proteins of mitochondria.  
 We have also evaluated complex I activity, and, as previously characterized by our 
group (Esteves et al., 2008; Esteves et al., 2010c), sPD cybrid cell lines show a stable 
decrease in this mitochondrial activity (Figure V.1C).  
 
Figure V.1. Mitochondrial deficits are related with an altered ETC complex I activity.  
A. Immunoblot for mitochondrial markers (Hsp60, VDAC/Porin, TOM20, COXIV, NDUFA2) from 
CT and PD cybrids. B. Densitometric analysis of mitochondrial marker levels (n=8, *p<0.05, 
versus CT cybrids). C. Mitochondrial respiratory chain complex I activity. Data are reported in 
nmol/min/mg as the mean ± SEM (n=12; **p<0.01, versus CT cybrids).  
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To evaluate mitochondrial distribution and morphology, we used TOM20 staining and 
determined indices of mitochondrial interconnectivity and mitochondrial elongation. 
Mitochondrial interconnectivity is calculated as the mean area/perimeter ratio and is 
consistent with the degree of mitochondrial branching, namely the connectivity/dynamics 
between mitochondria (Koopman et al., 2005b; Koopman et al., 2005a). A higher 
mitochondrial interconnectivity means a higher access and communication between 
mitochondria. We have found that, in PD cybrids, mitochondrial distribution was more 
perinuclear than in CT cybrids (Figure V.2). Moreover, PD cybrids showed a decrease in 
mitochondria elongation and interconnectivity, both features correlating with increased 
mitochondrial fragmentation. In fact, in PD cybrids, mitochondria appear as small dots 
instead of a mitochondrial interconnected net.  
 
 
Figure V.2. Mitochondrial distribution, elongation and interconnectivity are altered in sPD 
cybrids. 
A. TOM20 immunostaining (green) of CT and PD cybrids showing alterations in mitochondria 
distribution, elongation and interconnectivity in PD cybrids. Hoechst 33342-stained nuclei are in 
blue. Scale bar: 20 µm. B. Mitochondrial elongation (n=3, ***p<0.001, PD versus CT cybrids). C. 
Mitochondrial interconnectivity (n=3, *p<0.05, mitochondrial interconnectivity PD versus CT 
cybrids).  
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 The aforementioned alteration in sPD cybrid morphological and biochemical 
features is in agreement with an altered mitochondrial ultrastructure and may account for 
the clinical phenotype of the patients included in this study. Accordingly, in this study, we 
have examined 15 cell profiles of each cell line and categorized them as to whether they 
contained predominantly normal or abnormally shaped mitochondria and autophagy-
related structures. Regarding mitochondrial structure, we have found that sPD cybrids 
had many morphologically abnormal mitochondria comparative to CT cybrids. In general, 
Figure V.3A shows that mitochondria in CT cybrids were small and round or rod-like and 
elongated (as shown in Figure V.3Aa-d). The matrices were dark and uniform and the 
cristae were homogeneously distributed (as shown in Figure V.3Ab-d). sPD cybrid 
mitochondria were mostly found enlarged with oval rather than rod-like profiles (as 
shown in Figure V.3Ah). These abnormal mitochondria contained pale and patchy 
matrices and disrupted cristae (as shown in Figure V.3Ai-k). Some of sPD cybrid 
mitochondria contained inclusions of electron-dense amorphous substances within 
matrix that are thought to represent deposits of calcium and inorganic phosphates 
(denoted as filled triangles in Figure V.3Aj and k) (Lloreta-Trull and Serrano, 1998; 
Ghadially, 2001; Trimmer et al., 2004b).  
 In order to verify whether these changes in sPD cybrid mitochondrial ultrastructure 
are exclusively due to the transferred sPD patient mitochondria, we have extended our 
analysis to the cybrid parental cell line (Rho0 cells). These cells, which lack functional 
mitochondria due to mtDNA depletion, were found to have high accumulation of swollen 
pale mitochondria with discontinuous cristae (denoted as arrows in Figure V.3Ba). In 
addition, mitochondrial shape showed a rather circular or oval contour and mitochondria 
were found apart from each other (Figure V.3B). Cristae-like structures were perfectly 
discernible in Rho+ cell line mitochondria (Figure V.3A), whereas in Rho0 cells (Figure 
V.3B) we observed few cristae-like structures with an atypical structure going from one 
point to another of the mitochondrial peripheral contour (denoted as filled triangles in 
Figure V.3Bb and c). Indeed, these observations suggest that abnormal mitochondria 
features found in sPD cybrids are clearly due to the transferred mitochondria. 
 
 
 
 
 
 
 
 
Mitochondrial metabolism dictates the autophagic outcome 
 
 
117 
Figure V.3. Mitochondrial deficits induced the accumulation of morphologically abnormal 
mitochondria and nonfused autophagic vacuoles.  
A. Electron micrographs of CT and sPD cybrids. Lower inserts show higher magnification images 
to illustrate morphological features of mitochondria and individual examples of autophagic 
vacuoles in both CT and sPD cybrids. Black arrows, autolysosomes; white arrows, 
autophagosomes; arrows heads, electron-dense amorphous inclusions within mitochondria. Scale 
bars: 2 µm (top) and 0.5 µm (middle and bottom). B. Electron micrographs of NT2 Rho0 cells. 
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Higher magnification fields show morphological features of mitochondria and autophagic vacuoles 
in Rho0 cells. (a) Dark arrows: swollen pale mitochondria with discontinuous cristae; Dark arrow 
heads: enlarged autophagosome enclosing mitochondria and other materials; (b and c) dark 
arrow heads: abnormal membranous structures. Scale bars: 2 µm (top) and 0.5 µm (bottom). C. 
Quantification of autophagosomes (APG) and autolysosomes (APGL) in cybrid cell lines and 
mtDNA depleted (Rho0) cells. The total number of vesicles was quantified from 15 cell profiles for 
each cell line (n=3, *p<0.05, ***p< 0.001, versus APG CT cybrids; *p<0.05, **p< 0.01, versus 
APG+APGL CT cybrids;
 ##
p<0.01, versus APG+APGL sPD cybrids). 
 
 
 In addition, ultrastructural analysis revealed that sPD cybrid cells also contain 
cytosolic vesicles (denoted as arrows in Figure V.3Ah) that appear to be autophagic 
vacuoles enclosing dark bodies and other cytoplasmic inclusions identical to the 
cytoplasm surrounding the vacuoles, which are compatible with autophagosomes 
(Figure V.3Al-n). In contrast, vesicles containing amorphous materials looking total or 
partially degraded similar to autolysosomes and/or lysosomes were more prominent and 
easily detectable in CT cybrids comparative to sPD cybrids (denoted as arrows in 
Figure V.3Aa versus h). Quantitative analysis of the electron micrographs showed an 
increase in the number of autophagosomes (APG) in those cells compared with CT 
cybrids (Figure V.3C). 
 Similarly, Rho0 cells accumulated a large number of autophagic vacuoles (Figure 
V.3C), but apparently no lysosomes or cytoplasmic inclusions (Figure V.3Ba). 
Interestingly, for these cells, we have also detected a great number of mitochondria 
inside “giant” autophagosomes, indicating a relatively high index of autophagic 
sequestration (denoted filled triangles in Figure V.3Ba and d). 
 Since newly formed autophagosomes mature and eventually fuse with lysosomes, 
thereby delivering their contents to lysosomes for degradation, the exacerbated 
accumulation of autophagosomes observed in sPD cybrids and more evident in Rho0 
cells prompted us to assess the effects of sPD-mitochondrial dysfunction on the 
autophagic activity. 
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5.3.2 Mitochondrial deficits in cells harboring PD patient mitochondria or in 
mtDNA-depleted cells compromise quality control autophagic response  
We next evaluated autophagosome formation by directly measuring the cellular 
distribution of endogenous LC3B and by monitoring the autophagic flux, as determined 
by comparing the accumulation of autophagosomes after the inhibition of lysosomal 
proteolysis with NH4Cl/leupeptin (NL) relative to the steady-state levels of 
autophagosomes (Rubinsztein et al., 2009)  
 Under basal conditions, sPD cybrids show an increase in both the number and size 
of endogenous LC3B puncta relative to CT cybrids. (Figure V.4Aa versus c, and B), but 
when lysosomal degradation was inhibited this number increased more markedly in CT 
cybrids (Figure V.4Ab versus d, and B), indicating a higher basal autophagic activity for 
CT cybrids. Removal of serum further activated autophagy in a higher extent in CT 
cybrids than in sPD cybrids, as depicted by the higher increase in the number of bright 
puncta without treatment (Figure V.4Aa versus e, compared with c versus g, and B). 
Similar results were obtained when lysosomal degradation ability was inhibited (Figure 
V.4Ab versus f, compared with d versus h, and B). 
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Figure V.4. QC autophagic response is impaired in cells harboring PD patient 
mitochondria.  
A. LC3B immunostaining (green) of CT and PD cybrids maintained in the presence [Serum (+)] or 
absence [Serum (−)] of serum and inhibitors of lysosomal proteolysis [NL(+); NL(-)]. Hoechst 
33342-stained nuclei are in blue. Scale bar: 10 µm. B. Mean number of LC3B-positive vesicles 
per cell profile (n=3, *p<0.05, ***p<0.001 versus S+ CT cybrids; 
##
 p<0.01, versus S- CT cybrids).  
 
 
 These immunofluorescence results were confirmed by determining the autophagic 
flux by immunoblot. By this approach, we have also detected an increase in the basal 
levels of LC3B-II, a phosphatidylethanolamine-conjugated form that is localized to 
autophagosomes, in sPD cybrids when compared with CT cybrids (Figure V.5A and B). 
As in the LC3B puncta staining data, the increase in LC3B-II upon inhibition of lysosomal 
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degradation was higher for CT cybrids under normal nutrient conditions as well as upon 
induction of autophagy by starvation [serum (-) conditions]. Accordingly, we observed 
that, although the basal levels of autophagic vacuoles are increased in sPD cybrids, their 
rate of autophagic degradation is significantly lower when compared with CT cybrids 
(Figure V.5C and D, respectively). Also, when compared with CT cybrids, sPD cybrids 
showed increased basal levels of the autophagic substrate p62 which were not 
potentiated after lysosomal inhibition, demonstrating an impaired lysosomal turnover of 
protein cargo via autophagy in these cells (Figure V.23A and B). 
 
 
Figure V.5. QC autophagic activity is impaired in cells harboring PD patient mitochondria.  
A. Immunoblot for endogenous LC3B from CT and PD cybrids after culture in serum (+) or serum 
(-) conditions and treatment with NL. B. Densitometric analysis of endogenous levels of LC3B 
(n=18, ***p<0.001 versus S+ CT cybrids; ### p<0.001, versus S+ PD cybrids; $$$p<0.001, versus 
S- CT cybrids; &&& p<0.001, versus S- PD cybrids). C. Determination of autophagic vacuole (AVs) 
levels. Values of LC3-II in the absence of NL represent the steady-state AV content (n=18, 
*p<0.05, ***p<0.001, versus S+ CT cybrids). D. Assessment of autophagic flux, calculated as the 
ratio of LC3-II densitometric value of NL-treated samples over the corresponding untreated 
samples (n=18, **p<0.01, versus S+ CT cybrids).  
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 We obtained similar results with the parental cell line NT2 when treated with MPP+ 
(1 mM, 24 h), a classic inhibitor of complex I (Figure V.6A-D).  
 
 
Figure V.6. Mitochondrial dysfunction mediates autophagic stress in MPP
+
-treated cells.  
A. Immunoblot for LC3B from NT2-Rho+ cells treated with or without lysosomal inhibitors (NL). B. 
Densitometric analysis of LC3B levels (n=3, **p<0.01, ***p<0.001, versus untreated cells; 
##
p<0.01, versus MPP
+
-treated cells). C. Determination of autophagic vacuole (AVs) basal levels. 
Values of LC3-II in the absence of NL represent the steady-state AV content (n=3, *p<0.05, 
versus untreated cells) D. Assessment of autophagic flux, calculated as the ratio of LC3-II 
densitometric value of NL treated samples over the corresponding untreated samples (n=3, 
**p<0.01, versus untreated cells). 
 
 
These results were also corroborated in differentiated PD cybrid cell lines that exhibit 
processes similar to neuronal cells (Figure V.7A and B). Consistent with our results in 
cybrid cells and MPP+-treated NT2 cells, LC3B content increased significantly more in 
neuronal-like CT (nCT) cybrid cells when exposed to lysosomal inhibition for 4 h, 
indicating that these cells were more prone to develop an autophagic response rather 
than nPD cybrids (Figure V.7A and B). 
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Figure V.7. Autophagic abnormalities are evident in neuronal-like cybrid cell lines.  
A. Immunofluorescence for LC3B (green) in neuronal-like CT and PD cybrids treated with or 
without lysosomal inhibitors (NL). Beta-tubulin III (red) and Hoechst 33342 (blue) co-stainings 
were used as neuronal and nuclei markers, respectively. Scale bars: 10 µm. B. Mean number of 
LC3B-positive vesicles per cell profile (n=2, ***p<0.001 versus nCT cybrids). 
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The increased accumulation of LC3-II obtained for all those cellular models was also 
evident in sPD patient peripheral blood lymphocytes (Figure V.8A and B). Moreover, 
under serum starvation conditions, CT cybrids activated nonselective “bulk” autophagy in 
a greater extent than PD cybrids, although no alterations were observed in the 
autophagic flux.  
 
 
Figure V.8. PBMCs from sporadic PD patients exhibit increased levels of LC3B-II.  
A. Immunoblot image for LC3B in PBMCs from control subjects (CT) and sporadic PD patients 
(sPDs). B. Densitometric analysis of LC3B levels (*p<0.05, versus CT subjects). 
 
 
 Similar results were obtained for cells lacking the mitochondrial genome (Rho0 
cells) and thereby a dysfunctional mitochondrial respiratory system. In the absence of 
such system, these cells require alternative mechanisms for the maintenance of an 
appropriate redox state and energy supply. If sufficient pyruvate and uridine are 
provided, these cells can grow without a functional mitochondrial electron transport chain 
and oxidative phosphorylation. Theoretically, this would increase the glycolytic pathway 
flux for continual regeneration of NAD+, including that regenerated by the plasma 
membrane oxidoredutase (Larm et al., 1994), ensuring that glycolytic pathway will 
provide sufficient ATP to sustain essential cellular metabolic activities and cell viability 
(Morre et al., 2000).  
 In agreement with the EM data in Figure V.3B , Rho0 cells showed a higher 
number of autophagic vacuoles in comparison with their parental counterpart cell line 
containing a full complement of mtDNA (Rho+ cells), distinguished as LC3B-positive 
puncta by immunofluorescence (data not shown) and by autophagic vacuole basal levels 
(Figure V.9A and B). However, this was not accompanied by an increase in the number 
of these organelles in response to lysosomal inhibition (Figure V.9A and B), supporting 
a lower autophagic flux in Rho0 cells (Figure V.9C).  
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Figure V.9. Autophagic stress is increased in mtDNA-depleted cells relative to full 
complement mtDNA-containing cells.  
A. Immunoblot for LC3B from mtDNA-depleted cells (Rho0) and their parental cells containing a 
full complement of mtDNA (Rho+) treated with or without lysosomal inhibitors (NL). B. 
Densitometric analysis of LC3B levels (n=3, *p<0.05, versus Rho+-untreated cells). C. 
Determination of autophagic vacuole (AVs) basal levels. Values of LC3-II in the absence of NL 
represent the steady-state AV content (n=3, *p<0.05, versus Rho+-untreated cells). D. 
Assessment of autophagic flux, calculated as the ratio of LC3-II densitometric value of NL-treated 
samples over the corresponding untreated samples (n=3, *p<0.05, versus Rho+-untreated cells). 
 
 
 To evaluate whether mitochondrial dysfunction could lead to the impairment in the 
autophagic response due to a bioenergetic failure, we have also compared the 
autophagic response of Rho0 cells grown in the presence [pyr/urd (+/+)] or absence 
[pyr/urd(-/-)] of pyruvate and uridine. Subsequently, autophagy was induced exposing 
cells to serum starvation conditions. Under these conditions, cells were also maintained 
in non-supplemented media to determine the extent to which the autophagic response 
depends on ATP production derived from glycolysis. No statistically significant 
differences were observed between cells grown in pyr/urd (+/+) or in pyr/urd (-/-) media 
for 24 h (Figure V.10Aa versus c and e versus g, and B). Moreover, the shift to a 
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punctuate pattern of LC3B upon inhibition of lysosomal-degradative ability was not 
statistically different between cells subject to both types of pyr/urd treatment, under both 
normal growing (Figure V.10Ab versus d, and B) and serum removal conditions 
(Figure V.10Af versus h, and B).  
 
 
Figure V.10. QC autophagic response is impaired in mtDNA-depleted cells.  
A. LC3B immunostaining (green) of Rho0 cells maintained in serum (+) or serum (−) conditions 
and NL treatment, following growth in the presence [pyr/urd (+/+)] or absence [pyr/urd (-/-)] of 
pyruvate and uridine. Hoechst 33342-stained nuclei are in blue. Scale bar: 10 µm. B. Mean 
number of LC3B-positive vesicles per cell profile [n=3, **p<0.01, versus S+ pyr/urd (+/+); 
### 
p<0.001 versus S- pyr/urd (+/+)].  
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We also checked the effect of growing cells in pyr/urd (-/-) medium for 48 h on the 
autophagic response, but no significant changes were observed (data not shown). These 
results were supported by our biochemical data showing significantly higher LC3B-II 
levels only upon serum withdrawal (Figure V.11A-C), which was correlated with an 
impaired autophagic response/activity (Figure V.11D). 
 
 
Figure V.11. QC autophagic activity is impaired in mtDNA-depleted cells.  
A. Immunoblot for endogenous LC3B from Rho0 cells maintained in serum (+) or serum (−) and 
NL treatment following growth in pyr/urd (+/+) or pyr/urd (-/-) conditions. B. Densitometric analysis 
of LC3B endogenous levels [n=5, *p<0.05, **p<0.01, versus S+ pyr/urd (+/+); 
##
 p<0.01, versus 
S+ pyr/urd (-/-); 
&&
 p<0.01, versus S- pyr/urd (+/+); 
$$
p<0.01, versus S- pyr/urd (-/-)] C. 
Determination of autophagic vacuole (AVs) levels. [n=5, *p<0.05, versus S+ pyr/urd (+/+)]. D. 
Assessment of autophagic flux (n=5). 
 
 
 Overall, these data supports that the defect on both QC and “bulk” autophagy 
observed in PD cells was not due to changes on ATP availability through glycolysis. 
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5.3.3. Autophagic degradation is impaired in MPP+- treated primary cortical 
neurons  
To extend these findings and further confirm our previous observation that mitochondrial 
deficits can compromise the degradative ability of the autophagic system, we used 
MPP+-treated primary cortical neurons, a well-established in vitro model of PD-
associated neuronal dysfunction directly caused by mitochondrial impairment (Beal, 
2001; Nicotra and Parvez, 2002; Martinez and Greenamyre, 2011). In this model, we 
have also found a rapid accumulation of LC3B-positive vesicles within 4 h after blocking 
of lysosomal proteolysis, indicating a constitutive autophagic flux in primary cortical 
neurons (Figure V.12Aa versus b, and e versus f). However, we could not observe an 
increase in the number of LC3B-positive vesicles in MPP+-treated cells (50 µM, 24 h) 
when compared with CT cells (Figure V.12Aa versus c, and B), both in CT conditions 
or in the presence of rapamycin, an mTOR inhibitor that induces autophagy (Figure 
V.12Ae versus g, and B).  
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Figure V.12. MPP
+
-induced mitochondrial dysfunction mediates autophagy-lysosome 
pathway impairments in primary cortical neurons. 
A. LC3B immunostaining (green) of primary cortical neurons treated with MPP
+ 
for 24 h. In the 
last 4 h, cells were co-treated with or without rapamycin and lysosomal inhibitors (NL). Beta-
tubulin III (red) and Hoechst 33342 (blue) co-staining was used as a neuronal and nuclei marker, 
respectively. Scale bar: 10 µm. B. Mean number of LC3B-positive vesicles per cell profile (n=3, 
**p<0.01, ***p<0.001, versus CT; 
###
 p<0.001, versus MPP
+
-treated cells;
 &
p<0.05; 
&&
p<0.01, 
versus rapamycin (Rap)-treated cells; 
$$$
p<0.001, versus Rap+MPP
+
-treated cells). 
 
 
These data were also verified by immunoblotting, showing no significant effect on the 
levels of LC3B-II when cells were exposed to MPP+ (Figure V.13A-C). This was 
accompanied by a significant reduction on the autophagic flux (Figure V.13F), similar to 
the results obtained using cellular models of mitochondrial dysfunction. Rapamycin was 
able to develop an autophagic response, which indicates that the decreased flow 
observed by MPP+ treatment is specific. Even in the presence of rapamycin, MPP+-
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treated cortical neurons were unable to develop an efficient autophagic response, since 
autophagic flux is decreased when compared with rapamycin treatment and did not 
reach CT values.  
 
 
Figure V.13. MPP
+
-induced mitochondrial dysfunction mediates autophagy-lysosome 
pathway impairments in primary cortical neurons.  
A. LC3B immunoblot of primary cortical neurons treated with MPP
+ 
for 24 h. In the last 4 h, cells 
were co-treated with or without rapamycin (Rap) and lysosomal inhibitors (NL). B. Densitometric 
analysis of LC3B endogenous levels (n=13, *p<0.05, ***p<0.001, versus untreated cells; 
###
p<0.001, versus MPP
+
-treated cells; 
&&
p<0.01, versus Rap-treated cells; 
$$$
p<0.001, versus 
Rap+MPP
+
-treated cells). C. Determination of autophagic vacuole (AVs) levels. Values of LC3-II 
in the absence of NL represent the steady-state AV content (n=13, *p<0.05, versus CT). D. 
Assessment of autophagic flux, calculated as the ratio of LC3-II densitometric value of NL-treated 
samples over the corresponding untreated samples (n=13, *p<0.05, **p<0.01, versus CT; 
&
p<0.05, versus Rap-treated cells). 
 
 
 Although with minor differences between chronic and acute models, together these 
data suggest that mitochondrial impairment leads to alterations in the autophagy system, 
as mainly translated by a reduction in the autophagic flux. 
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5.3.4 Induction of autophagy is not primarily affected in sPD 
transmitochondrial cybrids 
We further tried to understand the nature of the changes in the autophagy-lysosome 
pathway found in the context of our sPD transmitochondrial cybrid model. Since this 
pathway encompasses multiple steps, changes not only in the clearance but also in the 
initiation could concur for the accumulation of autophagic vesicles observed. In order to 
clarify if an abnormal induction of autophagy could also be involved and contribute to the 
observed autophagic vesicles accumulation, we started by analyzing the rates of LC3B-II 
synthesis. We evaluated possible changes in synthesis in the presence of lysosomal 
proteolytic activity inhibitors at three different time points (Figure V.14A). The changes in 
LC3B-II levels when degradation is clamped would reflect the synthesis of 
autophagosomes in the experimental time frame if the autophagy system is under 
steady-state (Rubinsztein et al., 2009). According to our previous data on LC3B-II flux 
(Figure V.5A-D), the basal levels of LC3B-II were significantly higher in sPD cybrids in 
comparison with CTs (after 4 h). However, no significant differences between sPD and 
CT cybrids were observed for the levels of LC3B-II along this time course when 
lysosomal activity was inhibited (Figure V.14B). Since LC3B-II levels were maximal at 
the earliest time point considered (2 h), we also determined changes in LC3B-II 
formation between CT and sPD cybrids at earlier time points (30 min and 1 h). As 
expected, no changes were found between these two cell lines (data not shown). In 
addition, Figure V.14C shows that the rates of autophagosomes synthesis were similar 
in CT and sPD cybrids when comparisons were defined for 4 versus 2 h as well as 6 
versus 4 h, further supporting the notion that the system was under steady-state. These 
results indicate that the initiation step is not affected in sPD cybrids. 
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Figure V.14. AV synthesis is not primarily affected in PD cybrid cells.  
A. LC3B immunoblot for autophagosome synthesis assessment in CT and PD cybrids treated 
with or without lysosomal inhibitors (NL) at three different time points (2, 4 and 6 h) (n=4). B. Time 
course for autophagic vacuole (AVs) levels. AV levels correspond to the densitometry values of 
LC3-II for each condition at each time point (n=4, ***p<0.001, versus CT cybrids; ###p<0.001, 
versus PD cybrids, for each time point). C. Assessment of autophagic synthesis. Rates of AV 
synthesis were determined by comparing LC3-II levels at two different time points after the 
addition of NL (4 versus 2 and 6 versus 4h) (n=4).  
 
 
 We next decided to explore some of the key proteins belonging to the PI3-kinase 
complex machinery that controls the nucleation of autophagic vesicles. One of these 
proteins is Beclin-1. Beclin-1 is a key autophagy protein that acts as an essential 
activator of autophagy and for this reason its cellular abundance has been correlated 
with autophagic activity (Shibata et al., 2006). Surprisingly, we did not find significant 
differences in the total cellular levels of this protein in sPD cybrids in comparison with CT 
cybrids (Figure V.15A and V.15B) in the presence of serum. However, when cells were 
challenged to induce autophagy by serum withdrawal, a large increase in the levels of 
Beclin-1 was observed for CT cybrids, which was not found for sPD cybrids, 
demonstrating the inefficient capability of these cells to efficiently prompt a “bulk” 
autophagic response, as previously observed in Figure V.5A and D.  
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 Another hypothesis is that the cellular availability of Beclin-1, rather than just total 
cellular abundance, might be the key point to abnormal induction of autophagy (Wong 
and Cuervo, 2010). Beclin-1 interacts with the class III phosphatidylinositol 3-kinase 
(Vps34) to localize other autophagy proteins to the pre-autophagosomal membrane 
(Funderburk et al., 2010). In conditions in which autophagy is inhibited, Beclin-1 is 
inactivated by its interaction with Bcl-2, which functions as a brake to autophagy and 
autophagic cell death by affecting the interaction between Beclin-1 and Vps34. Thus, we 
sought to determine whether Bcl-2 has a role in modulating the autophagic response 
observed in our sPD models. Consistent with data from other study involving PD cybrids 
(Veech et al., 2000), we have found that our sPD cybrids exhibited significantly 
increased basal levels of Bcl-2 relatively to CT cybrids (Figure V.15C and D). 
Additionally, alterations in the total levels of Bcl-2 were also associated with lysosomal 
inhibition and serum removal, more remarkably in CT cybrids, which showed dramatic 
increases in the levels of this protein in such conditions (Figure V.15C and D). 
 
 
Figure V.15. Autophagic induction is not compromised in PD cybrid cells. 
A. Immunoblot for Beclin-1 from CT and PD cybrids after culture in serum (+) or serum (-) 
conditions and treatment with or without NL. B. Densitometric analysis of endogenous levels of 
Beclin-1. (n=8, ***p<0.001, versus S+ CT cybrids). C. Immunoblot for Bcl-2 from CT and PD 
cybrids after culture in serum (+) or serum (-) conditions and treatment with NL. D. Densitometric 
analysis of endogenous levels of Bcl-2. (n=6, *p<0.05, **p<0.01, ***p<0.001, versus S+ CT 
cybrids). 
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 We next assessed the cellular subcompartmentalization of Bcl-2 and Beclin-1 in 
cytosol and mitochondria-enriched fractions. We have observed that the content of Bcl-2 
was increased in the mitochondria-enriched fractions of sPD cybrids relative to CT 
cybrids (Figure V.16A and B), which is in accordance with the results obtained for the 
whole-cell lysates (Figure V.15C and D). Conversely, no major differences were 
detectable in the levels of Beclin-1 between subcellular fractions of CT and sPD cybrids 
(Figure V.16A and C). However, the changes in the total cellular abundance obtained 
for both proteins approximately match the sum of their cytosolic and mitochondrial 
enrichment. 
 
 
Figure V.16. Beclin-1 cellular availability is not compromised in sPD cybrid cells.  
A. Representative immunoblots for Bcl-2 and Beclin-1 cellular subcompartmentalization in 
mitochondria (M)- and cytosol (C)-enriched fractions. B. and C. Densitometric analysis of the 
levels of Bcl-2 (B) (n=3, **p<0.01, versus S+ CT cybrids; ##p<0.01, versus S- CT cybrids) and 
Beclin-1 (C) (n=3). 
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 As well, the targeting of Beclin-1 by Bcl-2 represents the crucial point to 
understand the mechanism of autophagy regulation. Therefore, we have also 
investigated the physical interaction Beclin-1/Bcl-2. When normalized to Beclin-1, the 
amount of Bcl-2 associated with Beclin-1 did not differ in sPD and CT cybrids (Figure 
V.17A and B). In addition, the anti-apoptotic protein Bcl-2 inhibits starvation-induced 
autophagy via targeting the BH3-like domain in Beclin-1 (Pattingre et al., 2005; Maiuri et 
al., 2007). However, the association Beclin-1/Bcl-2 was unchanged in sPD cybrids in 
comparison with CT cybrids in serum deprivation conditions, which indicates that “bulk” 
autophagy induction is not compromised in sPD cybrid cells. 
 
 
Figure V.17. Bcl-2/Beclin-1 physical interaction is not altered in sPD cybrid cells. 
A. Co-immunoprecipitation of Beclin-1 and Bcl-2 in CT and PD cybrids maintained in serum (+) or 
serum (-) conditions. Levels of Beclin-1 (top) and Bcl-2 (bottom) in the input, immunoprecipitate 
(IP) and flow through (FT) are shown. B. Determination of Bcl-2/Beclin physical interaction (n=3). 
 
 
 Taken together, these data strongly suggest that the defects in autophagic flux and 
more remarkably in the autophagic response under serum starvation conditions are not 
due to defects in the nucleation complex machinery, and the initiation step of autophagy 
is not primarily affected in our models of sPD. 
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5.3.5 Deficient intracellular traffic results in incomplete autophagosome 
degradation and reduced autophagosome and mitochondria movements in 
sPD transmitochondrial cybrids 
Autophagic failure found in our sPD cybrids model can begin from a delayed or 
interrupted traffic of autophagosomes along the microtubule system, which provides the 
tracks necessary for an efficient mobilization of cargos through the autophagy pathway. 
In support of this hypothesis, we have shown earlier that mitochondrial deficits induce 
alterations in microtubule network, mainly characterized by an increase in 
free/polymerized tubulin ratio that was responsible for high levels of α-synuclein 
oligomeric forms (Esteves et al., 2010a). 
 In order to correlate our previous findings with defective autophagic clearance, we 
have modulated microtubule-dependent trafficking of autophagosomes by using taxol (a 
microtubule polymerizing agent) and nocodazole (a microtubule depolymerizing agent) in 
concentrations that did not interfere with cell viability (data not shown), in the presence or 
absence of lysosomal inhibitors. Taxol was effective in promoting autophagy turnover in 
sPD cybrids, as reflected by decreased autophagosome content (Figure V.18A and B) 
and improved autophagic flux (Figure V.18A and C). In contrast, nocodazole 
considerably enhanced autophagosome accumulation in CT cybrids (Figure V.18A and 
B) associated with a decreased autophagic flux similar to what was observed in sPD 
cybrids (Figure V.18A and C).  
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Figure V.18. Disruption of microtubule network results in a deficient autophagic turnover in 
PD cybrid cells. 
A. Immunoblot for endogenous LC3B from CT and PD cybrids after treatment with Taxol (Tax) or 
Nocodazole (Noc) for 24 h. In the last 4 h, cells were co-treated with or without lysosomal 
inhibitors (NL). B. Determination of autophagic vacuole (AVs) levels. Values of LC3-II in the 
absence of NL represent the steady-state AV content (n=4, *p<0.05, ***p<0.001, versus CT 
cybrids; ##p<0.01, versus PD cybrids). C. Assessment of autophagic flux, determined as the ratio 
of LC3-II densitometric value of NL-treated samples over the corresponding untreated samples. 
(n=4, *p<0.05, **p<0.01, versus CT cybrids; ###p<0.001 versus PD cybrids). 
 
 
These findings suggest that autophagosomes clearance may be dependent on the 
functional status of the microtubule-dependent intracellular traffic. If so, the dynamic 
interaction of autophagic vacuoles with the microtubule system tracks may be altered in 
our sPD models hampering autophagosome transport and so the fusion with lysosome. 
Accordingly, we observed a decreased degree of co-localization between LC3-positive 
vacuoles and Lamp-1-positive vacuoles in sPD cybrids, an effect that was reversed by 
taxol treatment (Figure V.19A and B). This result may indicate an impairment of 
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autophagosomal intracellular trafficking. In contrast, nocodazole treatment decreased 
LC3B/Lamp-1 co-localization in both CT and sPD cybrids (Figure V.19A and B).  
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 Moreover, changes in autophagy progression between CT and sPD cybrids were 
also addressed by measuring the vesicle size distribution profile in the absence and 
presence of lysosomal inhibition (NL) (Bains and Heidenreich, 2009). Comparing the 
vesicle size distribution in these conditions reveals a further increase in larger vesicles 
> 1.5 μm, which under normal autophagy conditions are supposed to be quickly 
degraded (Bains and Heidenreich, 2009). In addition, we observed that in sPD cells 
there is a significant increase of the largest size autophagic vacuoles (>2.25 μm) 
indicating an accumulation of these structures which positively correlates with a 
decreased vesicular trafficking (Figure V.20).  
 
 
Figure V.20. Accumulation of autophagic vacuoles in CT and sPD cybrid cells. 
LC3B immunostaining was used to determine AV size distribution from CT and PD cybrids after 
treatment with or without lysosomal inhibitors (NL). AV size distribution was graphed as percent 
of total vacuoles within the indicated size ranges. (n=4, *p<0.05, **p<0.001, versus CT cybrids). 
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In this context, we have also monitored autophagic vacuoles movements. For each 
observed autophagic vacuole, we recorded whether it moved or remained static 
(Figure V.21A), and subsequently the relative percentages of stationary or movable 
events were calculated (Figure V.21B). As shown in Figure V.21B, sPD cybrids 
exhibited a significant decreased number of movable autophagic vacuoles. In addition, 
microtubule disruption by nocodazole promoted a decrease in the number of movable 
autophagic vacuoles to similar values in both CT and sPD cybrids.  
 We have also determined autophagic vacuole transport velocity as described 
previously (Lee et al., 2011). Cumulative percentage data displayed a left shift in 
autophagic vacuole transport velocity in sPD cybrids compared with basal CT cybrids 
(Figure V.21C1 and 2). The shift in curve profiles was minimized when cells were 
treated with nocodazole or taxol (Figure V.21C1 and 2). Intriguingly, the effect of taxol 
was more pronounced for sPD cybrids, resulting in a deflection of the cumulative curve 
to a similar profile observed for CT cybrids (Figure V.21C2). Concerning average 
velocities, sPD cybrids demonstrated a significant reduction in autophagic vacuole 
movement velocity similar to what was observed for CT cybrids treated with 
nocodazole. On the other hand, taxol was able to restore autophagic vacuole velocity 
in sPD cybrids (Figure V.21D). 
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Figure V.21. Disruption of microtubule network results in reduced autophagic vacuole 
movements in PD cybrid cells. 
A. Representative kymograph images (out of three experiments) of AV movement in CT and PD 
cybrid cells treated with nocodazole (24 h), taxol (24 h). Scale bars: 5 µm. B. Number of 
movable AVs when compared with those of total AVs (n=3, *p<0.05, versus CT cybrids). C1. 
and C2. Cumulative data for AV transport velocity in CT and PD cybrid cells treated with Noc 
(C1) or treated with taxol (C2) (n=3). D. Average transport velocity of AVs (μm/s) (n=3, 
**p<0.01, versus CT cybrids; 
#
p<0.05, versus PD cybrids). 
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We believe that this process relies on a dynamic state of mitochondria at several levels 
of organization and interaction, such as the distribution of mitochondria within a cell, 
and the dynamic interaction with the vesicular trafficking and turnover mechanisms, as 
both autophagic vacuoles and mitochondria are driven by dynein and kinesin motors 
and depends on microtubule system tracks for transport within the cell (Arduino et al., 
2010; Arduino et al., 2011a).  
 This premise led us to analyze alterations in mitochondrial movements in sPD 
cybrids. Similar to what was performed for autophagic vacuoles, we recorded whether 
mitochondria moved or remained static (Figure V.22A), and subsequently the relative 
number of stationary or movable events was calculated (Figure V.22B). As shown in 
Figure V.22B, sPD cybrids exhibited a significant decreased number of movable 
mitochondria in the fields studied. In addition, microtubule disruption by nocodazole, 
disruption of vesicular traffic by neutralizing acidic vesicles with NH4Cl/leupetin (Strous 
et al., 1985), and serum removal further promoted a decrease in the number of 
movable mitochondria to similar values in both CT and sPD cybrids. In contrast, taxol 
was able to re-establish the number of movable mitochondria in sPD cybrid cells. 
 We have also measured mitochondrial transport velocity as described previously 
(Macaskill et al., 2009). Regarding average velocities, sPD cybrids demonstrated a 
significant decline in mitochondrial movement velocity. As expected, taxol promoted an 
increase in moving mitochondria velocity in both CT and sPD cybrids (Figure V.22C). 
A dramatic negative effect was found with nocodazole and even more remarkably 
following autophagic modulation (serum removal and lysosomal degradation inhibition) 
(Figure V.22C). As observed previously for autophagic vacuoles, cumulative 
percentage data displayed a left shift in mitochondrial transport velocity in sPD cybrids 
when compared with basal CT cybrids (Figure V.22D1-4). In addition, this difference in 
curve profiles was abolished when cells were treated with nocodazole (Figure V.22D1) 
and under starvation (Figure V.22D3). Interestingly, the effect of lysosomal 
degradation inhibition was more pronounced for CT cybrids, resulting in a cumulative 
curve that was left-shifted relative to the sPD cybrid subjected to the same treatment 
(Figure V.22D2). Such effects were completely counteracted by taxol, reflected by a 
pull-down change in the cumulative curve profile (Figure V.22D4). Surprisingly, this 
change was more obvious for sPD cybrids rather than for CT cybrids.  
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Figure V.22. Disruption of microtubule network results in reduced mitochondrial 
movements in PD cybrid cells.  
A. Representative kymograph images (out of three experiments) of mitochondrial movement in 
CT and PD cybrid cells treated with nocodazole (24 h), taxol (24 h) and lysosomal inhibitors 
(NL, 4 h) or subjected to starvation (starved, 6h). Scale bars: 5 µm. B. Number of movable 
mitochondria when compared with those of total mitochondria (n=3, *p<0.05, **p<0.01, 
***p<0.001, versus CT cybrids; 
##
p<0.01, 
###
p<0.001, versus PD cybrids). C. Average transport 
velocity of mitochondria (μm/s) (n=3, *p<0.05, ***p<0.001, versus CT cybrids; 
#
p<0.05, 
##
p<0.01,
 
###
p<0.001, versus PD cybrids). D1-4, Cumulative data for mitochondrial transport velocity in CT 
and PD cybrid cells treated with Noc (D1), NL (D2), subjected to starvation (D3) or treated with 
taxol (D4) (n=3).  
 
 
 Altogether, our data suggest that a correlation exists between mitochondrial 
motility and autophagic turnover, both processes being dependent on the dynamic 
stability and functional integrity of microtubule network.  
 
5.3.6 Alterations in autophagic activity and defective microtubule-
dependent transport result in a poor α-synuclein aggregate clearance 
Autophagy deregulation has long been implicated in cellular ageing and α-synuclein 
toxicity during PD. Indeed, in PD, α-synuclein accumulation has been linked to 
alterations in chaperone-mediated autophagy and lysosomal system functioning 
(Cuervo et al., 2004; Martinez-Vicente et al., 2008; Vogiatzi et al., 2008; Xilouri et al., 
2009). Therefore, we next investigated the impact of alterations in the autophagic 
activity due to mitochondrial deficits and altered microtubule transport in autophagy 
substrates and PD-related α-synuclein clearance.  
 We started by evaluating the levels of p62/SQSTM1, a selective substrate for 
autophagy as this protein is normally localized to the autophagosome via LC3 
interaction and is continuously degraded by the autophagy–lysosome system (Bjorkoy 
et al., 2005). According to our previous data on LC3B-II flux (Figures V.5A-D), we 
have verified that p62 levels were significantly increased in sPD cybrids relative to CT 
cybrids (Figure V.23A and B).  
 We then analyzed the α-synuclein solubility and its propensity for oligomerization 
in the presence or absence of lysosomal proteolytic activity inhibitors by performing a 
Triton X-100 detergent fractionation. Overall, Figure V.23C and E shows that Triton-
soluble and -insoluble a-synuclein band patterns, resulting from a-synuclein 
oligomerization, were comparable. However, it was clear that α-synuclein was 
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preferentially accumulated in oligomeric forms, in the detergent-soluble fraction (Figure 
V.23C and D). Interestingly, among them, we detected a band corresponding to the 
tetrameric form (denoted by an arrow in Figure V.23C) that has been recently shown 
as a helically folded structure in cells under physiological conditions (Bartels et al., 
2011). We have observed that the generation of SDS-resistant and high molecular 
weight-soluble species of α-synuclein was enhanced in sPD cybrids relative to CT 
cybrids (Figures V.23D and V.23F). Moreover, we have also detected in sPD cybrids 
that lysosomal inhibition did not potentiate α-synuclein oligomers accumulation within 
cells (Figures V.23C-V.23F). Likewise, activation of nonselective autophagy upon 
serum removal was not able to efficiently shift back to a completely soluble non-
oligomerized phenotype, further supporting the argument that the final steps of the 
autophagy-lysosome pathway are compromised in these cells.  
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Figure V.23. α-Synuclein and p62 degradation by autophagy is impaired in cells 
harboring mitochondrial dysfunction.  
A. Immunoblot for p62 from CT and PD cybrid cells cultured in S+ or S- conditions and treated 
with or without lysosomal inhibitors (NL). B. Densitometric analysis of p62 levels (n=6, **p<0.01, 
versus S+ CT cybrids; #p<0.05, versus S- CT cybrids). C. and E. Immunoblots for α-synuclein 
oligomeric forms from CT and PD cybrid cells cultured in S+ or S- conditions and treated with or 
without lysosomal inhibitors (NL). Representative blots of Triton X-100-soluble oligomeric 
species (C) and Triton X-100-insoluble, SDS-resistant oligomeric species (E). The arrow 
indicates a band of a tetrameric form of α-synuclein. D. and F. Densitometric analysis of α-
synuclein-soluble oligomers content (D) (n=12, *p<0.05, **p<0.01, versus S+ CT cybrids; 
##p<0.01, versus S+ PD cybrids) and α-synuclein-insoluble oligomers content (F) (n=12, 
***p<0.001, versus S+ CT cybrids).  
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5.3.7 Impairment of autophagic turnover prompts apoptosis in cells 
harboring mitochondrial dysfunction 
Autophagy is well recognized as a survival mechanism especially during conditions of 
nutrient limitation. Based on the “bulk” degradation of cytoplasmic material, autophagy 
is utilized to generate both nutrients and energy in starving cells. Under these 
conditions, autophagy is critical for maintaining cell survival. We have previously 
reported that, in our sPD cybrid model and MPP+-treated cells, both mitochondria and 
endoplasmic reticulum-dependent apoptotic pathways are initiated during particular 
stressful circumstances of PD pathology (Esteves et al., 2008; Arduino et al., 2009a; 
Arduino et al., 2009b).  
 Here, we examined whether autophagic degradation impairment observed in our 
cellular models is also related to the apoptotic events described formerly. In order to 
check whether autophagy could be activated in cells with mitochondrial deficits as an 
attempt to prevent cell suicide by apoptosis, we used pharmacological modulators of 
autophagy and determined their roles on caspase-3-mediated apoptosis. 
 We observed that treatment of our cells with 3-methyladenine (3-MA), a 
pharmacological compound that inhibits the early sequestration events in autophagy, 
further stimulated caspase-3 activation in all models studied (Figures V.24A-C). 
Interestingly, co-incubation with MPP+ significantly enhanced this activation in NT2 
cells (Figure V.24C).  
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Figure V.24. Impaired autophagic turnover triggers caspase-3 over-activation in cells 
harboring mitochondrial deficits.  
Caspase-3 activation was addressed by Ac-DEVD-pNA cleavage in CT and PD cybrids (A) (n= 
12; ***p<0.001, versus S+ CT cybrids); NT2 Rho0 cells (B) (n= 5; **p<0.01, ***p<0.001, versus 
untreated Rho0 cells) treated with or without lysosomal inhibitors (NL), 3-methyladenine (3-MA) 
or rapamycin (Rap) for 4 h; and in MPP
+
-treated NT2 Rho+ cells treated with or without 3-MA 
for 4 h (C) (n= 6-8; *p<0.001, versus untreated cells; 
###
p<0.001, versus MPP
+
-treated cells; 
&&
p<0.01, versus 3-MA-treated cells) or Rap for 6 h (D) as indicated (n= 6-8; ***p<0.001, versus 
untreated cells; 
#
p<0.01, versus Rap-treated cells; 
&&&
p<0.001, versus MPP
+
-treated cells).  
 
 
 Rapamycin-induced autophagy did not prevent caspase-3 activation in sPD 
cybrids, which indicates that the autophagy-lysosomal pathway is impaired in this 
model as described previously (Figure V.24A). However, rapamycin per se was able to 
further activate caspase-3 in Rho0 cells. (Figure V.24B). In MPP+-treated cells, 
rapamycin counteracted the deleterious effects of MPP+ on caspase-3 activation 
(Figure V.24D). Perhaps surprisingly, these results indicate different apoptotic 
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outcomes upon modulation of authophagy in the different paradigms of mitochondrial 
dysfunction. 
 In an acute model, such as MPP+-treated cells, activation of autophagy by 
rapamycin can still protect cells. In chronic models with great compromise of 
mitochondrial function (Rho0 cells), both activation of autophagy by rapamycin or 
inhibition by 3-MA could be harmful to cells. Additionally, in an intermediate chronic 
stage, such as cybrids, cells may eventually succumb to biochemical processes 
typically associated with apoptosis when autophagy is inhibited by 3-MA, in accordance 
with NT2 cells, but has no additive effect on sPD cybrids. Moreover, when autophagy is 
stimulated by rapamycin, sPD cybrids are unable to efficiently proceed with the 
pathway probably due to vesicular traffic impairment, and still activate apoptosis. The 
mechanisms underlying these differences in cellular responses are unclear but might 
be related with different capacities of the cell models to compensate for autophagic 
dysfunction. 
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5.4 Discussion  
In this study, we have demonstrated that a prolonged metabolic failure due to 
mitochondrial dysfunction, either in cellular models harboring sPD subjects mtDNA 
(sPD cybrids) or knock-down of all mtDNA (Rho0 cells) or in MPP+-treated cortical 
neurons, causes a functional decline in the activity of the autophagic system. 
Consistently, in our models, autophagosomes are actively formed but some of their 
structural components and autophagic substrates are unable to be efficiently degraded 
within lysosomes. We propose that these alterations in autophagosome clearance can 
originate from a decreased efficiency in the mobilization of autophagosomes from their 
site of formation toward lysosomal compartments along the microtubule network, 
thereby impeding the assumed neuroprotective functions of autophagy.  
 Progress in the understanding of autophagy has emphasized its importance in 
cellular homeostasis, with significant consequences for the development of new 
therapeutic strategies for neurodegenerative disorders such as PD. In fact, 
ultrastructural examination has revealed an abnormal presence of autophagic vacuoles 
in myelinized neurons of the SNpc in PD patients, in contrast to the rare detection of 
autophagosomes in normal brains during ageing (Anglade et al., 1997).  
 Although the presence of accumulating autophagosomes could represent an 
aberrant activation of autophagy, we provide evidence that autophagy is not over-
stimulated in our models and, instead, defective clearance of the autophagic vacuoles 
might account for those observations. In our study, the rapid accumulation of 
autophagosomes within a few hours after blocking of lysosomal proteolysis, even in 
primary cortical neurons, evidences a proper basal level of autophagic activity. 
However, and of significant relevance to PD pathology, the data on autophagic flux 
indicate that formed autophagosomes are not efficiently eliminated by lysosomal 
degradation. The situation in cortical neuron cultures treated with MPP+ was somewhat 
different than in other cellular models, but essential features of the effects of PD-related 
mitochondrial impairment in the lysosomal pathway were confirmed in this primary 
neuron setting. 
 The aforementioned results raise the possibility that alterations in mitochondrial 
energy metabolism play a role in the modulation of autophagy and, therefore, multiple 
defects in mitochondria-dependent metabolism might be the initial events in sPD-
related autophagy pathology.  
 Mitochondria are the site of many biochemical reactions fundamental for normal 
cellular functioning, particularly cellular energy production. Our data further confirm and 
extend prior studies demonstrating sPD cybrids ATP levels are reduced in sPD cybrids 
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relative to those of CT cybrids (Esteves et al., 2008; Esteves et al., 2009). In addition, 
mitochondrial respiration and pathways influenced by aerobic metabolism are also 
altered in sPD cybrids. sPD cybrids show reduced SIRT1 phosphorylation, reduced 
PGC-1α levels and increased NF-kB activation (Esteves et al., 2010c). In this context, 
although our findings indicate that ATP may be required to the autophagic response, 
especially during serum starvation, the lack of effect of the pyruvate/uridine deprivation 
on the autophagic response in Rho0 cells leads us to hypothesize that an imbalance in 
glycolytic ATP production is unlikely to represent a primary signal for autophagy 
deregulation, reinforcing the concept that mitochondrial dysfunction has a main role on 
the control of the autophagic response. In fact, it is well established that autophagy is 
an energy-sensitive process (Plomp et al., 1987; Schellens et al., 1988; Plomp et al., 
1989). Although the various steps of the autophagic process may differ in their 
response to the energy status of the cell, early evidence indicated that all steps of this 
pathway are responsive to relatively small changes of intracellular ATP (Schellens and 
Meijer, 1991). Whether or not autophagosomes accumulate under ATP-depleted 
conditions would depend on the relative effects of energy depletion on sequestration 
and post-sequestrational steps of the autophagic pathway. In view of that, it was 
described that rapid mitochondrial depolarization with ATP loss did not induce 
mitochondrial degradation by autophagy, implying that additional mechanisms may 
regulate mitophagy in neurons (Van Laar et al., 2011). 
 Our results clearly support the idea that autophagy failure stemming from 
mitochondrial dysfunction is not translated into defects in autophagosome formation but 
mainly in the autophagosomes trafficking along the microtubule network toward the 
lysosomal compartment. Accordingly, in all of our paradigms, LC3B was observed in 
punctuated structures in both basal or serum deprivation conditions, supporting that the 
recruitment to the pre-autophagosomal structure is not affected. In addition, we did not 
find significant differences in the total cellular levels and subcompartimentalization of 
Beclin-1, a principal regulator in autophagosome formation. However, sPD cybrids 
exhibited increased basal levels of Bcl-2 mainly associated with increased targeting to 
mitochondria. Thus, the anti-autophagic activity of Bcl-2 was not verified as the mild 
changes observed in the binding and sequestration of Beclin-1 by Bcl-2 were not 
expected to disturb the formation of the class III PI3-kinase complex that is critical to 
the induction of autophagy. Even under serum starvation conditions, Bcl-2/Beclin-1 
association in sPD cybrids was similar to that in CT cybrids allowing Beclin-1 to 
proceed with autophagy.  
 Autophagosome and lysosome movement relies on microtubules as tracks and 
dynein as a motor (Fass et al., 2006; Kimura et al., 2008). Thus, tubulin cytoskeleton is 
Mitochondrial metabolism dictates the autophagic outcome 
 
 
153 
fundamental to maintain the spatial organization of autophagy-lysosome pathway by 
conducting the trafficking of organelles and vesicles involved in different interactions 
during this process. We have previously described that sPD cybrids have mitochondria-
dependent cytoskeletal changes, which manifest as microtubule depolymerization and 
increase in free tubulin levels (Esteves et al., 2010a). In this study, our results using 
modulators of microtubules assembly and intracellular traffic point to the fundamental 
requirement of an efficient microtubule network for the transport and so the clearance 
of autophagic cargos.  
 We confirm that autophagic flux is microtubule-dependent as depolymerization of 
microtubules with nocodazole inhibited the degradation of autophagosomes within 
lysosomes and microtubule stabilization with taxol potentiated autophagosome 
clearance and cargos motility. In addition, our results on live-cell imageing of 
autophagic vacuoles and mitochondrial transport clearly demonstrate that 
mitochondrial deficits as the ones described in our sPD cybrids (Esteves et al., 2008; 
Esteves et al., 2009; Esteves et al., 2010c) significantly impair autophagic vacuoles 
and mitochondrial motility, which alter autophagic and mitochondrial dynamics due to 
disruption of microtubule network trafficking. Moreover, these findings are in 
accordance with previous observations involving dyneins as essential motors (Jahreiss 
et al., 2008; Kimura et al., 2008), as starvation induced a slight decrease in the 
autophagosome flux in CT cybrids and a substantial decline in mitochondria motility. 
However, it is well established in the literature that starvation induces “bulk” autophagy. 
A possibility is that those findings could be associated with an intracellular redistribution 
and specific alterations in the membrane binding ability of cytoplasmic dyneins to 
organelles (Lin and Collins, 1993; Lin et al., 1994), contributing to their defective 
transport, but further studies are needed to clarify this point. 
 Thus, the key role of mitochondria as ATP fuel suppliers for microtubule turnover 
and microtubule-based motor proteins implies that inherent mitochondrial dysfunction 
and/or related defects in their distribution in sPD cybrids will have a profound effect on 
the autophagy-related vesicular trafficking and, as a consequence, autophagy turnover 
maintenance and function. Interestingly, alterations in microtubules associated with 
deficient axoplasmic flow, altered mitochondrial turnover and loss of synaptic 
connectivity, was observed in vulnerable neurons in AD (Cash et al., 2003). 
 In conjunction with altered mitochondrial function and motility, tubulin 
cytoskeleton alterations may contribute to the accumulation of protein aggregates and 
autophagic vesicles, and/or associated substrates, as observed in our sPD cybrid 
model. The levels of p62 and α-synuclein oligomerization profiles were concomitantly 
altered in these cells. These findings strongly support the hypothesis that aggregate-
Chapter V 
 
 
154 
prone proteins, such as α-synuclein, initially interact with p62, and then aggregation of 
the protein complex occurs in a p62-dependent manner but the aggregates are not 
efficiently degraded by autophagy. Our data show that the levels of autophagic activity 
and its efficiency in the clearance of specific substrates and/or aggregated α-synuclein 
are dependent on the metabolic status of the cell.  
 Under these circumstances, the resulting accumulation of -synuclein oligomers, 
other toxic protein products, and/or damaged organelles, such as dysfunctional 
mitochondria, will obviously be detrimental for cell functioning and survival. Intracellular 
accumulation of toxic protein oligomers might in turn contribute to further failure of the 
autophagic system in cells, as aggregates might physically block vesicular trafficking by 
secondarily interacting with or sequestrating key elements involved in this process. 
Interestingly, when neuronal cybrids are differentiated, the resultant neurites exhibit 
several characteristics of blocked axons, such as α-synuclein aggregates reminiscent 
of LBs (Trimmer et al., 2009) and accumulation of vesicles resembling nonfused 
autophagic structures. Moreover, an inefficient degradation of dysfunctional 
mitochondria due to a decreased autophagic activity will uphold a positive feedback 
loop that will further propagate the neurodegenerative pathway in PD (Chu, 2012). 
Accordingly, long-term accumulation of autophagic compartments within cytosol can 
also be harmful as autophagosomes can became leaky, and if enzyme leakage occurs 
after fusion, it can lead to lysosomal breakdown and release of lysosomal hydrolases, 
which frequently activates cell death (Wong and Cuervo, 2010).  
 In summary, data reported in this work support our hypothesis that a 
mitochondrial dysfunction induces an alteration in microtubules assembly that unable 
autophagy turnover which, in turn, potentiates the accumulation of α-synuclein 
oligomers and, finally, prompts apoptosis.  
 Although it is predictable that autophagy may be a new therapeutic target in PD, 
the results obtained in this study indicate that therapeutic modulation in the context of 
sPD should be aimed at improving autophagy intermediates “backing up”. For example, 
targeting trafficking proteins (Pandey et al., 2007) and proteins involved in promoting 
autophagosomes-lysosomes fusion, such as those regulating endosomal fusion and 
multivesicular bodies (Jager et al., 2004; Filimonenko et al., 2007), will likely improve 
the efficiency of autophagosome maturation into autolysosomes for subsequent 
substrate degradation. 
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6.1 Summary 
 
Sporadic Parkinson’s disease (sPD) is characterized by mitochondrial dysfunction and 
abnormal accumulation of protein aggregates in a specific subset of neurons. We have 
previously shown that defects in microtubule (MT)-based transport associated to an 
altered mitochondrial metabolism contribute to autophagic pathology and neuronal 
toxicity observed in this devastating disorder. However, the molecular mechanism(s) 
underlying how these various events are connected remains elusive. 
 In this study we demonstrate that SIRT2, a NAD+ dependent protein deacetylase, 
controls the functional ability of the autophagic system by modulating MT network 
acetylation dynamics and provide insights into the association between intracellular 
metabolism and proteotoxicity in sPD.  
 We used transmitochondrial cybrids that recapitulate pathogenic alterations 
observed in sPD patient brains. We observed that NAD+ metabolism is altered in sPD 
cybrids contributing to sirtuin 2 (SIRT2) deacetylase activation and subsequent 
decreased tubulin acetylation. Pharmacological inhibition of SIRT2 deacetylase activity 
selectively enhanced acetylation at Lys40 of α-tubulin, stabilized MTs and facilitated 
the clearance of misfolded proteins and autophagic substrates through the MT network, 
preventing the alterations observed in sPD cybrids cells. This increase in intracellular 
traffic improved the flux of autophagy cargos and promoted their lysosomal 
degradation.  
 Our data provide a strong evidence for a functional role of tubulin acetylation on 
autophagic vesicular traffic and cargos clearance. Moreover, we identify MTs and 
SIRT2 mediated-MT acetylation as therapeutic targets in disorders such as sPD in 
which intracellular transport is altered. 
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6.2 Introduction 
 
Parkinson’s disease (PD) is a devastating neurodegenerative disorder of unknown 
origin mainly characterized by the loss of dopaminergic neurons from the substantia 
nigra pars compacta (SNpc) and the presence, in the affected brain regions, of 
intraneuronal proteinacious cytoplasmic inclusions termed Lewy Bodies (LBs) (Forno, 
1996). The presence of LBs in vulnerable neurons affected by PD suggests that 
defective management of misfolded and aggregated protein may contribute to the 
pathogenesis of the disease. Cytoplasmic protein aggregates are carried by dynein 
motors and transported along the microtubule (MT) network to the microtubule-
organizing center (MTOC) in the pericentriolar region, where they are concentrated 
(Johnston et al., 1998; Kopito, 2000). These MT-dependent deposits of protein 
aggregates are called aggresomes and share with LBs some striking biochemical and 
molecular characteristics (McNaught et al., 2002), which may explain the biogenesis of 
these structures found in PD. Therefore, the impairment of the MT system has been 
increasingly associated with abnormal accumulation of α-synuclein, the major 
component of LBs (Lee et al., 2006).  
 Although the mechanism whereby α-synuclein accumulates in LBs is not fully 
understood, evidence suggests that defective axonal transport of α-synuclein may itself 
contribute to the process. Supporting this observation, we have previously shown, in 
cellular models of sporadic PD (sPD) harboring mitochondrial dysfunction (sPD 
cybrids), cytoskeleton alterations which manifest as MT depolymerization and 
increased formation of α-synuclein oligomers (Esteves et al., 2009, 2010a). In addition, 
altered α-synuclein oligomerization pattern was further associated with decreased 
proteolytic flux through autophagy, resulting from a deficient mobilization of 
autophagosome cargos toward the lysosomal system due to disruption of MT-
dependent trafficking (Arduíno et al., unpublished data).  
 The discovery that chemical inhibitors of SIRT2 change the characteristics of 
protein inclusion body and are protective against α-synuclein-induced cytotoxicity 
(Outeiro et al., 2007) support the association between α-synuclein aggregation and MT 
stability. In fact, SIRT2 is a cytoplasmic class III histone deacetylase that interacts with 
and deacetylates MTs in vitro and in vivo (North et al., 2003; North and Verdin, 2007). 
Acetylation has been associated with stable MTs, although this relationship is not clear-
cut. Some studies have shown that acetylation enhances MT stability (Hubbert et al., 
2002; Matsuyama et al., 2002), whereas others have suggested that acetylation occurs 
only on stable and not dynamic MTs, but the acetylation itself does not stabilize MTs 
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(Haggarty et al., 2003). Interestingly, recent evidence indicates that α-tubulin 
acetylation promotes the recruitment of both cytoplasmic dynein and kinesin-1 
molecular motors to MTs, stimulating motor processivity on the cytoskeleton and 
anterograde and retrograde vesicle flux in neurons (Reed et al., 2006; Dompierre et al., 
2007), which suggests a possible mechanistic association between inhibition of 
deacetylase activity and the enhancement of MT-dependent trafficking.  
 Since MT-dependent intracellular trafficking is altered in sPD (Arduíno et al., 
unpublished data) and that SIRT2 inhibitors demonstrate a neuroprotective effect 
(Outeiro et al., 2007), we investigated whether MT acetylation could regulate 
intracellular transport and compensate for the observed autophagic deficits observed in 
our models of sPD.  
 We found that both SIRT2 and HDAC6 inhibitors enhance tubulin acetylation and 
prevent alterations in MT network stability and functional integrity observed in sPD 
cybrids. However, inhibition of SIRT2 and HDAC6 deacetylase activity differentially 
affects autophagic activity and cargos degradation through the autophagy-lysosomal 
pathway. We show that increased autophagy turnover and associated transport is 
determined exclusively by SIRT2 inhibition in our models.  
 Our data demonstrate that SIRT2 selectively controls MT acetylation and 
establish a functional mechanistic link between intracellular metabolism and 
proteotoxicity in sPD, by influencing both the formation and catabolism of altered 
proteins. 
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6.3 Results 
 
6.3.1 SIRT2 deacetylase activity is increased in the cytosol of hybrid cells 
harboring sPD patient mitochondria  
To gain insight into the metabolic status and mitochondrial function in sPD cybrid cells, 
we have previously performed a deep characterization of the mitochondrial oxidative 
phosphorylation system and mitochondrial respiration by using high resolution 
respirometry (Esteves et al., 2008; Esteves et al., 2010c). In these analyses, we have 
observed several defects in energy metabolism-dependent processes, including a 
decline in ATP synthesis capacity and a sustained reduction in mitochondrial complex I 
and IV activities in sPD cybrid cells relative to control (CT) cells. In addition, we have 
also found that although the whole cell basal oxygen consumption was comparable 
between sPD and CT cybrids, the mitochondrial maximum respiratory capacity was 
decreased in sPD cybrids. These observations on mitochondrial function and ATP 
production predict alterations on the steady state levels and redox state of pyridine 
nucleotides, such as NADt (NAD+ plus NADH), which constitute important indicators 
and regulators for cell state and metabolic signaling activity (Pollak et al., 2007). 
 As shown in the Figure VI.1, we observed that the total NAD+/NADt ratio was 
significantly increased in PD cybrids when compared to CT cybrids. 
 
 
Figure VI.1. NAD
+ 
metabolism is altered in sPD cybrid cells.  
Total nicotinamide adenine dinucleotide (NADt, NADH plus NAD
+
) levels were determined as 
described in Chapter II and NAD
+ 
levels were obtained subtracting NADH to NADt levels. 
NAD
+
/NADt ratios were then corrected for total protein levels. Values are mean±S.E.M (n=4, 
*p<0.05 versus CT cybrids). 
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 SIRT2 is activated by elevated NAD+ levels. In addition, NAD+/NADH intracellular 
pools (cytosolic, mitochondrial and nuclear) are distinct and not entirely interdependent, 
suggesting that NAD+ biosynthesis is compartmentalized and that NAD+ levels may be 
differentially regulated within each compartment (Magni et al., 2008). In line with this, 
we next assessed the cellular subcompartmentalization of SIRT2 in cytosol-, 
mitochondria-, nuclei and cytoskeleton-enriched fractions. We have observed that the 
content of SIRT2 was increased in the cytosolic fraction of sPD cybrids relative to CT 
cybrids (Figure VI.2A and B). 
 
Figure VI.2. SIRT2 is preferentially localized in the cytosolic pool in sPD cybrid cells.  
A. Cell lysates of cytosol-, mitochondria-, nuclei- and cystoskeleton-enriched fractions from CT 
and sPD cybrids were examined by immunoblotting using the anti-SIRT2, anti-α-tubulin, anti-
TOM20, anti-TATA box, and anti-vimentin antibodies. Representative immunoblot for SIRT2 
cellular subcompartmentalization in cytosol-, mitochondria-, nuclei- and cystoskeleton-enriched 
fractions. B. Densitometric analysis of the levels of SIRT2 normalized against to each fraction 
corresponding loading control. Values are mean±S.E.M. (n=6, *p<0.05 versus CT cybrids). 
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These results further confirm and extend prior observations demonstrating that SIRT2 
levels are, among the cellular subcompartments, higher in the cytosolic pool as well as 
in the nuclear pool where it can be located, regulating cell cycle as well (Afshar and 
Murnane, 1999; North et al., 2003; North and Verdin, 2007). 
 The increased total NAD+/NADt ratio in conjunction with high SIRT2 levels in sPD 
cybrids cytosolic pool led us to hypothesize that SIRT2 deacetylase activity may be 
enhanced in sPD cybrids. Indeed, we have observed a decrease in the cystosolic 
levels of acetylated α-tubulin in sPD cybrids when compared to CTs (Figure VI.3A and 
B), which constitutes an indirect evidence for an increased SIRT2 deacetylase activity 
over the tubulin cytoskeleton in those cells. 
Figure VI.3. Altered NAD
+ 
metabolism regulates SIRT2 activation in the cytosolic pool of 
sPD cybrid cells. 
A. Cell lysates of cytosol-enriched fractions from CT and sPD cybrids were examined by 
immunoblotting using the anti-acetyl-α-tubulin and anti-α-tubulin antibodies. Representative 
immunoblot for SIRT2 levels in cytosol-enriched fractions. B. Densitometric analysis of the 
levels of SIRT2. Values are mean±S.E.M. (n=3). 
 
 
Together, these data suggest that mitochondrial metabolism may regulate SIRT2 
deacetylase activity in a NAD+-dependent manner in our cybrid cell models and can 
physiologically correlate MT dynamics to energy status in PD milieu. 
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6.3.2 Promotion of tubulin acetylation levels by specific inhibition of 
SIRT2 and HDAC6 prevents MT network impairments in sPD cybrid cells 
We then decided to directly explore the actual role of SIRT2 deacetylase on the α-
tubulin cytoskeleton integrity in our cybrid cell models. 
 SIRT2 colocalizes with the MT network and deacetylates Lys40 of α-tubulin 
(North et al., 2003). The same residue of α-tubulin is also deacetylated by HDAC6, a 
class II HDAC, and deacetylation by HDAC6 leads to changes in cellular motility 
(Hubbert et al., 2002). SIRT2 and HDAC6 are found along MTs in a complex structure 
(SIRT2/HDAC6/α-tubulin complex), suggesting that the two proteins coordinately 
regulate the level of tubulin acetylation (North et al., 2003). In addition, tubulin only 
binds the SIRT2/HDAC6 complex and not individual HDAC6 or SIRT2 proteins 
(Nahhas et al., 2007).  
 Thus, we firstly determined the acetylation state of α-tubulin in our models by 
analyzing the effects of two deacetylase inhibitors, AK-1 and Tubastatin A, which 
specifically inhibit SIRT2 and HDAC6, respectively. Under basal conditions, sPD 
cybrids showed decreased acetylation levels at Lys40 of α-tubulin relative to CT 
cybrids (Figure VI.4A and B). Treatment with both AK-1 and Tubastatin A significantly 
restored the acetylation of α-tubulin in a dose-dependent manner. This effect was more 
obvious for Tubastatin A, which significantly enhanced the acetylation levels in both CT 
and sPD cybrid cells (Figure VI.4C and D). The total levels of α-tubulin in CT and sPD 
cybrids is not different (Esteves et al., 2009, 2010a), further supporting a specific 
decrease of tubulin acetylation in sPD cybrids. 
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Figure VI.4. Tubulin acetylation is selectively modulated by specific inhibition of SIRT2 
and HDAC6 tubulin deacetylases.  
A. Cell lysates from CT and sPD cybrids treated with or without AK-1 (1 µM and 5 µM, 24 h) 
were examined by immunoblotting using the anti-acetyl-α-tubulin and anti-GAPDH antibodies. 
Representative immunoblot for acetylated α-tubulin levels. B. Densitometric analysis of the 
levels of acetylated α-tubulin. Values are mean±S.E.M. (n=5, ***p<0.001, versus untreated CT 
cybrids; 
##
p<0.01, versus untreated sPD cybrids). C. Cell lysates from CT and sPD cybrids 
treated with or without Tubastatin A (Tub A, 5 µM and 10 µM, 24 h) were examined by 
immunoblotting using the anti-acetyl-α-tubulin and anti-GAPDH antibodies. Representative 
immunoblot for acetylated α-tubulin levels. D. Densitometric analysis of the levels of acetylated 
α-tubulin. Values are mean±S.E.M. (n=5, **p<0.01, ***p<0.001, versus untreated CT cybrids; 
###
p<0.001, versus untreated sPD cybrids). 
 
 
 Acetylation has been shown to increase MT stability. Therefore, we next 
considered how AK-1 and Tubastatin (SIRT2 and HDAC6 inhibition, respectively) could 
contribute to increased MT stability and structural integrity. 
 We have evaluated MT morphology at steady-state in CTs and AK-1- or 
Tubastatin A-treated cells by indirect immunofluorescence. We have found that similar 
to CT cybrids, MTs in sPD cybrids also emanated from MTOC, but appeared shorter 
and more gnarled than in CT cells. Inhibition of SIRT2 and HDAC6 deacetylase activity 
further improved MT network in both CT and sPD cybrid cells. Interestingly, Tubastatin 
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A induced a more extensive MT bundling (Figure VI.5) visualized as bright fluorescent 
foci appearing in MTOC and cell periphery.  
 
 
Figure VI.5. Inhibition of SIRT2- and HDAC6–dependent tubulin deacetylation improves 
MT network morphology.  
Cells from CT and sPD cybrids were treated with or without AK-1 (5 µM, 24 h) or Tubastatin A 
(Tub A, 10 µM, 24 h) and the MTs were visualized by indirect immunofluorescence using an 
anti-α-tubulin antibody (red). Hoechst 33342-stained nuclei are in blue. Scale bar, 10 µm.  
 
 
 In support, quantitative immunobloting of soluble (free) and 
cytoskeleton/microtubule bound (polymerized) tubulin confirmed an increased MT 
destabilization in sPD cybrids in comparison to CT cybrids. This was reflected by a 
higher free/polimeryzed tubulin ratio, as previously reported in another set of cybrid 
cells (Esteves et al., 2009). Notably, the proportion of total α-tubulin that is assembled 
significantly increased after both AK-1 and Tubastatin A treatments, evidenced by a 
decrease in the ratio free/polimeryzed tubulin ratio in sPD cybrids to values similar to 
CT cybrids (Figure VI.6 A-D). 
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Figure VI.6. Inhibition of SIRT2- and HDAC6-dependent tubulin deacetylation improves 
MT network structural integrity.  
A. Cell lysates containing soluble (free) and MT-bound (polymerized, polim) tubulin from CT and 
sPD cybrids treated with or without AK-1 (5 µM, 24 h) were examined by immunoblotting using 
the anti-α-tubulin and anti-GAPDH antibodies. Representative immunoblot for α-tubulin levels. 
B. Densitometric analysis of the levels of free and polymerized α-tubulin. Values represent the 
ratio free/polymerized tubulin calculated as the ratio of free α-tubulin densitometric value over 
the corresponding polymerized α-tubulin value. Values are mean±S.E.M. (n=4-8, ***p<0.001, 
versus untreated CT cybrids; #p<0.05, versus untreated sPD cybrids). C. Cell lysates containing 
soluble (free) and MT-bound (polymerized, polim) tubulin from CT and sPD cybrids treated with 
or without Tubastatin A (Tub A, 5 µM, 24 h) were examined by immunoblotting using the anti-α-
tubulin and anti-GAPDH antibodies. Representative immunoblot for α-tubulin levels. D. 
Densitometric analysis of the levels of free and polymerized α-tubulin. Values represent the ratio 
free/polymerized tubulin calculated as the ratio of free α-tubulin densitometric value over the 
corresponding polymerized α-tubulin value. Values are mean±S.E.M. (n=4-8, ***p<0.001, 
versus untreated CT cybrids; ##p<0.01, versus untreated sPD cybrids). 
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Together, these results show that the structural and functional defects related to MT 
depolimerization observed in sPD cybrids may be associated with reduced acetylation 
levels of their tubulin cytoskeleton. In addition, the MT network impairments observed 
in sPD cybrids can be overcome by enrichment in tubulin acetylation via inhibition of 
SIRT2 and HDAC6 catalytic activities. 
 
6.3.3 Specific inhibition of SIRT2 catalytic activity improves the 
autophagic turnover in sPD cybrid cells  
Autophagosome formation, sorting, and subsequent cargo transport towards 
lysosomes are regulated by MTs (Matteoni and Kreis, 1987; Fass et al., 2006; Kochl et 
al., 2006). Specifically, hyperacetylation of tubulin results in higher affinity of motor 
proteins to MTs (Reed et al., 2006; Dompierre et al., 2007), which lead to extended 
motor attachment and enhanced motor processivity on the cytoskeleton. 
 We have previously shown that in our sPD cybrid model autophagosomes are 
actively formed but not efficiently eliminated by lysosomal degradation. Defective 
autophagic clearance ability was associated with impairments in MT trafficking 
stemming from mitochondrial dysfunction (Arduíno et al., unpublished data). As SIRT2 
and HDAC6 regulate tubulin acetylation and MT assembling, we considered the 
possibility that the decreased autophagic degradation associated to the deregulation of 
MT-dependent vesicle trafficking may involve SIRT2 and HDAC6 deacetylase activity. 
To test this hypothesis, we evaluated autophagosome formation by directly measuring 
the cellular distribution of endogenous LC3B and the turnover of the lipid-conjugated 
form of the autophagosome marker light chain 3, LC3B-II, (autophagic flux), as 
determined by comparing the accumulation of autophagosomes after inhibition of 
lysosomal proteolysis with NH4Cl/leupeptin (NL) relative to the steady-state levels of 
autophagosomes (Rubinsztein et al., 2009).  
 As previously shown, under basal conditions, sPD cybrids demonstrate an 
increase in both the number and size of endogenous LC3B puncta relative to CT 
cybrids (Figure VI.7Aa versus c), but when lysosomal degradation was inhibited this 
number increased more markedly in CT cybrids (Figure VI.7Ab versus d). Treatment 
with AK-1 further activated autophagy in a higher extent in sPD cybrids than in CT 
cybrids, as depicted by the higher increase in the number of bright puncta (Figure 
VI.7e versus f, compared with g versus h). In contrast to the effects of SIRT2 inhibition, 
no effects were observed upon Tubastatin A treatment on autophagosome formation 
and autophagic activity (Figure VI.7i versus j, compared with a versus b, and k versus 
l, compared with c versus d). 
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Figure VI.7. Inhibition of SIRT2- and HDAC6-dependent tubulin deacetylation differentially 
regulates the autophagic turnover.  
Cells from CT and sPD cybrids were treated with or without AK-1 (5 µM, 24 h) or Tubastatin A 
(Tub A, 10 µM, 24 h), following culture in the presence or absence of lysosomal inhibitors (NL) 
for the last 4 h. LC3B (green)-positive vesicles were visualized by indirect imunofluorescence. 
Hoechst 33342-stained nuclei are in blue. Scale bars, 10 µm. 
 
 
 The induction of autophagy was also evaluated by examining the levels of LC3B-
II. Consistent with the LC3B puncta staining data, when compared with CTs, AK-1 
treatment led to a decreased autophagosome content (decreased LC3-II levels) 
associated to improved autophagic flux in sPD cybrid cells (Figure VI.8).  
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Figure VI.8. Inhibition of SIRT2-dependent tubulin deacetylation improves the autophagic 
turnover.  
A. Cell lysates from CT and sPD cybrid cells treated with or without AK-1 (5 µM, 24 h) in the 
presence or absence of lysosomal inhibitors (NL, last 4 h) were examined by immunoblotting 
using the anti-LC3B and anti-α-tubulin antibodies. B. Determination of autophagic vacuole (AVs) 
basal levels. Values of LC3-II in the absence of NL represent the steady-state AV content. 
Values are mean±S.E.M. (n=3-6, ***p<0.001, versus untreated CT cybrids; 
##
p<0.01, versus 
untreated sPD cybrids). C. Assessment of autophagic flux, determined as the ratio of LC3-II 
densitometric value of NL treated samples over the corresponding untreated samples. Values 
are mean±S.E.M. (n=3-6, **p<0.01, versus untreated CT cybrids; 
#
p<0.05, versus untreated 
sPD cybrids). 
 
 
Conversely, inhibition of HDAC6 by Tubastatin A induced a dramatic reduction on the 
autophagic flux in CT cybrids and no positive effects were observed for sPD cybrid 
cells (Figure VI.9), indicating that this effect may be related with the direct involvement 
of HDAC6 in the autophagic pathway (Kawaguchi et al., 2003). 
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Figure VI.9. Inhibition of HDAC6 catalytic activity declines the autophagic turnover. 
A. Cell lysates from CT and sPD cybrid cells treated with or without Tubastatin A (Tub A, 10 µM, 
24 h) in the presence or absence of lysosomal inhibitors (NL, last 4 h) were examined by 
immunoblotting using the anti-LC3B and anti-α-tubulin antibodies. Representative immunoblot 
for LC3B-I and II levels. B. Determination of autophagic vacuole (AVs) basal levels. Values of 
LC3-II in the absence of NL represent the steady-state AV content. Values are mean±S.E.M. 
(n=3-6, ***p<0.001, versus untreated CT cybrids). C. Assessment of autophagic flux, 
determined as the ratio of LC3-II densitometric value of NL treated samples over the 
corresponding untreated samples. Values are mean±S.E.M. (n=3-6, **p<0.01, versus untreated 
CT cybrids). 
 
 
Collectively, these data suggest that SIRT2-mediated tubulin acetylation is a major 
determinant for an efficient autophagic activity. 
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6.3.4 SIRT2-dependent tubulin deacetylation regulates α-synuclein protein 
inclusion clearance 
There is evidence that SIRT2 inhibitors ameliorate the neurodegenerative phenotypes 
of cell and animal models of PD by dramatically modulating the formation of α-
synuclein protein inclusion (Outeiro et al., 2007). Additionally, α-synuclein has been 
shown to interact with MTs (Iseki et al., 2000; Payton et al., 2001; Alim et al., 2004; 
Zhou et al., 2010), which prompted us to ask whether SIRT2 and HDAC6 inhibition 
might also modify the oligomerization pattern of α-synuclein previously observed in our 
sPD cybrid cells [(Esteves et al., 2009, 2010a) and Arduíno et al., unpublished data)]. 
 Treatment with AK-1 significantly reduced the presence of both soluble and 
insoluble high molecular weight oligomeric species of α-synuclein in both CT and sPD 
cybrids (Figure VI.10).  
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Figure VI.10. Inhibition of SIRT2-dependent tubulin deacetylation improves α-synuclein 
clearance. 
A. and B. Cell lysates from CT and sPD cybrid cells treated with or without AK-1 (5 µM, 24 h) in 
the presence or absence of lysosomal inhibitors (NL, last 4 h) were examined by 
immunoblotting using the anti-α-synuclein (LB509) and anti-α-tubulin antibodies to assess the α-
synuclein oligomeric form content. Representative blots of Triton X-100-soluble oligomeric 
species (A) and Triton X-100-insoluble, and SDS-resistant oligomeric species (B). C. and D. 
Densitometric analysis of α-synuclein-soluble oligomers content (C) (n=6-12, ***p<0.001, versus 
untreated CT cybrids ###p<0.001, versus untreated sPD cybrids) and α-synuclein-insoluble 
oligomers content (D) (n=6-12, *p<0.05, ***p<0.001, versus untreated CT cybrids; ###p<0.001, 
versus untreated sPD cybrids). Values are mean±S.E.M. 
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However, in contrast to the effects of SIRT2 inhibition, no effects were observed on α-
synuclein inclusion size in both soluble and insoluble fractions for Tubastatin A 
treatment in our cybrid cells (Figure VI.11). 
 
 
Figure VI.11. Inhibition of HDAC6-dependent tubulin deacetylation fails to promote α-
synuclein cleaning up. 
A. and B. Cell lysates from CT and sPD cybrid cells treated with or without Tubastatin A (10 µM, 
24 h) in the presence or absence of lysosomal inhibitors (NL, last 4 h) were examined by 
immunoblotting using the anti-α-synuclein (LB509) and anti-α-tubulin antibodies to assess the α-
synuclein-oligomeric form content. Representative blots of Triton X-100-soluble oligomeric 
species (A) and Triton X-100-insoluble, SDS resistant oligomeric species (B). C. and D. 
Densitometric analysis of α-synuclein-soluble oligomers content (C) (n=8-12, ***p<0.001, versus 
untreated CT cybrids) and α-synuclein-insoluble oligomers content (D) (n=8-12, ***p<0.001, 
versus untreated CT cybrids). Values are mean±S.E.M. 
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 The differential efficacy of these two distinct inhibitors against α-synuclein 
oligomerization in these cells is consistent with their differential effect on the 
autophagic flux. Thus, these data show that specific deacetylation by SIRT2 on Lys40 
of tubulin improves autophagy and thereby enhances α-synuclein clearance, 
preventing α-synuclein toxicity and consequently PD-related neurodegeneration. 
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6.4 Discussion 
 
In this study, we have demonstrated a role for deacetylation at Lys40 of α-tubulin in the 
impairment of the autophagic activity and protein cargo clearance in cellular models 
harboring sPD subject mtDNA (sPD cybrids). We show here that specific inhibition of 
SIRT2 deacetylase activity rescues MT-dependent autophagic transport alterations 
previously observed in sPD cybrids, thus providing a novel insight into how, 
molecularly, autophagic activity and inherent autophagic clearance are impacted by 
mitochondrial function.  
 Our previous work has raised the possibility that alterations in mitochondrial 
energy metabolism play a role in the modulation of autophagy and, therefore, multiple 
defects in mitochondria-dependent metabolism might be the initial events in sPD-
related autophagic pathology. Mitochondrial dysfunction and oxidative stress have 
been extensively associated with the majority of neurodegenerative diseases as well 
with sPD (Henchcliffe and Beal, 2008). In fact, we have previously reported that 
pathways influenced by aerobic metabolism are altered in sPD cybrids. sPD cybrids 
showed reduced SIRT1 phosphorylation, reduced peroxisome proliferator-activated 
receptor-gamma coactivator-1alpha (PGC-1α) levels and increased NF-kB activation 
(Esteves et al., 2010c). In addition, cellular ATP levels in sPD cybrids are reduced 
relatively to those of CT cybrids (Esteves et al., 2008; Esteves et al., 2009). Some of 
these redox-dependent changes may occur in part as a downstream consequence of 
increased oxidative stress, as sPD cybrids show enhanced generation of reactive 
oxygen species (ROS) and other free radicals, increased protein oxidation, and 
decreased glutathione pool, despite the presence of a presumably compensatory 
increase in the activities of the major antioxidant enzymes relative to CT cybrids 
(Swerdlow et al., 1996; Cassarino et al., 1997; Esteves et al., 2009). All of these 
defects result in a deregulation of mitochondrial energy metabolism, as revealed by a 
decreased mitochondrial respiratory capacity (Esteves et al., 2010c). Although basal 
oxygen consumption rate between sPD and CT cybrids was comparable, when 
mitochondria were challenged via chemical-induced uncoupling into a state of 
maximum oxygen consumption, sPD cybrids revealed increased proton leak in 
conjunction with a reduced respiratory reserve capacity and ATP production, when 
compared with CT cells. This means that under basal respiratory conditions sPD 
cybrids are respiring closely to their maximum respiratory capacity and that oxygen 
consumption is greatly due to proton leak (Esteves et al., 2010c). Given the decrease 
in the activity of complex I in sPD cybrids one could expect a decrease in the 
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NAD+/NADt ratio (Vemuri et al., 2007; Vinogradov, 2008). However, our results showed 
the inverse situation suggesting that other pathways dependent on mitochondrial 
function, but not directly associated to complex I activity, play a role. A possible 
explanation might be changes in glycolitic flux. A slow decline in glycolytic metabolism 
may occur, as persistent mitochondrial overfeeding possibly causes system overflow 
metabolism, and consequently a bioenergetic collapse under these conditions. In 
addition, because ATP is the principal carrier of energy in cells, this reduction is likely 
to interfere with many important ATP-dependent cellular processes. These hypotheses 
were confirmed by our findings that cellular levels of NADt (NAD+ plus NADH), whose 
generation is dependent on the levels of ATP (Magni et al., 1999), were significantly 
decreased and that the ratio NAD+/NADt was increased in sPD cybrid cells.  
 Cellular energy status, reflected in NAD+ levels and NAD+/NADH ratios, are 
thought to influence stress-protein synthesis (Westerheide et al., 2009), autophagic 
activity (Lee et al., 2008; Salminen and Kaarniranta, 2009), sirtuin-mediated protein 
deacetylation (Bordone and Guarente, 2005; Rodgers et al., 2008) and increased 
mitogenesis (Bonawitz et al., 2007; Cunningham et al., 2007), all of which impact upon 
the processes influencing proteostasis and related neurodegeneration. In this study, we 
report a new finding regarding the interplay between mitochondrial metabolism and 
SIRT2 and HDAC6 activities in the context of sPD with important consequences for the 
modulation of the autophagic system and MT-dependent intracellular trafficking. We 
confirm that both SIRT2 and HDAC6 are MT-associated proteins and active tubulin 
deacetylases whose inactivation leads to a dramatic accumulation of acetylated MTs 
(Hubbert et al., 2002; North et al., 2003) in our sPD cybrid cells.  
 Although α-tubulin acetylation is one of the most common post-translational 
modifications (Janke and Bulinski, 2011), its biological relevance remains uncertain. 
Here, we provide evidence that tubulin acetylation is functionally associated with 
intracellular trafficking and consequently with autophagic turnover maintenance. 
Elevation of MT acetylation resulting from the selective inhibition of SIRT2 catalytic 
activity enhanced MT-directed transport of autophagic vacuoles as evidenced by 
increased proteolytic flux through the autophagy-lysosome pathway. These data are 
consistent with previous reports demonstrating that α-synuclein-mediated neurotoxicity 
in several models of PD is due in part to deacetylation of α-tubulin by SIRT2 (Outeiro et 
al., 2007). Also, hyperacetylation of α-tubulin was found to trigger resistance to axonal 
degeneration in slow Wallerian degeneration mice, and this was overcome by SIRT2 
overexpression (Suzuki and Koike, 2007). 
 It is well established that α-tubulin is a substrate of both SIRT2 and its 
cytoplasmic interacting protein HDAC6 and, thus, one would expect a similar effect 
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from inhibition of HDAC6. However, we found that inhibition of HDAC6 by Tubastatin A 
induces a dramatic reduction on the autophagic flux in CT cybrids and no positive 
effects were observed for sPD cybrid cells. Consistently, no significant effects were 
observed regarding the altered oligomeryzation pattern of α-synuclein observed in sPD 
cybrids. These results suggest that deacetylation of other substrates by HDAC6 may 
be essencial to the autophagic dependent protein degradation. In fact, HDAC6 tubulin 
deacetylase activity has been shown to be required for HDAC6 dependent aggresome 
formation and autophagic clearance of protein aggregates (Kawaguchi et al., 2003; 
Pandey et al., 2007). HDAC6 is involved in the transport process as an adaptor protein 
by binding to p150, a component of the dynein motor complex, and acts as a bridge 
between the dynein motors and the ubiquitinated proteins leading to aggresome 
formation (Hubbert et al., 2002). Nevertheless, given that MT stabilization and motor 
dependent transport is enhanced when MTs are acetylated one would expect that the 
deacetylase activity of HDAC6 is inhibited during these transport processes and that 
deacetylase deficient forms of HDAC6 should be able to rescue agressome formation 
and enhance autophagic turnover. Corroborating this assumption, HDAC6 inhibition in 
primary cultures of neurons resulted in an effective MT acetylation and stimulated 
axonal transport, compensating for the BDNF vesicle transport- and release-defect 
phenotypes that are observed Hungtinton’s disease (Dompierre et al., 2007). 
 However, despite the beneficial effects observed in some vesicular transport 
systems upon inhibition of HDAC6, in our study we have found a remarkable decrease 
in autophagic flux following the inhibition of this deacetylase. This apparently 
contradictory effect might be explained by the role of HDAC6 in the autophagy-
lysosome pathway, playing an essential role in the fusion between autophagosomes 
and lysosomes by recruiting and deacetylating cortactin, which in turn recruits actin 
filaments to tether the two vesicle populations (Lee et al., 2010b; Lee and Yao, 2010). 
In addition, it was found that protein aggregates and impaired mitochondria are 
processed by a common pathway involving HDAC6- and parkin-dependent ubiquitin-
selective autophagy and aggresomal machinery (Lee et al., 2010a), thus providing a 
unifying model toward understanding the two most common pathological features of 
PD: mitochondrial dysfunction and protein aggregation. 
 In summary, in this study we dissected the molecular mechanisms by which 
mitochondrial metabolism in sPD can affect MT-directed autophagic turnover that in 
turn regulates intracellular protein homeostasis by modulating aggresome formation 
and protein aggregates degradation. Our findings demonstrate the pathogenic role of 
α-tubulin deacetylation mediated by SIRT2 in sPD cybrid cell models and highlight the 
neuroprotective effects of HDAC6 in PD. This observation implies that the ability to 
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regulate α-tubulin deacetylase activity to modulate protein homeostasis may have 
important implications for the development of new therapheutic strategies for 
pathological conditions such as sPD.  
 
  
 
 
 
 
 
 
 
 
CHAPTER VII 
Final Remarks 
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Parkinson’s disease (PD) is a disabling neurodegenerative disorder that is strongly 
associated with ageing, increasing exponentially in incidence above the age of 65 (de 
Lau et al., 2004). The incidence of PD is expected to rise dramatically worldwide in the 
next 25 years with the extension of life expectancy by improved health care. Although 
there are signs of distributed neuropathology, as judged by Lewy bodies (LBs) 
formation (Braak et al., 2004), the motor symptoms of PD, including bradykinesia, 
rigidity and resting tremor, are clearly associated to the degeneration and death of 
SNpc dopaminergic neurons (Obeso et al., 2010). The determination that those 
cardinal manifestations are primarily due to a profound depletion of dopamine in the 
striatum led to the development of rational therapies aimed at correcting this deficiency 
(Calne et al., 1974; Gopinathan et al., 1981; Lieberman et al., 1981). However, despite 
several breakthrough discoveries in the symptomatic PD therapy, the current therapies 
are palliative at best and just provide effective control of symptoms, particularly in the 
early stages of the disease (Thomas, 2009). This is due to the development of motor 
complications including wearing-off (the return of PD symptoms too soon after a given 
levodopa dose), the presence of involuntary abnormal movements (dyskinesias and 
dystonia), and the emergence of treatment-resistant symptoms such as gait 
impairment, cognitive decline, autonomic dysfunction and medication-induced 
psychosis (Savitt et al., 2006). Clearly, the current symptomatic therapies cannot 
completely improve later-stage symptoms and fail to halt the degeneration process in 
the dopaminergic and nondopaminergic systems. This indeed emphasizes the urgency 
of developing a more effective therapeutic for PD patients. However, a major hurdle for 
the development of neuroprotective therapies is the restricted understanding of disease 
causes and mechanisms leading to death of dopaminergic neurons. 
 While the etiological factors involved in the development of PD are still uncertain, 
a combination of genetic susceptibilities and environmental factors seems to play a 
critical role. Nevertheless, over the course of the past decade, remarkable advances 
have been made in the identification of genes associated with familial forms of PD. 
Although familial PD is relatively rare compared with idiopathic disease, the associated 
genes provide an opportunity to gain important insights into molecular pathways that 
lead to Parkinsonism and that may be important in the sporadic forms of this disease 
(sPD) as well. Recent evidences seem to converge on mitochondria as a primary target 
in the process of dopaminergic neuronal loss observed in PD. Mitochondrial 
metabolism and energy production impairment are certainly two of important causes 
and the study of the protein products involved in genetic forms of PD profoundly 
contributed to extend our knowledge in this topic.  
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 Another organelle that has been widely linked to the pathogenesis of PD is the 
endoplasmic reticulum (ER). The ER is an integral component of the cellular machinery 
that coordinates protein synthesis, folding, degradation and transport to ensure 
accurate and efficient delivery of proteins to the compartments of the secretory 
pathway, a process generally known as proteostasis (Balch et al., 2008). One of the 
hallmarks of PD is the formation of LBs, which reflects a deficiency in proteostasis that 
is accompanied by signs of ER stress and an attempt to sequester cytotoxic proteins 
(Ryu et al., 2002). Indeed, in this work we demonstrated that in particular stressful 
conditions mimicking sPD, any alteration in the mitochondrial functionality seems to 
deeply affect the ability to support cellular stresses, thus making the cells more 
susceptible to additional insults. We observed that mitochondrial dysfunction induced 
by an acute stimulus of the neurotoxin MPP+ renders cells more susceptible to develop 
an ER stress response, which was mainly translated into a sustained flux of Ca2+ from 
the ER to mitochondria accompanied by the activation of ER- and mitochondria-
dependent apoptotic pathways (Chapter III).  
 Moreover, we also provide evidence that ER stress response may participate in 
mitochondrial stress-induced abnormalities. We demonstrated that sustained ER stress 
caused by accumulation of unfolded or misfolded proteins potentiates Ca2+-overload 
and impairment of mitochondrial function primarily characterized by dissipation of 
mitochondrial membrane potential and substantial decline in the mitochondrial 
respiratory chain complex I activity. These cumulative events also coursed in apoptotic 
cell death induction (Chapter IV). Our findings add on to the exciting concept that 
mitochondria and ER are actively networking which is fundamental for the maintenance 
of cellular homeostasis. However, they emphasize that in the context of sPD the close 
physical and functional association between ER and mitochondria may provide the 
opportunity for stress or dysfunction in one organelle to potentially disrupt homeostasis 
in the other organelle, triggering a cascade of deleterious events that culminate in 
neuronal degeneration. We propose that Ca2+ is the main intervenient in the ER and 
mitochondria crosstalk, functioning as a key modulator of cell death signals triggered 
by the ER and mitochondria. Ca2+-mediated cellular stress has long been thought to be 
important in neurodegeneration, but it usually is envisioned as a late stage 
consequence of organelle damage imposed by some other challenge (Surmeier, 2007). 
Relevant to sPD pathology, the unusual reliance of SNpc dopaminergic neurons on 
voltage-dependent L-type Ca2+ channels in autonomous pacemaking suggests that the 
mitochondrial stress created by sustained Ca2+ entry could be responsible for their 
selective vulnerability, rather than simply a late stage consequence. This hypothesis is 
consistent with the central role of mitochondria in the pathogenesis of sPD.  
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 Despite the unequivocal evidence for the involvement of mitochondria and ER in 
the sPD pathogenesis, it seems that sPD is distinctively characterized by an additional 
proteostasis burden that causes SNpc dopaminergic neurons to fail massively. 
Actually, LBs and other types of protein deposits found in PD patient brains are not 
merely neuropathological hallmarks of the disease, but rather putative effectors of sPD 
pathogenesis. A strict policy of quality control mechanisms acts to coordinate the rates 
of protein synthesis with degradation, preventing such intracellular aggregates from 
forming (Balch et al., 2008; Powers et al., 2009). Besides ER, cellular proteolytic 
systems, such as the autophagic-lysosomal pathway, are actively dedicated to protein 
quality control and their failures have severe negative consequences for cellular 
homeostasis and cellular functioning, which ultimately result in proteotoxicity. 
 We demonstrated that a prolonged metabolic failure due to mitochondrial 
dysfunction, either in cellular models harboring sPD subject mtDNA (sPD cybrids) or 
knock-down of all mtDNA (Rho0 cells), or in MPP+-treated rat cortical neurons causes 
a functional decline in the activity of the autophagic system. Consistently, in all of our 
paradigms, autophagosomes are actively formed but some of their structural 
components and autophagic substrates are unable to be efficiently degraded within 
lysosomes (Chapter V). Although the presence of accumulating autophagosomes 
could represent an aberrant activation of autophagy, we provided evidence that 
autophagy is not over stimulated in our models but, instead, defective clearance of the 
autophagic vacuoles might account for those observations. In addition, we established 
the proof of concept that autophagy failure stemming from mitochondrial dysfunction is 
a consequence of alterations in microtubules (MT) assembly that hamper mitochondria 
and autophagosomes transport along the MT network toward the lysosomal 
compartment. Consequently, deficient autophagy turnover potentiates the 
accumulation of α-synuclein oligomers and, ultimately, promotes apoptosis. These 
findings describe novel and important features in the neuropathological cascade of PD, 
connecting three important features of sPD: mitochondrial, autophagy and MT 
dysfunctions. 
 We further dissected the molecular mechanisms by which mitochondrial 
metabolism in sPD can affect MT-directed autophagic turnover that in turn regulates 
intracellular protein homeostasis. We demonstrated a role for the acetylation at Lys40 
of α-tubulin in the regulation of the autophagic activity and protein cargo clearance in 
cellular models harboring sPD subject mtDNA (sPD cybrids). In addition, we showed 
that specific inhibition of SIRT2 deacetylase activity rescues MT-dependent autophagic 
transport alterations previously observed in sPD cybrids, thus providing a novel insight 
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into how, molecularly, autophagic activity and inherent autophagic clearance are 
impacted by mitochondrial function (Chapter VI). 
 Collectively this thesis proposes a new conceptual foundation as to how 
mitochondrial dysfunction can affect intracellular protein quality control systems, the ER 
and the autophagy-lysosomal system, that in turn regulate cellular protein homeostasis 
(Figure VII.1).  
 
 
Figure VII.1. Intracellular pathways altered by mitochondrial dysfunction.  
Our rationale correlates intracellular events triggered by dysfunctional mitochondria, due to 
inherited mtDNA, with an accumulation of dysfunctional mitochondria and protein aggregates, 
leading to dopaminergic cell death. 
 
 
 While it may be difficult to decipher the individual contribution of the different 
molecular pathways affected by mitochondrial dysfunction, our findings reinforce the 
concept that restoration of Ca2+ homeostasis and of MT network function is indeed able 
to provide neuroprotection against PD-related dopaminergic neurodegeneration and 
may thus represent a potentially beneficial new therapeutic strategy for PD. 
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